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Abstract
MODELLING OF THE AVIAN IMMUNE SYSTEM FOR THE OPTIMIZATION OF
SPECIFIC ANTIBODY PRODUCTION
by
FREDY ANDRES OLARTE DUSSAN
Doctor of Philosophy in Electrical Engineering
UNIVERSIDAD NACIONAL DE COLOMBIA
Supervisors: Hernando Diaz Morales and Carlos Clavijo Ramirez
This thesis presents a methodology to optimize specific antibody production in poultry. Antibodies
(also known as immunoglobulins) are very valuable biotechnological tools used in research, diagnosis and
treatment. Usually, antibody production consist of inoculating an animal with a particular concentration
of an antigen several times and collecting antibodies in secondary responses (when greater amounts of
these proteins are produced). Mammals are frequently used for producing immunoglobulins that can be
obtained from animal’s blood. Recently, immunoglobulin production based on poultry has gained more
attention, since it is possible to obtain larger amounts of these molecules than those generated using
mammals. In addition, avian antibodies can be extracted from the egg’s yolk avoiding the bleeding
stage used for other animal models. However, to the best of the authors’ knowledge the inoculation
schedules are completely empirical. It means that days selected for administering boosters are chosen
only based on experience. From our point of view, an optimal design of an inoculation timetable can be
tackled as an engineering problem, in which the avian immune system is a dynamical system that can be
modeled and inoculations are extrinsic signals that can be manipulated. Consequently, this document
describes the design of a methodology to maximize specific antibody production in birds. It is based on
a mathematical model that allows to define an optimization problem for selecting days to administer
antigen boosters.
In the first stage of the project, a mathematical model was built to represent the dynamics of the
humoral response of birds. This model is comprised of six ordinary differential equations that account for
the main populations of the adaptive response: antigen, antigen presenting cells, T and B lymphocytes,
memory B cells and immunoglobulins. These populations and their interactions describe the dynamics
of antigen presentation, clonal expansion and immunological memory processes. The mathematical
model also includes 28 parameters. The values of these parameters were obtained from the specialized
literature in mammalian and avian immunology. However, some of them have not been reported and
adequate numerical values had to be found through simulation. Subsequently, the qualitative behavior of
the model was analyzed and it was established that simulated immune responses to antigen inoculation
were similar to experimental responses, reported in the literature. Finally, a sensitivity analysis showed
the effect of varying parameter values on the populations of the model. These results showed that
populations had low sensitivities to some of the values proposed by simulation.
Simultaneously to the model design, in vivo experiments were performed to characterize the immune
response of hens. T and B lymphocyte populations were quantified as well as antibody concentrations on
plasma and yolk. The immunoglobulin concentration were measured in milligrams per milliliter, instead
of the usual titer. Three experimental groups were utilized, each one composed of four hens, to test
the kinetics of the humoral response and to quantify the total specific Y immunoglobulin production.
The first group was a control one, while the second and third correspond to birds inoculated with two
different concentrations of the proteinic extract of Leishmania infantum. In this assay, an empirical
scheme for administering the inoculations was used. Therefore, the second immunization was applied
about a month after the first one in order to generate a secondary response. Some other features of the
immune response were also characterized during this stage. For instance, the relation between plasma
and yolk responses was quantified in terms of proportionality and delay. Also, the preimmune levels
were determined and compared to the secondary responses. Results of this part of the project allowed
to validate some of the assumptions used in the model.
In the third phase of the thesis, antibody measurements were used to tune some parameters of the
model in order to reproduce the response of the experimental groups. However, some conditions of
the parameter estimation process had to be established first. In particular, a careful selection of the
parameters to be estimated was necessary, since the size of the data set was lower than the number of
parameters included in the model. Using a Monte Carlo testing scheme, five parameters were selected for
the parameter estimation. This process consisted in choosing randomly a subset of five parameters, then
perform the estimation and quantify the error. Parameters that produced the lower errors were selected.
Parameter estimation is usually set as an optimization problem, in this case a least squares problem. For
solving this problem, several optimization algorithms can be employed. Therefore, the performance of
four of them was explored. Those algorithms are based on different strategies: two of them use gradient
and hessian information, another one belongs to the techniques known as direct search and the last one is
a heuristic algorithm. Utilizing the simplex Nelder-Mead algorithm for solving the least squares problem,
the model represented adequately the experimental data for the average response of each experimental
group and also for two individual hens. In an additional test, the estimation process was also carried
out for the observed data minus preimmune levels, and once again the adjustment was successful. The
sensitivity of the algorithm to the initial guesses of the model’s parameters was determined through
massive simulations varying those values by up to ±50%. The frequency distribution of the estimated
values showed that paramteter estimates were clustered around the nominal value, despite significant
changes in the initial guesses.
In the last part of this thesis, the models obtained from experimental data were used to analyze
the effect of varying the inoculation day on antibody production. The first set of experiments was
for the case of a single booster and it was carried out evaluating all possible combinations by massive
simulations. The minimum time required between immunizations to produce a secondary response was
established for the models adjusted to the data of two experimental groups. These simulations suggested
that it was possible to obtain a secondary response in a shorter time than that empirically proposed. As
another performance index, the total immunoglobulin produced in an interval of time was employed to
determine the optimal day to apply a booster. Results were very similar for both performance indexes
(first secondary response and total antibody production) suggesting nearby days. The robustness of the
solution was characterized by calculating the optimal day for the model tuned with all parameter values
found in the sensitivity analysis of the parameter estimation algorithm. Also, the effect of varying the
values of the parameters on the selected day was determined modifying up to 40% each parameter of the
model and determining the first day that a secondary response occured. These results showed that larger
variations were obtained when parameters related to the immunological memory changed significally.
Nevertheless, those values produced very delayed responses that did not match the experimental data.
The selection of inoculation days that maximize antibody production can be defined as a binary
constrained optimization problem. For any finite number of inoculations this problem can be solved
using a genetic algorithm approach. Therefore, this strategy was applied in the next step of the optimal
timetables assessment, the case of two boosters. Once again, models tuned with data of the experimental
groups were utilized to define optimal inoculation schedules. Results for the first booster day coincided
with those obtained in the analysis carried out by massive simulations. In addition, sensitivity analyses
were performed to determine the effect of varying parameter values on the selected days. The last case
studied was a mid-term production with a time horizon of five months. In this in silico experiment, a
comparison between an empirical timetable and an optimized schedule was carried out. Results showed
that independently of slight variations on parameter values, it would be possible to reduce the time
among boosters and increase the efficiency of the antibody production based on poultry.
Finally, using an in vivo experimentation, the predictions of the model were corroborated. A group
of hens was immunized following the optimal scheme determined for one booster. For this experiment,
immunoglobulin concentration in yolk was measured showing that the immune system elicited a sec-
ondary response with a reduction of 35% in the initial time utilized to administer the booster. This time
implies a significant reduction on the costs associated with bird’s keeping and feeding, thus improving
the production process.
Keywords: Antibodies, Mathematical modeling, Optimization, Nonlinear systems.
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Resumen
MODELAMIENTO DEL SISTEMA INMUNE AVIAR PARA LA OPTIMIZACIO´N DE LA
PRODUCCIO´N DE ANTICUERPOS ESPECI´FICOS
por
FREDY ANDRES OLARTE DUSSAN
Doctorado en Ingenier´ıa Ele´ctrica
UNIVERSIDAD NACIONAL DE COLOMBIA
Directores: Hernando Diaz Morales y Carlos Clavijo Ramirez
Esta tesis presenta una metodolog´ıa para optimizar la produccio´n de anticuerpos espec´ıficos en aves.
Anticuerpos (tambie´n conocidos como inmunoglobulinas) son herramientas biotecnolo´gicas de gran valor
usadas en investigacio´n, diagno´stico y tratamiento. Usualmente, la produccio´n de anticuerpos se realiza
por medio de la inoculacio´n en varias oportunidades de un animal con una concentracio´n particular
de un ant´ıgeno y la recoleccio´n de estas mole´culas en las respuestas secundarias (cuando se producen
grandes cantidades de estas prote´ınas). Frecuentemente, se usan mamı´feros para producir anticuerpos a
partir de la sangre de estos animales. Recientemente, la produccio´n de inmunoglobulinas utilizando aves
de corral ha generado mayor intere´s debido a que es posible obtener mayores concentraciones de estas
mole´culas que aquellas que se producen utilizando mamı´feros. Adicionalmente, los anticuerpos aviares
se pueden extraer de la yema de los huevos evitando la etapa de desangrado necesaria para obtener
anticuerpos en otros animales. Sin embargo, hasta donde llega nuestro conocimiento los esquemas de
inoculacio´n son completamente emp´ıricos. Esto significa que los d´ıas seleccionados para administrar
los refuerzos se escogen basados u´nicamente en la experiencia. Desde nuestro punto de vista, el disen˜o
de un cronograma de inoculacio´n o´ptimo se puede enfrentar como un problema de ingenier´ıa, en el
cual el sistema inmune del ave es un sistema dina´mico que se puede modelar y las inoculaciones son
sen˜ales extr´ınsecas que se pueden manipular. En conclusio´n, este documento describe el disen˜o de una
metodolog´ıa que maximiza la produccio´n de anticuerpos espec´ıficos en aves. Esta metodolog´ıa se basa
en un modelo matema´tico que permite definir un problema de optimizacio´n que selecciona los d´ıas de
aplicacio´n de los refuerzos.
En la primera etapa del proyecto, se construyo´ el modelo matema´tico que representa la dina´mica
de la respuesta inmune humoral en aves. Este modelo esta´ compuesto por seis ecuaciones diferenciales
ordinarias que consideran las principales poblaciones de la respuesta adaptativa: ant´ıgeno, ce´lulas pre-
sentadoras de ant´ıgeno, linfocitos T y B, ce´lulas B de memoria e inmunoglobulinas. Estas poblaciones
y sus interacciones describen la dina´mica de los procesos de presentacio´n de ant´ıgeno, expansio´n clonal
y memoria inmunolo´gica. El modelo matema´tico incluye adema´s 28 para´metros. Los valores de estos
para´metros fueron obtenidos de la literatura especializada en inmunolog´ıa en mamı´feros y aves. No ob-
stante, algunos de ellos no han sido reportados y por tanto se recurrio´ a la simulacio´n para obtener un
valor adecuado. Posteriormente, el comportamiento cualitativo del modelo fue analizado y se establecio´
que las repuestas inmunes simuladas eran similares a las respuestas experimentales reportadas en la
literatura. Finalmente, se caracterizo´ el efecto sobre las poblaciones del modelo de variaciones en los
valores de los para´metros a trave´s de un ana´lisis de sensibilidad. Estos resultados mostraron que las
poblaciones tienen bajas sensibilidades a algunos de los para´metros propuestos mediante simulacio´n.
Simulta´neamente al disen˜o del modelo, se realizaron algunos experimentos in vivo para caracterizar
la respuesta inmune de un grupo de gallinas. Se midieron las poblaciones de linfocitos T y B as´ı como
las concentraciones de anticuerpos en plasma y yema. La concentracio´n de inmunoglobulinas se midio´
en miligramos por mililitro, en lugar del t´ıtulo. Tres grupos experimentales se emplearon, cada uno
compuesto de cuatro gallinas, para evaluar la cine´tica de la respuesta humoral y cuantificar la produccio´n
total inmunoglobulinas isotipo Y. El primer grupo fue de control, mientras que el segundo y tercero
fueron inoculados con dos concentraciones diferentes del ant´ıgeno: extracto prote´ico de Leishmania
infantum. En este ensayo, se utilizo´ un esquema emp´ırico para la aplicacio´n de los refuerzos. Por
tanto, la segunda inmunizacio´n se aplico´ un mes despue´s de la primera esperando generar una respuesta
secundaria. Otras caracter´ısticas de la respuesta inmune fueron determinadas durante esta etapa. Por
ejemplo, se cuantifico´ la relacio´n entre las respuestas en plasma y yema. Asimismo, se detectaron los
niveles preinmunes y se compararon con los picos de la respuesta secundaria. Los resultados de esta
parte del proyecto permitieron validar algunas de las suposiciones usadas en el modelo.
En la tercera fase de esta tesis, las mediciones de anticuerpos se utilizaron para sintonizar algunos
para´metros del modelo buscando reproducir la respuesta de los grupos experimentales. Sin embargo,
fue necesario definir primero algunas condiciones del proceso de estimacio´n de para´metros. En par-
ticular, se requirio´ de una cuidadosa seleccio´n de los para´metros incluidos en la estimacio´n debido a
que el taman˜o del conjunto de datos es menor que el nu´mero total de para´metros del modelo. Final-
mente, se seleccionaron cinco para´metros utilizando un esquema de tipo Monte Carlo. Este proceso
consistio´ en seleccionar aleatoriamente un subconjunto de cinco, realizar la estimacio´n y cuantificar el
error de ajuste. Los para´metros que produjeron los menores errores se seleccionaron. Usualmente, el
procedimiento de estimacio´n de para´metros se define como un problema de optimizacio´n, en este caso
un problema de mı´nimos cuadrados. Para solucionar este tipo de problema, se emplean varios algorit-
mos de optimizacio´n. En nuestro caso, evaluamos el desempen˜o de cuatro. Estos algoritmos se basan
en diferentes estrategias: dos de ellos usan informacio´n de gradientes y hessianas, otro pertenece a las
te´cnicas conocidas como de bu´squeda directa y el u´ltimo es un algoritmo heur´ıstico. El modelo repre-
sento´ adecuadamente los datos experimentales cuando la estimacio´n se realizaba utilizando el algoritmo
simplex Nelder-Mead. En una prueba adicional, la estimacio´n de para´metros se realizo´ usando los datos
menos el nivel preinmune y nuevamente el ajuste fue exitoso. La sensibilidad del algoritmo a los valores
in´ıciales de los para´metros se determino´ por medio de la realizacio´n de simulaciones masivas con varia-
ciones de hasta ±50%. La distribucio´n de frecuencias de los valores estimados mostro´ que los resultados
se localizaban alrededor del valor nominal a pesar del cambo considerable en los valores in´ıciales.
En la u´ltima parte de esta tesis, se utilizaron los modelos sintonizados con los datos experimentales
para analizar el efecto de la variacio´n en el d´ıa de la inoculacio´n en la produccio´n de anticuerpos. El
primer conjunto de experimentos fue para el caso de un solo refuerzo y se realizo´ evaluando todas
las posibles combinaciones por medio de simulaciones masivas. El tiempo mı´nimo requerido entre
inmunizaciones que produce una respuesta secundaria se determino´ para los modelos sintonizados con
los datos de los dos grupos experimentales. Estas simulaciones sugirieron que es posible obtener una
respuesta secundaria en un tiempo ma´s corto que el propuesto emp´ıricamente. Otro ı´ndice de desempen˜o
utilizado fue la concentracio´n total de inmunoglobulinas producida en un intervalo de tiempo definido.
La robustez de la solucio´n se caracterizo´ calculando el d´ıa o´ptimo para el modelo sintonizado en todos los
valores de los para´metros hallados en el ana´lisis de sensibilidad de la etapa de estimacio´n de para´metros.
Adicionalmente, se evaluo´ el efecto de variar los valores de cada para´metro del modelo hasta en un 40%.
Estos resultados mostraron que se obtuvieron variaciones significativas cuando se modificaban los valores
de los para´metros relacionados con la memoria inmunolo´gica. Sin embargo, estos valores produc´ıan
respuestas muy retardadas en el tiempo que no correspond´ıan a las observaciones experimentales.
La seleccio´n de los d´ıas de inoculacio´n que maximizan la produccio´n de anticuerpos se puede definir
como un problema de optimizacio´n binaria con restricciones. Para cualquier nu´mero finito de inocula-
ciones este problema se pude resolver usando un algoritmo gene´tico. Por tanto, se utilizo´ esta estrategia
para analizar el caso de dos refuerzos. Una vez ma´s, los modelos sintonizados con los datos de los
grupos experimentales fueron utilizados para definir los cronogramas de inoculacio´n. Posteriormente, se
llevaron a cabo los mismos ana´lisis con dos y cuatro refuerzos. Finalmente, usando experimentacio´n in
vivo se corroboraron las predicciones del modelo. Se inmunizo´ un grupo de gallinas siguiendo el esquema
disen˜ado para un refuerzo. Para este experimento, se midio´ la concentracio´n de inmunoglobulinas en
yema y se encontro´ una respuesta secundaria con una reduccio´n del 35% en el tiempo utilizado para
aplicar el refuerzo. Este tiempo representa una reduccio´n significativa en los costos asociados con el
mantenimiento de las aves mejorando el proceso de produccio´n de anticuerpos.
Palabras clave: Anticuerpos, Modelos matema´ticos, Optimizacio´n, Sistemas no lineales.
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Chapter 1
Introduction
All species, from bacteria to mammals, face attacks by organisms trying to take advantage of their
resources to increase their chance to survive [82]. When these foreign agents are not controlled they
can produce diseases to the beings under attack. Presumably in response to these evolutionary pres-
sures, the immune system evolved to protect individuals against several threats [2]. Microorganisms
causing diseases (pathogens) in mammals, can be grouped into four categories: bacteria, fungi, virus
and parasites [61]. Different pathogens elicit immune system responses involving many components of
the system that work in a coordinate way in order to control the invasion [1, 8, 30, 64, 104].
The immune system is composed of the set of cells, molecules and organs involved in the recognition
and control of foreign agents. In mammals (and other vertebrates) the immune system by convention
is often divided in: innate (non specific) and adaptive (specific) [1, 61]. This division is based on the
mechanism used by cells and molecules to recognize the pathogen. The innate system identifies a broad
range of microorganisms that share features on their surfaces. The adaptive system, on the other hand,
recognizes singly every antigen (foreign agent that initiates immune response) [1, 30, 61]. The specific
recognition of the adaptive system lies in a set of millions of different specialized cellular membrane
receptors, which are capable of distinguishing almost all antigens in nature. A remarkable feature of the
adaptive system is their ability to remember antigens previously identified, and in the case of reinfection
the immune system response is stronger and faster (secondary response) [61, 93, 114].
In this sense, one of the most important molecule in the adaptive response is the immunoglobulin
or antibody [80, 72]. This protein is produced by immune system cells and it has the ability to bind to
the antigen surface with great specificity depending upon its three dimensional complementarity with
the antigen’s molecular shape. Additionally, the antibody molecule has a constant region recognized as
a signal by cells and molecules for pathogen destruction [1, 30, 61]. These features make the antibodies
valuable tools in biomedical and biotechnological applications because variable regions bind to interest
proteins and the constant region function as a signal for measurements [10, 80].
Antibody production for the applications mentioned above is commonly induced by inoculation of
a foreign agent into the vertebrate animal, usually a mouse or a rabbit, triggering an immune system
response [27, 112]. Subsequently, the antibodies are extracted by biochemical techniques from the
animal’s blood, which implies bleeding or sacrificing the animal. Commonly, antibody extraction is
carried out at secondary responses when the amount of circulating antibodies is maximum [55]. However,
criteria for booster time selection is never explicit.
Recently, antibody production in chicken and other poultry has increased addressing ethical issues
related with animal welfare, since is not necessary to bleed the animal given the significant amount
of antibodies contained in the eggs [27, 53, 60, 112]. This technique has several advantages over the
traditional one: increase antibody production, broad application range and reduce animal stress [39,
101]. The number of recent publications of poultry based antibody production reflects the increasing
interest in this field. Researchers have explored several subjects such as: birds’ immunization procedures,
variety of antigens, adjuvants (immune response enhancer substances), combined antigen and adjuvant
concentrations, birds’ handling, immunoglobulins’ characteristics and use of DNA vaccines [10, 27, 38,
39, 53, 56, 101, 112]. Nevertheless, a distinctive feature in those experiments is that booster times are
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absolutely empirical. Therefore, an analytical tool for determining the effects of booster time variations
would be very valuable.
Mathematical models have been proposed in different biological subjects in order to explain complex
behaviors among populations, regardless the kind of organisms, cells or molecules in the model [84, 86,
102]. One of the most successful fields of mathematical modeling is theoretical immunology, which main
objective is to construct mathematical or computational models of the immune system processes [3, 13,
42, 93]. Many models are based on ordinary differential equations (ODE) that represent population’s
change as a function of time. This kind of model has been used to describe interactions between
adaptive immune cells [4, 12, 18, 20]. Particularly, a set of models depict the dynamics of antibodies
and the adaptive immune cells [41, 49, 68, 70, 83]. Furthermore, an important number of reports have
presented models of the immune response against parasitic (Malaria [77] and Leishmaniasis [22]) and
viral (Hepatitis C [6] or HIV/AIDS [34, 86, 92]) diseases.
It is important to emphasize that biological systems are complex systems because of features such
as: a huge number of interacting components, time varying parameters, uncertainty and a limited
knowledge about the underlying mechanisms that explain the behavior of the biological processes. In
addition, those systems have non linear interactions, i.e. 1) the stimulus magnitude may change the
overall response and 2) the response to several stimuli is not equal to the addition of each individual
response. Therefore, the mathematical concepts and tools developed to study this type of systems
are necessary [7, 84, 92, 93]. Furthermore, a typical issue in those models is the lack of accuracy in
equation’s parameter values [7]. Usually, the parameter values are not accurate enough or their variation
is significantly large for the set of measurements available [3]. Parameter estimation methodologies have
been proposed in order to find reliable values from experimental data [96]. Some examples of parameter
estimation in biological processes have been published [11, 116, 117].
Here three fields of study have been treated: immune system, antibody production and mathematical
models for biological processes. The last subject involved in this proposal is automatic control theory.
This field of engineering studies ways to change the dynamic performance of a given system using the
external signals that can be manipulated in some way. Controller design is the procedure of constructing
a system which takes measurements of a system response and transforms them into output regulatory
signals, yielding an expected performance [5]. The controller design has been used to tackle some
immunology problems [66, 109]. In particular, it has been used to design more effective treatments
against diseases like HIV/AIDS [28, 62]. Robust control theory deals with the problem of achieving
expected performances under mathematical uncertainty in the model or its parameters [43, 118]. Robust
control has been used to design treatments against HIV involving uncertainty related to variations among
patients or non modeled dynamics [88, 119]. Non linear robust control theory was used to propose a
treatment against a general pathogen under uncertainty [23].
This thesis describes a methodology for optimizing antibody production in poultry. This methodol-
ogy is based on a mathematical model for the avian immune response that only includes the main cells
and molecules of the humoral response. The set of parameter values used for the model is obtained from
the specialized literature or by simulation producing a typical immune response. Later, the qualitative
behavior of the model is analyzed.
In order to validate and refine the mathematical model, a set of experiments are carried out to
characterize the immune response of twelve hens. In these assays, immunoglobulin concentration in yolk
and peripheral blood as well as T and B lymphocytes are measured for an interval of three months. All
this information is utilized to determine adjusted values for some parameters by an estimation process.
Lastly, the model performance when varying the inoculation day is assessed. By massive simulations,
the optimal day for applying a booster is calculated. In a second experiment, using eight hens, the
model prediction is confirmed. The methodology for optimizing the antibody production is generalized
employing a genetic algorithm to solve the constrained nonlinear binary programming problem that
represents day selection for booster administration in birds.
2
1.1 Immune System
The immune system can be defined as the set of cells, proteins, tissues and organs that protect individuals
against foreign agents invasion or cancerous cells. In mammals, this system consists of two parts: the
innate immune system (non specific) and the adaptive immune system (specific) [1, 30, 48, 61, 64].
Innate Immune System
The innate immune system is the subset of cells and molecules of the immune system, that responds im-
mediately after a foreign agent tries to invade the individuals. It does not recognize a specific pathogen’s
characteristic, but it recognizes a broad range of pathogens (microorganisms causing diseases such as:
bacteria, virus, fungi and parasites). The innate system includes mechanical barriers such as the skin or
mucose tissues, chemicals like fatty acids on the skin and microbiological as the living bacteria in guts
[1, 61].
The innate immune system detects the pathogen by recognizing shared molecular patterns or chem-
ical components on their cover surfaces. Those patterns have been preserved through the evolution.
The innate system is made up by complement system’s proteins and the following cell populations:
neutrophils, granulocytes, mast cells, macrophages, dendritic cells and natural killer cells [30, 61].
The initial response of innate immune system is followed by the action of phagocytic cells (neu-
trophils, dendritic cells and macrophages) which ingest and destroy pathogens after recognition through
a cluster of membrane receptors. These cells release chemical signals (citokines and chemokines) that
attract more macrophages, neutrophils and dendritic cells triggering inflammatory processes [104]. The
inflammatory response is mostly caused by granulocytes and mast cells. The inflammation increases
the flow to the affected area of immune cells and molecules and isolates the area under attack [1, 48].
Dendritic cells take part in the innate response in a very similar way. These cells ingest extracellular
material, circulating in blood and lymph or in sites of infection. Then they break antigenic proteins in
small fragments and present them to adaptive immune cells. Macrophages and dendritic cells present
peptides (small chains of amino acids) to adaptive immune cells through molecules known as Major
Histocompatibility Complex (MHC) [1, 30, 48, 61].
Natural killer cells derive from the same line of adaptive immune cells, but they are part of the
innate system since they do not recognize the invaders in a specific way. All natural killer cells have
the same set of receptors and are especially design to protect the individual from viral attacks. Some
viruses try to fool the immune recognition blocking the MHC expression. Natural killer cells check if
the cell is expressing the correct MHC molecules on its membrane, otherwise they induce cellular death
(apoptosis) to the target cells [8].
In addition to the barriers and cells mentioned above, a set of proteins protect the organism against
pathogen’s invasion. These proteins, known as the complement system, are capable of triggering a se-
quence of reactions. Basically, those proteins are cleaved and the resulting segments bind to other pro-
teins. This process begins when some complement’s proteins bind to the pathogen surface by themselves
or with the help of antibodies (proteins produced by adaptive immune cells). Complement molecules
finish their job recruiting more phagocytes and inflammation cells, marking the pathogens for more
efficient degradation or drilling holes into the pathogens’ membrane [1, 48, 61].
Adaptive Immune System
The adaptive immune system has the ability to recognize almost any foreign agent. Because each antigen
has a three dimensional molecular structure or shape, and the immune system produces a very large set
of cells that individually have a receptor capable of recognizing every antigen’s shape. By definition,
antigen is any protein, DNA, RNA, polysaccharides or any other organic or inorganic substance that
produces a specific immune response [63].
The recognizing ability of the adaptive immune system is due to the fact that its cells can produce
a huge membrane receptor diversity. Each cell expresses just one and distinct type of receptor that
recognizes a very few antigen set [61, 80]. The diversity of receptors in humans is estimated at least in
108 [61].
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There are two types of adaptive immune cells: B lymphocytes produced in the bone marrow and T
lymphocytes produced in the thymus. The first ones synthesize antibodies and the second ones regulate
the immune response and detect intracellular pathogens [1, 48, 86, 93].
T cells identify and destroy the pathogens lying inside the cells, and conduct the adaptive response.
The underlying mechanism in intracellular recognition is based on every cell’s ability of presenting
peptides in MHC molecules. Those peptides may belong to the own cell or proteins destroyed in vesicles
(small compartments limited by membranes where a cell isolates and destroys extra- and intracellular
material). T lymphocytes have a receptor which binds to MHC and can distinguish between self and
non self peptides. The immune response produced by T cells is called cell mediated response [1, 30, 43].
T lymphocytes are divided in two kinds, ones which carry CD4 co-receptor or helper and ones which
carry CD8 co-receptor or cytotoxic. Each cell population recognizes one of the two types of vertebrate
MHC molecules expressed on membranes. T helper cells recognize MHC-II complex which exposes
peptides from the vesicles, whereas cytotoxic cell receptors bind to MHC-I which presents peptides from
proteins synthesized by the cell. There are two classes of T helper cells: Th1 and Th2. Th1 cells are
important in macrophage activation for pathogen destruction inside of those cells. On the other hand,
Th2 cells deliver a signal necessary for clonal expansion of B cells [1, 48, 61]
Antigens are processed and presented by Antigen Presenting Cells APC (macrophages, dendritic
cells or B cells) to T lymphocytes, which duplicate after recognition of the presented foreign peptide.
During clonal expansion CD8 T cells divide as many as 15 to 20 times increasing their number 50
thousand-fold. When the infection ends the 90-95% of those cells die (by apoptosis). Usually, this
happens around ten days after pathogen elimination, and the remain cells survive as memory cells [114].
Citotoxic cells induce cellular death by similar mechanisim that NK cells [48, 114].
All mentioned T lymphocytes bear a receptor made of a molecular αβ complex. A different type of
cell with γδ complex receptors can also be found in the vertebrate immune system, and their function
is thought to be related to a narrow type of pathogens [48, 61].
On the other hand, B cells detect antigens that are in the extracellular milieu or circulating in
blood or lymph using their membrane receptors. Antibodies are secreted versions of B cells membrane
receptors. When B cells have recognized their specific antigen, as well as a co-stimulatory signal released
by Th2 cells, they differentiate into plasma cells in a clonal expansion process that produce 1000 identical
daughter cells. Plasma cells synthesize and release antibodies at high rates. Antibodies participate in
organism defense in three ways: neutralizing toxins, marking pathogens for more efficient macrophage
recognition (opsonization) and activating complement molecules [3, 13, 20, 30, 41, 48, 61]. The immunity
due to B cells is called humoral immunity.
Antibodies or immunoglobulins are “Y” shaped proteins, with a constant region and two identical
hyper variables regions, see figure 1.1. In mammals, there are five types of immunoglobulins depending
upon their constant region, known as isotypes (IgA, IgM, IgD, IgE, and IgG) having each one a different
function. Basically, the antibody binds to the antigen using the variable region and it delivers a signal to
proteins and cells through their constant region [55, 80, 72]. One antigen can be recognized by different
surfaces of their three dimensional shape. A particular antigen segment which binds to the antibody is
called epitope [87], as shown in figure 1.2.
The receptor diversity in B and T lymphocytes is produced through an enzymatic process that
joins certain genetic segments randomly. This process is called genetic rearregment. The receptor
synthesis begins with a constant segment, which defines the isotype. Subsequently some diversity and
variable segments selected among many possible ones are joined to the first one. Additionally, a random
nucleotide insertion between segments increases variability. Another process, known as hypersomatic
mutation, occurs only in B cells when they are activated and produce modifications in the sequence
that codes for the immunoglobulin. Cells with mutations that improve the recognizing process thrive
and those which reduce it perish. In this way antibodies’ specificity is improved through the time by
clonal selection [61, 70, 83].
A very important feature of the adaptive immune system is the ability to remember those antigens
that it has faced. B and T cells generated in response to the antigen are divided into two groups: one
that fights against the invader and another that becomes memory cells. The latter have a large life span
and can become effector cells very quickly [1], and keep stable concentrations through individual’s life
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Table 1.1 presents a list of cells and molecular populations that participate on innate, humoral and
cell mediated immune response and their functions. Immune response stages are sketched in figure 1.3.
Initially, the antigen is inoculated (week one), and approximately one week later specific antibodies
concentration increases, reaching a maximum around the third week. At this phase, antigen has been
processed by APCs and presented to naive T cells, with the consequent activation of those cells. Out
of the whole repertoire of T and B lymphocytes just a few ones have a receptor complementary to this
antigen. When these cells bind to the antigen they are activated and begin the clonal expansion (clonal
selection theory). After that, the pathogen is eliminated and all effector cells (plasma and citotoxic) die,
remaining a reduced population of memory cells. At week seven (see figure) two antigens are inoculated,
and each one produces an immune response. The new antigen has a behavior similar to the previous
one (primary response), while the effect of memory cells produces a stronger and faster response for the
first antigen inoculated (secondary response).
A humoral immune response diagram is summarized in figure 1.4. Citotoxic cells, natural killer cells,
granulocytes and complement molecules are not considered in this process because they do not have a
direct influence in antibody production. APCs are macrophages or dendritic cells that have ingested
the antigen. These cells phagocyte and break down the antigen in little fragments for presentation to
T helper cells. B lymphocytes recognize the antigens’ epitopes and after receiving a signal (citokine)
delivered by Th2 cells they mature to plasma cells and produce immunoglobulins. Th2 M and B M
symbolize memory cells of each population. Double lines represent interactions between populations and
single lines indicate change from one state to another (activation). The double dashed lines between B
and Th2 lymphocytes denote an important fact: B cells are also presenting cells but when the response
begins their effect is almost negligible [61].
A very different theory of the immune system behavior was proposed by Jerne [63], and it is called
anti-idyotipic networks. According to this model antibodies are also antigenic elements which means
that they produce immunological response and produce antibodies that recognize the variable zones
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Population Innate Humoral Cell Funcio´n
Neutrophil x · · Phagocytosis
Mast Cells x · · Inflammation
Macrophages x · x Phagocytosis y presentation
Dendritic x · x Presentation
Granulocyte x · · Inflammation
NK (Natural Killer) x · · Cell infected death
T helper (Th1) x · x Cytotoxic activation
T helper (Th2) · x · B cell activation
T cytotoxic · · x Cell infected death
B Cells · x x Antibody production
Antibodies x x · Antigen marking
Complement x · · Pathogen membrane attack
Table 1.1: Immune system molecules and cell populations
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Figure 1.3: Kinetics of the humoral response [1]
(anti-antibodies). In fact, it does not generate only one antibody but a set of anti-antibodies due to
several variable sites, idiotopes. However, the anti-antibody has idiotopes too, so the immune system
produces a second group of antibodies against the first one. In this model exogenous antigens generate
a perturbation of the antibody and that anti-antibody network.
Avian Immune System
An important research effort has been carried out for discovering the structure and functioning of mam-
malian immune system and is nowadays one of the best comprehended. Nevertheless, many mechanisms
beneath some responses are not completely understood [8, 48, 104, 114]. The current knowledge about
avian immune system, and in particular poultry’s, is more limited but with a lot of semblances to
mammalian system [90, 101, 105]. In fact, the immune system has the same constitutive elements in
all jawed vertebrates [29]. Particularly, first experiments on graft rejection was made on chickens and
the experimentation with Fabricius bursa gave signs of two kinds of adaptive immunity, cellular and
humoral.
More than 30 years ago, it was known that the chicken immune system is composed of innate
response, cellular response and humoral response similar to mammals [54]. However, some differences
at molecular and organismic levels are clearly established. The most significant is the existence of the
Fabricius Bursa in birds, where B cells diversity is produced through a mechanism different from that
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Figure 1.4: Humoral Response Diagram
the used by mammals, called genetic conversion. Avian immunoglobulins just have three isotypes: IgM,
IgA and IgGs (or IgYs in yolk) [40].
The innate response involves macrophages, dendritic cells, neutrophils, granulocytes, NK and com-
plement proteins. These cells and molecules promptly trigger a response against a foreign agent invasion.
The behavior of these cells is very similar to the mammalian case, though a different set of molecu-
lar signals(citokines and chemokines) [95, 105]. In this field chickens were also important. The first
interferon (citokine found specially in virus infections) was detected in chicken embryo. However, the
number of identified avian citokines is smaller than mammals [33, 37, 103]. On the other hand, NK cells
have the same function recognizing low MHC expressing cells.
The cellular response is composed of T helper and citotoxic T cells. In turn T helper cells are divided
in two kinds Th1 and Th2, with macrophage activation for the first one and B cell activation for the
second one, among their functions. Moreover, a larger population than human bears a γδ receptor. T
helper cells are characterized for carrying the CD4+ coreceptor and citotoxic cells the CD8+ exactly as
mammals [37]. The antigen presentation by MHC molecules work in the same way as the mammalian
molecules. Additionally, the same polymorphism (variation among individuals of the same species) is
presented in avian MHCs [33]. An outstanding fact in chicken immune system is the size of the genetic
region that codes for MHC molecules. It contains only 19 genes, 20-fold smaller than the human MHC
[67].
The humoral response, a response produced by B cells, initiates after the membrane receptor recog-
nizes an antigen epitope and the cell produces antibodies. B cells activation and antibodies production
is induced in the same fashion as described for mammals. Remarkably, avian immune system can pro-
duce large amounts and more specific antibodies when a mammalian antigen is inoculated given the
philogenetic distance between two species [103].
This section presented some of the basic components of the innate, humoral and cellular responses
in mammals and birds. Particularly, how B cells produce antibodies, the main molecule of humoral
response. Next section deals with techniques used for producing this molecule using poultry.
1.2 Yolk Immunoglobulin (IgYs) Production
Immunoglobulins or antibodies are proteins produced by B cells of the humoral immune system. An-
tibodies block toxins, like those contained in snake’s and insect’s poisons. They activate complement
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proteins and facilitate antigen destruction [1, 48, 61]. In addition, immunoglobulins are research tools
widely used in cell biology and medicine. Antibodies can be used to mark proteins or antigens, detect,
analyze and purify proteins [55, 72]. Furthermore, antibodies have been used as a treatment for viral
and bacterial infections [10].
Presently a fast antibodies production, in non invasive and cost effective way is acknowledged [27].
Avian immunoglobulins, particularly poultry’s, fulfill these conditions. It is possible to produce large
amounts of antibodies from hens’ eggs, in a scale of 100 to 250 mg per egg. A hen is able to lay up
to 300 eggs per year [51, 52, 60, 101]. Antibodies production using poultry has several advantages in
regard to mammalian generation. For instance, animal bleeding is not necessary since antibodies are
contained in the eggs and can be easily extracted from them [112]. Owing to philogenetic distance, IgYs
do not activate the mammalian complement system and they withstand destruction in the digest tract
when taking orally. While mammals do not transfer their immunity before birth, poultry concentrate
antibodies in their yolk [10, 27, 53]. In transovaric transit of IgYs, antibodies are moved from the blood
to yolk egg’s and levels of IgYs inside the eggs taking around a week to reach the blood levels [56]. In
addition, the IgY molecular conformation is different than the mammalian IgG. In fact, it is considered
that the former is an evolutionary ancestor of the latter, with an IgY heavier than IgG given additional
constant segment [27].
Meanwhile, poultry industry has been very interested in characterize egg production and define
different variables that take part in laying process. Grossman et al. have suggested models to predict
the amount of eggs that a hen and a flock can lay in a year [51, 52]. In those works one year data were
used for curve tunning, and after a year typical values of laying were five eggs per week. Ethard et al.
showed that avian inoculation does not affect eggs’ number or weight [38].
In literature, there are many experiments characterizing the inoculation process and the immunoglob-
ulin extraction in birds. Ethard et al. carried out several tests in 972 laying chickens and 10692 eggs,
and the response in terms of IgYs was measured when some variables change such as: (1) kind of anti-
gen, (2) concentration of inoculated antigen, (3) way and location of antigen application and (4) kind of
adjuvant used [38]. Reviews of these procedures for poultry and wild birds are presented in [101, 106].
Kinetics of the primary response has also been characterized for different chicken lines and different
antigens. Time and concentration of the maximum level of antibodies in blood were studied by Weigend
et al. [113]. Correlation between serum and yolk immunoglobulin concentrations for some antigens and
adjuvants was measured in poultry as well [39].
Notwithstanding none of those papers or reviews give importance to booster schedules. There is not
a clear argument that defines the inoculation timetable. Perhaps, the reason is based only on experience
or typical times of immune response, even though immune response depends upon the antigen inoculated
[113].
The previous section described features of antibody production from eggs’ yolk using poultry. The
importance of these molecules in research, detection and disease treatment was outlined. In addition,
some of the advantages of the immunoglobulin production in birds was itemized and compared with
production in mammals. Some works in the field of IgY production were mentioned and the variable
modified in those experiments. Events that trigger the generation of antibodies by the immune system
can be represented using a mathematical model. The next section shows one type of immune system
models and how these models can be used for analyzing the immune response.
1.3 Immune System Models
In 1202 Fibonacci introduced the first problem of mathematical biology, with an example of the pop-
ulation increase from a rabbit couple [84]. In 1927, Kermack and McKendrick settled the basis for
theoretical immunology [86]. In world war II, Volterra wrote the differential equations that describe
dynamics between two species, prey and predator. These equations begun the mathematical ecology
[102].
An important number of works in immune modeling are presented in theoretical biology literature,
they are based on clonal selection theory and antiidiotypic network theory [93]. Many models are
described with a set of ordinary differential equations (ODE), delay differential equations (DDE) or
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partial differential equations (PDE) [3]. Some others have built models for activation of antigen antibody
complexes using cellular automaton (grid with change rules between adjacent cells) [70]. Most of these
models are non linear and have a lot of uncertainty in model and parameters [3, 109]. Other authors
have proposed algorithms based on immune system behavior to solve engineering problems [31].
An ODE describes the rate of change of a population as a function of time and for theoretical
immunology those populations represent cells, pathogens, antigens or another molecules. Models are
created as a population balance, the right side of the equation is the difference between in and out
rates to the group. This kind of models is known as compartmental, because each population can be
represented as a compartment where some elements go in and some go out at specific rates, see figure 1.5.
On this graph, the change in a population is represented as function of rates of birth, cell differentiation,
death and infection. The movement to other compartment is also sketched (for instance an infection).
The second compartment can decrease owing to death or elimination as a result of the immune response.
The equations of each compartment are written as follows [13, 93]:
{
Population
Change
}
= {Birth Rate } ±
{
Infection
Rate
}
±
{
Differentiation
Rate
}
−
{
Death
Rate
}
In addition, some functions are developed to describe processes depending on population size. To
know population current size (or at any time) it is necessary to find the ODE’s solution. Usually, it is
not available and the equation is solved numerically using a computer, in order to observe the model’s
behavior [7]. Perelson presents a review of some of those works [93]. De Boer make a self-explanatory
introduction to the statement and analysis of those models [13].
Immunology models describe the time variation of the following cellular and molecular populations:
antigens, antibodies, T cells, B cells and antigen presenting cells. The differential equations that model
the immune system behavior, describe processes as: cellular production, cellular activation, clonal
expansion, infection and death [4, 13, 14, 68, 92, 93].
The simplest case is a population with birth and death rates per capita:
dN
dt
= (b− d)N (1.1)
where b is birth rate and d is death rate. These parameters are strictly positive with t−1 (one over
time) as unit. The symbol dN
dt
represents the population derivative as a function of time. The solution
of the last equation defines the population N(t) size for all time t. In this simple case the solution is:
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N(t) = N(0)e(b−d)t (1.2)
The equation (1.2) represents a function that grows or decreases exponentially in accordance with
the difference between birth and death rates from an initial population N(0). This example consideres
just one population and a very simple way of production and death, therefore is possible to obtain an
analytic solution for the equation (1.1). But this can not be done for the majority of models and just
the numerical solution is available [13].
A very common fact in biological processes is that birth and death rates depend on the population
size. A first approximation would be a linear relation f(N) = b(1 − N/k) for birth rate and f(N) =
d(1 +N/k) for the death rate. It means, a bigger population produces a smaller birth rate and a larger
death rate. The differential equation can be rewritten as:
dN
dt
= [b (1−N/k)− d]N (1.3)
dN
dt
= [b− d (1 +N/k)]N (1.4)
The parameter k has individuals as dimension, when N = k birth rate is equal to zero and the death
rate doubles. The k parameter is known as carry capacity [13, 20].
In this way, more conditions can be added to equations to mimic the behavior of the system, like
population boundaries (saturations) or activation functions (logarithmic or gausianan bells) [89, 93].
If the dynamic does not produce a response immediately when an entrance function is applied so the
system has a delay and a DDE is used [3, 11]. A third sort of equation, PDE is used when the system
change in space and time (for example cancer models) [44].
Some hypothesis about phenomena and interactions among immune system cells and molecules have
been approached with a theoretical framework. Some of those contributions are enumerated below:
Carneiro et al. [20] describe interactions between T cells, B lymphocytes, antibodies and antigen
for plasma cell maturation. Lymphocytes with different receptors for different antigens are sorted in
several compartments and their interactions are modeled using non linear functions. The difficulty of
having reliable data for functions parameters is emphasized. As a particular case the model is simplified
to just one antigen, and a mechanism for regulating the generation of T cells based on Igs concentration
is proposed. This model does not include the effect of introducing an antigen; it just explores among
different lymphocytes interactions and crossed reactions for antibody production against T cell receptors.
Cellular doubling are restricted, in part, by the telomeres size (repetitive sequences of nucleic acids
that are located at the chromosomes’ ends). De Boer [14] proposes a dynamic model for telomere length
reduction in naive T cells and memory T cells. The model is suggested as a differential equation set for
different telomere length compartments.
Borghans et al. [17] propose a model for dynamics of three T lymphocyte populations, that take part
in autoimmune diseases. The authors analyze how the treatments for this kind of illness using T cells
vaccination (TCV) could lead to the system to an equilibrium point. Two outcomes are possible, one
where autoimmune disease overwhelm the immune system and other where the vaccine has protected
the organism.
The immune system regulation (homestasis) also has made part of the dynamic system analysis. For
Borghans et al. the adaptive immune system keeps its total population due to a competition between T
and B cells for stimulatory and survival signals [18]. Therefore, this model describes the dependence of
lymphocyte birth and death rates in terms of population density. In addition interactions among APCs
and T cells are described through an activation function.
An important issue of biological models is the joint of experimental data with the proposed equations.
De Boer suggests a simple model of a first order set of ODEs for cellular division and death rates. Then,
he estimates those rates based on intracellular marking measurements [15]. Using telomere reduction
measurements and counting circular DNA segments released by naive T cell when they mature at
thymus, the author described the dynamics of naive T CD4+ lymphocytes and memory T cells [12].
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Bonhoeffer et al. estimated the fitness of two viral strains of HIV, in which one of them have mutated.
They used viral load data and an ODE based model [16].
Germinal centers (places where B cells mature and increase in number) dynamics are modeled using
a set of differential equations that describe the change of lymphocyte population as a function of time
inside the center [68]. There, the process of B cell maturation inside the secondary lymphoid organs is
modeled in detail.
Flores et al. [41] suggest an idiotypic network based model. It evolves to generate more affinity
to a specific antigen modeled as a weight. In this work B cell clones are sketched in a graph and
their weights are updated, defining antibodies binding force. Once again the compartmental model is
expressed as different B lymphocyte populations with different membrane receptors. This model just
defines dynamics between T and B cells and it does not represent the effect of the antigen or antibodies.
Additionally, the affinity among clones is defined in a matrix that model the evolution of the system
every time that antigens are presented.
Oprea and Perelson propose a detailed primary response model in spleen and describe the dynamics
of antibodies production [89]. In this work, it is evaluated whether the clonal expansion remains without
the presence of T lymphocytes or a constant citokine delivering is necessary. The model has as variables:
dendritic cells, B cells, T lymphocytes and antibodies. It is assumed that enough APC cells are available
when the pathogen tries to invade, and the antigen has several days of life span. In this model, the effect
of antigen presentation by B cells to naive T cell is negligible given that this situation is very unlikely.
After B cell population has raised, it is going to cooperate with T cell activation as well as APCs. The
model includes the possibility that activated T cells go back to non active compartment for negative
regulation.
The proteasome is a cell’s subsystem that degrade useless proteins. This is a macromolecule complex
reaching proteases that breaks down specially labeled proteins destinate for degradation in to peptides.
Luciani et al. simulate peptides dynamics inside the proteasome according to its length or aminoacids
number, and how this length changes in time when crosses the proteasome [73].
The relationship between immune system and many diseases has been subject of intense scrutiny.
Many models have been created to describe infectious diseases like: Hepatitis C [6], Tuberculosis [45],
Malaria [77] and Leishmaniasis [22]. Perhaps, the most modeled disease is HIV/AIDS. Several works
develop models for stages of this syndrome [34, 86, 92] and some authors have used tools from automatic
control theory to design treatment strategies [28, 62, 119].
Some conditions of the maturation stages of the T and B lymphocytes have been explored by Mehr
[81]. Theoretical and experimental studies show evidence of nonlinear relations and feedback loops
more complex than these proposed for maturing states of these cells. Based on a mathematical model
approach, conditions of the T cell development environment were analyzed, including the effect of mature
T lymphocyte on naive cells. Model predictions were validated by experimentation in mice. In addition,
these results suggested that, contrary to the general view, B lymphocyte development is synchronic and
unidirectional.
Using tools from the graph theory, Dunn-Walters and others built trees that allowed to describe
the maturation and selection process for B lymphocytes in the immune response [36]. The proposed
technique was applied using mouse and human genetic sequences that code for immunoglobulin. Com-
parisons among diverse data sets showed that clones did not originate from a single naive B cell, but a
B lymphocyte that has accumulated several mutations of previous immune responses.
The HTLV (Human T-Lymphotropic Virus) is a human virus, which causes T cell leukemias and
lymphomas in adults. This virus invades mainly T helper cells but can infect also CD8+ cells. Citotoxic
cells respond inducing apoptosis to other CD8+ cells (fratricide). Asquith and Bangham suggest a model
for fratricide process between citotoxic cells [4], given an answer about the impact of the fratricide in
disease progress. Maybe the most important contribution of this proposal was the consideration of
incomplete data and approximations made. The parameter and model uncertainty problem was treated
numerically, a lot of simulations were carried out and parameters were changed in 96000 values obtaining
an statistical behavior.
Karatueva et al. [66] present a DDE structure for immunology models. In addition, an infectious
disease is modeled with a temperature change effect in the body using six ODEs. The authors introduce
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an optimum control problem to get the treatment doses against infection when fever is present.
A ten differential equation model with delays for pneumonia where the inflammation is considered
is reported by Romanyukhaa [98]. In this work some parameters are estimated using clinical data. This
approach uses as a statistic tool, a square logarithmic function.
In this section, the mathematical modeling in immunology was introduced. The compartmental
structure of the dynamical models was described and several proposals concerning immune system and
immune response. This kind of model will be used to represent the avian humoral response, topic treated
at the previous sections of this proposal. The built model will require algorithms for parameter value
estimation. Afterwards, the model will be used to design an improved booster timetable based upon
automatic control engineering. Those issues are presented at the last section.
1.4 Parameter estimation and optimization algorithms
System identification is the procedure of obtaining a dynamical model from input - output process data.
Usually, the process model has been obtained from physical or biological considerations. This model
includes some parameters to be estimated from input - ouput data. System measurements always contain
errors (noise). Several techniques have been proposed to estimate parameters from noisy measurements
[24]. The simplest case of parameter estimation is linear system estimation. In this case, algorithms of
norm (difference between calculated and measured value) minimization can be directly applied, whereas
in non linear case an iterative scheme is necessary. The most popular used norm algorithm is norm two
based and for this case the problem is called least squares. This algorithm finds parameter values that
minimize the sum of square errors [96, 110].
The mathematical statement of the parameter estimation problem based on norm reduction can be
expressed as:
Let F : Θ→ Rmn
F (θ) =
(
f (t1; θ)
T
, f (t2; θ)
T
, . . . , f (tm; θ)
T
)T
θ ∈ Θ ⊆ Rr
Y =
(
yT1 , y
T
2 , . . . , y
T
m,
)T
∈ Rmn
θˆ = arg
{
min
θ
‖Y − F (θ)‖p
}
Where F (θ) is a vector of functions of the time and the vector Θ that contains the r model param-
eters (θ). In other words, it is a column of functions f (tm; θ) that correspond to the model equations.
Organized in the vector Y , experimental measurements (ym) are represented. θˆ is the estimated pa-
rameter vector when the distance between the function values and data is minimum [96]. The notation
(·)T represents vector transpose, for vectors written as columns. Rmn is a matrix with m rows and n
columns. Lastly, the subindex p refers to the type of norm that it is used to measure the difference
between data and value functions (‖Y − F (θ)‖). A least square problem is defined when p = 2.
For linear systems the solution of the estimation problem presented above is solved in one step.
Algorithms of parameter estimation for nonlinear models solve iteratively linear problems. Those linear
problems are obtained linearizing nonlinear problems [19]. But algorithms convergence depends strongly
on initial values. Biology models belong almost completely to the latter group [3]. Another methodology
represents models using Volterra series, this strategy estimates parameters directly from the nonlinear
model. Since these algorithms require a huge quantity of operations that raise exponentially when the
model equations increase, Volterra series are very difficult to apply [21].
Genetic algorithms are a different approach proposed in the context of computational intelligence
techniques. Those non linear optimization algorithms based on species evolution theory can be used
for parameter estimation [85]. This solution has drawbacks in convergence and like others optimiza-
tion algorithms can reach only local optimal points. Presently, software has been designed for solving
linear and nonlinear estimation problems. For instance, Simbiology, Matlab (popular tool used on en-
gineering tasks) based software platform for modeling, analyzing and simulating biological systems has
implemented least squares and genetic algorithms for parameter estimation [78].
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Parameter estimation for biology and medicine models may include additional difficulties than those
already mentioned. For instance, it is recognized that uncertainty associated with immunological,
epidemiological or ecological processes is usually very high, making difficult that models accurately
represent experimental observations. In addition, some of the variables can not be measured or the size
of data set is very small [3].
This problem has been approached with different views. For instance, Alavez in his doctoral thesis
deals with the problem of estimating some parameters and initial conditions for a liver damage model
caused by a hepatitis C virus [96]. Xia estimated some parameters of a HIV/AIDS infection model using
T CD4+ cells and viral load measurements [116]. Bocharov et al. suggest a strategy for parameter
estimation when differential equations contain delays and they estimated parameters of hepatitis B
model [11]. Some intracellular processes also have been modeled and their parameters estimated. For
example, in [117] G protein concentration dynamics is represented in a model and three parameters
are found using experimental data. Techniques of identification based on maximum likelihood has been
proposed for immunology models [7].
Parameter estimation problem has also been tackled using statistical methodologies. Following this
approach, it is possible to design models, estimators and verification tests for the calculated values. These
tools have been used to estimate parameters for immunological models [50]. In this work, dynamics of
B lymphocytes in the bone marrow was analyzed and a counterintuitive hypothesis about inverting the
cellular differentiation direction was proposed. Remarkably, the model reached a better fitting when a
term that represented the reflux was included.
The main objective in automatic control engineering is to modify the response of the process being
controlled. The system is manipulated in order to achieve desirable behaviors for practical applications.
Automatic control theory tries to make systems more efficient, safer or having optimal responses [5].
Currently, the attention in control design is addressed to the robustness (less sensibility to uncertainty)
[35, 43, 118].
The robustness is a property which guarantees that stability and system performance keeps under
untoward conditions in which the model does not represent the reality with accuracy. The uncertainty
could reflect non modeled dynamics, model errors or parameter variation. In robust controller design,
a completely known process, nominal model, is accompanied by an uncertain description that measures
the difference between the real system and the nominal model [43]. The robust control theory has been
used in applications like: aerospace systems, chemical processes, electric power transmission networks
and fluids control [35]. In particular, when the system’s model is linear there are convex optimization
tools for solving the problem of design with robust stability and performance. This design process
requires the solution of linear matrix inequalities LMIs [35, 118].
However when the model is non linear, and a linear approximation cannot be used, designing a robust
controller is a more complicated task. Techniques developed for dealing with the problem of stability
and optimal non linear robust performance are based on Lyapunov stability theory. Nonetheless, in
order to design a controller using this techniques it is necessary to solve a Hamilton-Jacobi-Isaacs
partial differential equation and this is a very difficult problem [43]. To overcome this difficulty some
modifications of non linear controller design methodologies have been proposed [43, 65, 75].
Several biomedical problems have been faced using linear and non linear robust control theories.
Treatment design is a very active field of research in medicine and control engineering. Several workers
have sought better doses in a treatment period in order to cure or control diseases. Treatment proposals
for HIV/AIDS using robust control theory are presented in [88, 119]. Chen et al. [23] suggested a
treatment against a pathogen, modeling the immune response when other foreign agents are inside the
organism and initial conditions on the infection are unknown.
Zurakowski and others have developed optimal treatments for HIV that minimize the risk of ap-
pearance of virus resistant strains [74]. However, authors emphasize that models of competition among
variations of the virus are only approximations and parameters may strongly vary for each patient.
Therefore, it is necessary to develop robust methodologies that can handle model uncertainty. A strat-
egy for dealing with variability is using a Bayesian estimation procedure (MCMC, Markov Chain Monte
Carlo) [58]. This technique was applied to twelve sets of data of the same number of HIV patients and
probability densities for six parameters were obtained. Finally, 1000 cases were randomly selected and
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the effectiveness of the designed treatments were evaluated.
In the parameter estimation section and for the optimal inoculation timetable design, several op-
timization algorithms are employed. A short summary of the algorithms utilized in this thesis are
presented here.
Optimization algorithms
In particular, in the parameter estimation stage several options were explored for solving the nonlinear
programming problem given by:
θˆ = arg
{
min
θ
‖Y − F (θ)‖p
}
if the selected value for p is two, the problem is reduced to least squares one. Algorithms seek for
the minimum of the following function:
min
θ
‖Y − F (θ)‖
2
2 = min
θ
(
(y1 − f1(θ))
2
+ (y2 − f2(θ))
2
+ · · ·+ (ym − fm(θ))
2
)
(1.5)
Iterative methods explored in the parameter estimation phase are discussed below.
Simplex Nelder-Mead
The Simplex Nelder-Mead algorithm finds the minimum of an unconstrained function. This technique
minimizes a multivariable nonlinear function without using any information about function derivatives.
For this reason, this algorithm is part of the direct search methods. Instead of calculating gradients,
this procedure maintain in each iteration a non-degenerate simplex (geometric figure with dimension n,
volume different than zero and it is the convex hull of its n + 1 vertices). In this algorithm, for each
iteration the objective function is calculated for all vertices and the simplex is modified using four basic
operations: reflect, expand, contract and shrink [71]. Each operation also includes parameters to define
the change in the simplex volume.
Figure 1.6 illustrates the operations utilized in the Nelder-Mead algorithm for the simplest case with
a simplex with three points. In all operations x3 is the worst value of the objective function and the
point that will be used to modify the simplex. Each iteration eliminates the worst vertex and either
reflect, expand or contract the simplex in order to obtain a new point. If several points produce the
same value of the objective function, the size of the simplex is reduced using the shrink operation. The
Nelder-Mead algorithm, as it is implemented in Matlab [79], can be summarized as:
1. Built a simplex around the initial point. xi represents simplex vertices with i = 1, 2, . . . , n+ 1.
2. Sort the n + 1 vertices in such a way that f(x1) ≤ f(x2) · · · ≤ f(xn+1). In each iteration the
algorithm discards the worst value and includes a new vertex.
3. Generate the reflected point: r = 2m − xn+1, where m =
∑
xi/n, i = 1...n. Then the value of
f(r) is calculated.
4. If f(x1) ≤ f(r) < f(xn), include r and finish this iteration.
5. If f(r) < f(x1), calculate the expansion point: s = m+ 2(m− xn+1), and calculate f(s).
a) If f(s) < f(r) include s and finish this iteration.
b) Otherwise, include r and finish this iteration.
6. If f(r) ≥ f(xn), perform a contraction between m and the better between xn+1 and r:
a) If f(r) < f(xn+1) calculate c = m+ (r −m)/2 and f(c). If f(c) < f(r), include c and finish
this iteration. Otherwise, follow with the step seven.
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Figure 1.6: Operations on a Simplex for the Nelder-Mead algorithm. The original simplex is represented
with solid lines.
b) If f(r) ≥ f(xn+1), calculate cc = m+ (xn+1 −m)/2 and f(cc). If f(cc) < f(xn+1), include
cc and finish this iteration. Otherwise, follow with the step seven.
7. Calculate the n points: vi = x1 + (xi − x1)/2 and f(vi), i = 2, ..., n+ 1. The simplex for the next
iteration is x1, v2, ..., vn+1.
Iterations continue until some stopping criterion is achieved; for instance, the difference between
function values of two consecutive iterations was below some threshold.
Trust-Region method
Trust-region methods solve iteratively a set of quadratic programming problems that include a region
constraint [9]. In this type of algorithms, the objective function is approximated with a quadratic
function q that represents the behavior of f (objective function) in a neighborhood N of the point x
[99, 46]. This neighborhood is known as the trust-region, where the optimization problem is given by:
min
s
{q(s), s ∈ N} (1.6)
If the second derivative of function f exists, the function q can be defined as the quadratic approxi-
mation of the function f using the first two terms of the Taylor series at the point x:
q(s) = sT gx +
1
2
sTHxs (1.7)
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where gx refers to the gradient of f at the point x and Hx is the Hessian matrix at the same point. The
solution of this problem can be obtained using the Newton method:
∇q(s) = gx +Hxs = 0 (1.8)
Hxs = −gx (1.9)
However, it can be proved easily [9] that solution converge to a minimum only if Hk is always positive
definite, and this is not always the case. The simplest way to generate a positive definite matrix is to
use an identity one (I); for this case the algorithm uses only the slope information to find the point for
the next iteration. This algorithm is known as steepest descent. Nevertheless, this method is very slow.
To keep some of the information of the second derivative but maintaining a positive definite matrix,
a new matrix can be calculated from the Hessian: Bx = Hx + λI. Once again, using Newton method
an analytic solution for s is given:
(Hx + λI)s = −gx (1.10)
Notice that, selecting a high value for λ, the size of the step s decreases. From this point, a fundamental
result can be obtained that ensures a global convergence if a proper size for the step is established
[9, 99]. Therefore, for each iteration a trust-region algorithm solves the following quadratic constrained
problem:
min
{
1
2
sTHxs+ s
T gx
}
such that ‖Ds‖ ≤ ∆ (1.11)
where D represents a diagonal scaling matrix, ∆ is a positive scalar and ‖·‖ is a norm, usually the
2-norm. Each subproblem in a neighborhood can be efficiently solved utilizing algorithms based on the
Newton methods for linear programming.Typically, the neighborhood N has a spherical or ellipsoidal
shape. The current point is updated to x+ s if f(x+ s) < f(x). Otherwise, the point x is maintained
and trust-region N is shrunk.
Levenberg-Marquardt
The Levenberg-Marquardt (LM) method belongs to the trust-region algorithms discussed above. Similar
to other algorithms for optimizing nonlinear functions, this technique is an iterative process that uses
the information obtained from derivatives to decide the next searching step. This algorithm can be also
interpreted as a combination between the Gauss-Newton and the steepest descent method [76].
Basically, the LM algorithm adjusts during the optimization the value of the parameter λ included
in equation 1.10. Variations on λ value produces two effects:
1. When λ takes greater values, s ≈ 1
λ
∇x, that represents shorter steps in the descent direction.
This condition is employed when the optimal solution is far away from the current solution.
2. For small values of λ, the solution is an approximation of the Gauss-Newton method.
In the LM algorithm the Hessian matrix is approximated by gxg
T
x , producing:
(
gxg
T
x + λI
)
s = −gx (1.12)
This algorithm solves in each iteration a linear optimization problem and displaces towards the
function minimum updating direction and step size. In each iteration two situations can occur: 1. the
value of the objective function decreases, implying that the quadratic approximation is adequate and the
effect of the gradient descent should be reduced (λ is decreased for the next iteration); 2. the updated
value of the function increases, it is necessary to follow the gradient more, i.e. establishing a larger value
for λ in the next iteration. This process continues until some convergence criterion is achieved.
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Genetic algorithms
Genetic algorithms are heuristic algorithms inspired on mechanisms of the theory of natural selection.
For each iteration, this procedure generates a set of possible solutions to the optimization problem
that are built from the previous solution population and using the objective function evaluated for
each individual (fitness). Since this type of algorithm does not use gradients, it can be utilized with
non-differentiable objective functions. Other features of these algorithms are: solutions are codified
to make possible to perform the operations defined for this procedure, a population of solutions is
explored simultaneously and it uses probabilistic rules for transitions to the next iteration. Unlike other
optimization strategies that use information from gradients or Hessians to decide the next point in the
solution space, genetic algorithms are basically blind [47].
Genetic algorithms use three operations to produce solutions: reproduction, crossover and mutation.
During the reproduction, solutions with higher fitness have a greater probability of producing copies
than those with lower fitness (value of the objective function). In other words, solutions with a fitness
larger than the average will produce a larger number of samples in the next generation (iteration),
while solutions with a low fitness decrease their number in the next generation. Therefore, the effect
of reproduction on solution population is that better ones grow in number, whereas those with a low
fitness eventually disappear.
However, reproduction does not explore new regions of the searching space, crossover is intended for
that purpose. This operation introduces a random change in solutions. Initially, a couple of solutions
are selected randomly and, also in a random fashion, a cross point is defined. Subsequently, each section
is used to produce a new solution from its parents segments. The last operator, mutation, generates an
arbitrary change in one of the features that codifies to the solution. However, this event rarely occurs.
The algorithm can be summarized as:
1. Initiate with a random population of possible solutions.
2. Codify solutions in character strings.
3. Evaluate objective function for each solution in the population.
4. Copy solutions depending on their fitness. Solutions with larger fitness have a higher probability
of obtaining new copies in the next iteration.
5. Perform the crossover.
6. Introduce mutations depending on a established probability.
7. Return to the third step until the change in the average fitness, between a population and next
one, is less than some threshold.
When bounds, linear or nonlinear constraints are included, an approach called ALGA (Augmented
Lagrangian Genetic Algorithm) can be used [25, 26]. This algorithm is based on defining subproblems
that combine the objective function with the Lagrangian and penalty parameters. Each subproblem is
solved using a genetic algorithm.
1.5 Document content
This chapter presented the problem tackled in this thesis and the basic concepts that will allow to
propose a solution for selecting the set of antigen booster days that maximize antibody production. The
behavior of the mammalian and avian immune systems was described, as well as the main molecular and
cellular populations that participate in humoral response. In addition, optimization algorithms utilized
in this thesis for parameter estimation or solving the timetable problem were briefly introduced. The
second chapter describes the mathematical model built for representing the avian immune response.
Variables and parameters are introduced as well as the qualitative responses obtained with an initial
set of parameter values; a sensitivity analysis is also presented in this chapter. Chapter number three
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describes a set of experiments performed on twelve hens for measuring immunoglobulin concentrations
in peripheral blood and yolk as well as concentrations of T and B lymphocytes. This information allowed
to numerically characterize some aspects of the humoral response and modify some initial parameter
values. In addition, these data are used to estimate some parameters in order to reproduce measured
responses; these results are presented in chapter four. However, the estimation process required the
evaluation of several aspects, such as: the number of parameters to be estimated, the algorithm for
solving a least square problems that represents the estimation and the initial guesses employed. In the
fifth chapter, adjusted models are utilized to define optimal timetables for one, two and four boosters.
An experimental validation of the model prediction for the case of one booster is also provided in that
chapter. Lastly, conclusions of this thesis are enumerated in the sixth chapter.
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Chapter 2
Dynamical model of the humoral immune
response in birds
This chapter introduces a dynamical model designed to represent the avian humoral response against an
antigenic protein. Initially, each equation of the model is described and compartments of each cellular
and molecular populations that represent the immune system dynamics are explained. Subsequently,
model parameters are enumerated and a set of initial guesses is proposed. These values will be used as a
starting point in an iterative estimation process, presented in chapter four. Using cellular and antibody
measurements obtained in this work, new parameter values can be obtained that constitute a good
fit to the experimental data. The immune response dynamics produced by the model was compared
to qualitative responses published in the literature. Finally, a sensitivity analysis was performed to
characterize the effect of each parameter on the model response.
2.1 Dynamical model description
This section discusses the mathematical model being proposed to represent the avian immune response
introduced in the first chapter. The process is described only by cell and molecule populations that
participate in the humoral response. The remaining immune system components have not been consid-
ered. Table 2.1 enumerates model populations and the variables used to represent them. Units used for
populations are given as concentration in cells per ml [Cel/ml] and molecules in mg per ml [mg/ml].
Diagram 2.1 illustrates model populations and their interactions; single arrows indicate change from
one state to another, while double arrows refer to populations components that affect each other.
Orange circles represent populations explicitly included in the model, whereas yellow circles symbolize
maturation stages that are not incorporated as additional model equations. In this description of
immune system, the antigen inoculation acts as the stimulus and antibody production is the response.
The process that results in the production of specific antibodies starts with inoculating the bird
with the antigen. Initially, innate immune system cells (APC) destroy and process the foreign agent
decreasing its concentration in peripheral blood and activating biochemical signals that generate an
increase in macrophages and dendritic cells. Later, antigen presenting cells show, through their MHC
molecules, peptides of the inoculated protein to naive T lymphocytes that become active depending
on whether they bear the adequate receptor. From this moment on, CD4+ T lymphocytes that are
capable of recognizing the foreign agent either mature to an activated state or differentiate into memory
cells. In the model developed in this work only the effector CD4+ T cell dynamics will be described.
Intermediate stages of maturation or activation of this component of the adaptive immune response
will be not considered. CD8+ T lymphocytes (cytotoxic cells) do not participate in humoral response,
therefore they are not included in the proposed model. Although CD4+ T lymphocytes increase their
concentration in secondary responses due to immunological memory, the increment is significantly lower
than that of B lymphocytes and for simplicity it will be neglected.
On the other hand, the set of naive B lymphocytes bear a huge receptor (membrane antibodies)
diversity capable of recognizing the antigen three-dimensional shape. When a B cell detects an epitope
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Population Variable
Antigen Ag
Antigen presenting cells A
CD4+ T cells with receptors for the specific antigen T
B cells with receptors for the specific antigen B
B memory cells Bm
Immunoglobulins Ig
Table 2.1: Cellular and molecular populations
a clonal expansion process begins if a biochemical signal released by T CD4+ lymphocytes is present. As
a result of the recognition, the number of B lymphocytes with specific receptor for the inoculated antigen
raises. The activation also produces a B lymphocyte differentiation into plasma or memory cells. The
proposed model represents only these two populations. Finally, plasma cells produce a soluble version
of its membrane receptor (immunoglobulin) that binds to the antigen and speeds up its destruction.
Antigen elimination halts the stimulus that elicits the immune response which disappears some days
later.
The macroscopic phenomenon modeled here requires many reactions of the innate and adaptive
immune systems that are not explicitly expressed in the mathematical model. For instance, phagocyte
(macrophages, neutrophils and dendritic cells) effect is summarized in one term that decreases antigen
concentration. Other factors such as increased opsonization rate due to complement proteins or changes
in blood flow toward the inoculation point caused by inflammation are not described in the model.
Intermediate stages in lymphocyte differentiation or other phenomena such as somatic hypermutation
or isotype switching are not considered either. In the model presented below it is proposed a simplified
representation of the immunoglobulin (IgY) production process in response to a specific inoculated
protein. A more detailed description of the process would require a larger number of equations and
parameters, and hence a much more difficult task in parameter estimation and inoculation timetable
optimization.
Antigen
Immune response is generated by events starting with the animal inoculation. Hence the first equation
describes antigen dynamics. This model is intended to represent only antigen inoculation rather than
pathogen presence, so after inoculation there is not a source that produces the foreign agent; i.e., antigen
does not reproduce. Its concentration can only increase due to an additional inoculation. Equation 2.1
models the decay of antigen concentration and includes a signal that symbolizes system input:
dAg
dt
= −δAgAg − δIgIgAg + bu(t) (2.1)
This equation is composed of three terms. The first one represents the reduction in concentration
due to natural protein degradation that depends on density. It occurs with a rate of δAg [day
−1].
The second term is used to model the change in the antigen elimination rate as a result of increased
phagocyte activity caused by antibody signals. This component of the equation depicts a law of mass
action where the product of the two populations determines the speed of foreign agent degradation.
This kind of mathematical representation is very common in chemical processes and it is the simplest
way of representing interactions among several species. The rate of antigen elimination due to the
antibody effect is given by δIg [ml mg
−1 day−1]. The signal u(t) refers to the system input (antigen-
adjuvant complex and inoculated vehicle). This function represents the events that initiate the immune
response as well as the signal that can be externally manipulated. Changes in u(t) occur at times
when inoculations are administered. Changes in this signal will be used to modify specific antibody
production. The parameter b [day −1] measures the rate of antigen concentration increase after a dose
inoculation of protein in some point of the bird body.
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Figure 2.1: Humoral response diagram. Antigen represents the stimulus and IgY production the re-
sponse.
Additionally, in the model, antigen concentration is used as a mechanism that determines the be-
ginning and the end of the humoral response. Equation 2.2 is proposed as an activation function for
the immune response. It depends on antigen dynamics, described by equation 2.1, and it is used in the
rest of the model equation to represent this event. When the antigen concentration is zero, for instance
before the inoculation or after the antigen has been completely cleared, the activation function is also
zero. Therefore, all terms in the model that include this function will remain constant. In that case,
lymphocyte and APC populations will not increase. In addition, this function represents a saturation
effect that occurs in humoral response when the concentration of the inoculated antigen is too high [61].
Curves for different values of the parameter n are showed in figure 2.2. Notice that larger values of n
produce faster changes in the function.
f (Ag) =
Agn
Agn + hnAg
(2.2)
Antigen Presenting Cells
The dynamics of antigen presenting cells (APC: mainly macrophages and dendritic cells) is modeled by
a three term equation:
dA
dt
= αA + ηf (Ag)A
(
1−
A
KA
)
− µAA (2.3)
This equation refers exclusively to the population of APC that has ingested the inoculated antigen
and presents it to T helper cells through histocompatibility complex class II. A constant production rate
of APCs, due to phagocyte generation from marrow bone stem cells, is represented by the αA [Cel ml
−1
day−1] term. However, this rate corresponds only to mature APCs that are found near the inoculation
region, not the circulating ones. A natural death term, depending on population density with a rate of
µA [day
−1] is also included. The inverse of this parameter measures cell life span in days.
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Figure 2.2: Activation function for different values of n and hAg = 0.2. This saturation function is used
in the model to initiate the immune response when antigen concentration increases and to halt it when
the foreign agent is cleared.
After inoculation, phagocytes migrate to the site of infection in response to biochemical signals as
chemokines and cytokines. The second term represents this increase in APC population due to innate
immune response to the specific antigen. Since this effect appears only in the antigen presence, a typical
mass-action term can be included. However, this allows for an unbounded population size. A sigmoidal
A (1−A/KA) factor has been added to account for a bound on the population size of APC in this
stage of the immune response. The KA [Cel/ml] parameter sets the population maximum size (carrying
capacity). Additionally, a sigmoidal function allows to establish a rising time that coincides with typical
times of APC migration. Phagocyte increase stops after the antigen is completely eliminated, hence
function 2.2 is used to model the depletion of the APC response. In this way, equation 2.3 is reduced to
a constant component of cell generation and a density depend death rate, when antigen concentration
falls to zero or before the inoculation. Parameter η [day−1] measures how effectively phagocytes move
and ingest the antigen.
Active CD4+ T Lymphocytes
T lymphocytes have a more complex set of interactions affecting the population growth. Specifically,
equation 2.4 refers to Type 2 T helper cell that participate in B lymphocyte activation. The immune
system possesses a very diverse population of naive T lymphocytes. When they become activated by
APC presentation, they mature, through several stages, into active cells that secrete cytokines in order to
activate other cells. Equation (2.4) represents activation and clonal expansion phenomena. Intermediate
maturation stages are not considered.
dT
dt
= αT + f (Ag) (σA+ γT )T
(
1−
T
KT
)
− µTT (2.4)
The number of specific CD4+ T cells, carrying a receptor capable of recognizing a specific antigen,
is kept very low in its absence. Adaptive immune response begins with T helper cell activation. This
process is modeled with a term that describes the rate of their encounters depending on the presenting
cell and T lymphocyte concentrations and a rate σ [ml Cel−1 day−1]. The coefficient γT defines the
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cloning speed from activated T lymphocytes. A mass action-like f(Ag)T term is included to represent
the fact that expansion persists only while the antigen is present. A sigmoidal function is included in
this equation for the same reasons explained for APC dynamics description, i.e., to establish a rising
time and an upper bound for the population size. The maximum value of T lymphocytes is set by
the KT [Cel/ml] parameter. New lymphocytes from bone marrow are produced at a constant rate αT
[Cel/ml day −1]. Finally, µT [day
−1] is a death rate. Notice that before exposure to the specific antigen,
the activation function is equal to zero, and equation 2.4 turns out a constant term of cell production
and a density dependent death term. In equilibrium the basal level of this population is obtained.
In addition to the processes described by equation 2.4, CD4+ T lymphocytes have immunological
memory. However, this effect is less significant for this cellular type than CD8+ T lymphocytes or
plasma cells. This stems from the fact that clonal expansion for these cells reaches a value that is
several orders of magnitude lower [1]. Therefore, in the T cell equation (2.4), the memory effect was
neglected.
Active B cells (Plasma cells)
The cells that secrete antibodies are modeled in this section. Equation (2.5) represents the dynamics of
active B cell or plasma cell population. The equation describing this population is as follows:
dB
dt
= αB(Bm) + f (Ag) [ζT + γB + ψBm]B
(
1−
B
KB(Bm)
)
− µBB (2.5)
The function αB(Bm) = βBBm + α¯B represents a memory cell-dependent production rate. Before
inoculation with the specific antigen, the memory cell population is zero and new lymphocytes are
produced with a density independent rate α¯B [Cel/ml day
−1]. After the immune challenge, the memory
cell level increases and the value of αB(Bm) becomes larger. The term βB [day
−1] describes the increase
in B cell concentration as the result of immunological memory. As above, the B cell equation includes
a density-dependent cellular death term. The rate of cellular death is defined by µB [day
−1].
Activation, clonal expansion and memory formation processes are described in equation 2.5. Here,
the difference between primary and secondary responses is the most important feature to be described by
the model. This difference is modeled by including a sigmoidal function whose carrying capacity depends
on memory cell concentration: KB(Bm) = KBp+KBBm. In this way, it is possible to generate a faster
dynamics and varying concentration peaks, depending on the memory cell population size. Bounds for
B lymphocyte population are defined by KBp [Cel/ml] for primary response and KBp +KB [Cel/ml]
for secondary responses. When antigen is inoculated for the first time, B cells activation by T cells is
more intense than secondary responses. A mass action term with a rate ζ [ml Cel−1 day−1] depicts this
process. The clonal expansion phenomenon is represented by a density-dependent component whose
rate of growth is set by γB [day
−1]. It is well known that secondary responses occur faster than primary
ones, therefore the third term defines the faster production of B cells due to immunological memory.
ψ [ml Cel−1 day−1] is the rate that measures the memory effect. Since the activation function f(Ag)
is multiplying the three terms of activation, clonal expansion and memory, the immune response only
begins after antigen inoculation and it decreases when the foreign protein is eliminated.
Since main cells for producing antibodies are plasma cells, other stages of B cell maturation such as
pre-B cells or plasmablasts are not taken into account in this model.
Memory Cells
The equation modeling the dynamics of memory lymphocytes is:
dBm
dt
= f (Ag)
(
1−
rBm
rBm + hBm
)
+BγmBm
(
1−
Bm
KBm
)
(2.6)
In mammals, the number of memory cells for a specific antigen remains approximately constant
throughout an individual’s life [61]. In birds, vaccine experiments suggest a similar behavior [32].
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Therefore, a sigmoidal function was employed in order to represent an upper bound to memory lym-
phocytes. Once this bound is reached, the number of memory cells remains constant. Nevertheless,
the initial condition for this population is zero and this value does not allow changes in the sigmoidal
function. In order to solve this problem a component that initiates the population growth when the
activation function is not zero was included in equation 2.6. This first term disappears almost immedi-
ately after antigen inoculation and it is used only to change the initial condition of the equation after
the immunological challenge. Notice that, this first term has no biological meaning, it is only a purely
mathematical term that changes an initial condition when an event (inoculation) occurs. The second
term is a sigmoidal function with a carrying capacity of KBm [Cel/ml] and a production rate that
depends on B population size (a proportion of the activated B cells turned into memory cells) and a
parameter of generation speed γm [ml Cel
−1 day−1].
Immunoglobulins
The one remaining equation (2.7) describes serum antibody dynamics. Antibodies are secreted by plasma
cells. Hence, antibody generation is directly related to the size of the B cell population, with a rate
constant φ [mg Cel−1 day−1]. The parameter µIg [day
−1] is the rate of natural decay of immunoglobulins.
IgYs are transferred from the blood to the yolk during egg formation. The levels of serum and yolk
antibodies take around a week to reach equilibrium [56]. Only one equation will be used for both types
of antibodies since the dynamics of both immunoglobulins are similar.
dIg
dt
= φB − µIgIg (2.7)
2.2 Initial values for model parameters
The set of equations described above corresponds to a non linear system with 28 parameters that can
not be analytically solved, hence a numerical approach is used to obtain a solution of the equations.
In order to use this methodology it is necessary to assign numerical values to all parameters. It is
important to emphasize that it was not possible to find the whole set of parameters for the avian
case from the available literature. Thus, parameter values were obtained from: 1) avian immunology
reports, 2) mammal immunology literature and 3) tuning them in an empirical fashion to produce
typical immune responses. On the other hand, some parameters do not have a biological interpretation
and were adjusted to achieve reasonable qualitative features of the process. Table 2.2 enumerate model
parameters and the units for each one. Cell and protein concentrations are represented by [Cel/ml] and
[mg/ml], respectively and inverses 1/x are symbolized by x−1.
δAg [day
−1]
An initial value for this parameter was proposed based on analogous immunological models and ex-
perimental results in birds. In the model built by Oprea [89], a similar term is proposed to represent
mammalian antigen elimination and the parameter value is estimated in days. In that work, the elim-
ination rate was 0.5 (two days). However, it is recognized that the time required to clear the antigen
varies among antigens and a portion of the inoculated protein is rapidly destroyed (by liver and kidney
action), whereas the rest of the foreign agent is distributed over the entire fluid volume.
For birds, a similar behavior has been observed experimentally. For instance, in [108] the kinetic
response of poultry against antigen sparfloxacin is characterized. The initial concentration in circulating
blood and the tendency in the antigen concentration are illustrated. In that report, an exponential decay
and a half life of one day are clearly established. Consequently, two days (δAg = 0.5) will be used as
half life time for antigen elimination. In the last section of this chapter the effect of modifying this
parameter will be assessed.
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Parameter Units Description
δAg [day
−1] Antigen elimination rate
δIg [ml mg
−1 day−1] Increase in antigen elimination rate due to Igs
hAg [mg ml ] Saturation level of the antigen activation function
b [day−1] Antigen increase rate after inoculation with the signal u(t)
αA [Cel/ml day
−1] Antigen presenting cell production rate
KA [Cel/ml] Carrying capacity of antigen presenting cell population
η [day−1] Antigen presenting cell growing rate as a result of immune response
µA [day
−1] Antigen presenting cell death rate
αT [Cel/ml day
−1] Antigen specific T lymphocyte production rate
σ [ml Cel−1 day−1] T cell activation rate by APCs
γT [day
−1] T lymphocyte clone production rate
µT [day
−1] T cell death rate
KT [Cel/ml] Carrying capacity of T lymphocyte population
α¯B [Cel/ml day
−1] Antigen specific B cell production rate
βB [day
−1] B cell increase rate as a result of memory
ζ [ml Cel−1 day−1] B lymphocyte activation rate by T cells
γB [day
−1] B lymphocyte clone production rate
ψ [ml Cel −1 day−1] B cell production rate from memory cells
KBp [Cel/ml] Carrying capacity of B cell population for primary response
KB [Cel/ml] Carrying capacity of B cell population for secondary response
µB [day
−1] B lymphocyte death rate
γm [ml Cel
−1 day−1] Memory cell population growing rate
KBm [Cel/ml] Carrying capacity of memory cells
φ [mg Cel −1 day−1] IgY production rate from B cells
µIg [day
−1] IgY elimination rate
n Degree of saturation function
r Biological meaningless parameter, memory pulse
hBm Biological meaningless parameter, memory pulse saturation level
Table 2.2: Molecular and cellular populations
δIg [ml mg
−1 day−1]
Generation of specific antibodies increases the capacity of phagocytes to recognize and internalize (di-
gest) the antigen. Qureshi [32] (chapter nine) found that the number of these cells in a culture of chicken
macrophages increased up to 80% in the presence of antibodies. Using the equation 2.1, an initial value
for this parameter was proposed. Prior to inoculation, antigen dynamic equation (2.1) is reduced to:
dAg
dt
= Ag (δAg + δIgIg) (2.8)
From Qureshi’s estimative of the increase of phagocyte activity:
δAg + δIgIg = 1.8δAg (2.9)
Therefore, the parameter value will be given by:
δIg =
0.8δAg
Ig
(2.10)
Finally, it will be assumed that the maximal antigen elimination rate occurs when antibody population
is maximum:
δIg =
0.8δAg
max (Ig)
= 20 (2.11)
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Immunoglobulin peak concentration was calculated using the carrying capacity of B cell population
and the antibody production rate. With these values, the primary response’s peak IgY concentration
reaches 0.05 mg/ml.
hAg [mg ml], n and b [day
−1]
The first two parameters, hAg and n are included in the activation function 2.2 to represent the saturation
of the response to the antigen application. It is recognized that the curve of humoral response intensity
against antigen concentration varies according to the foreign agent employed and the inoculation method
[101]. Initial values for these parameters were selected through simulation as hAg = 0.04 and n = 2.
These values were chosen in an attempt to reach the activation function maximum level with one half
of the dosage proposed for the experimental stage of this thesis.
The antigen increase rate was fixed at b = 4.4 in order to adjust the time required to diffuse the
antigen in the total blood and lymph volume. Input to the system was defined as a rectangular pulse
with a height equal to the dosage concentration and a width of six hours (0.25 days), the time interval
chosen to achieve homogeneous distribution of the antigen.
αA [Cel/ml day
−1] and µA [day
−1]
Antigen presenting cell dynamics is represented exclusively for the population that has ingested the
inoculated protein and present it to T lymphocytes by means of class II major histocompatibility
molecules. In addition, it has been supposed that the initial population size is small enough, including
only cells located near the inoculation region that engulf the antigen in a short time.
Prior to bird inoculation (Ag = 0), the differential equation for antigen presenting cells becomes:
dA
dt
= αA − µAA (2.12)
At cell population equilibrium:
A¯ =
αA
µA
(2.13)
On the other hand, presenting cells’ (especially dendritic cells’) half life has been experimentally
established. For human dendritic cells, for instance, half life is about a few days [100]. Depending on
the mammal species and the localization, DCs can live from three days up to four weeks [111]. We chose
a value of four days, giving (µA = 0.25). The dynamics of APC only models the concentration of cells
presenting the antigen of interest. Before the inoculation there should be no such cells. However, we
will assume that a single cell is present, so that the process can be initiated. This gives αA = 0.25.
η [day−1] and KA [Cel/ml]
The growth and decrease of APCs was represented using a sigmoid function. This proposal was based
on the fact that population must reach a maximal level due to the limited antigen available and the
system homeostasis. This function has two parameters that define the carrying capacity and the slope
in the population increase.
The speed of antigen internalization by DCs has been estimated experimentally with a value of about
three hours [59]. Studies in chicken macrophages showed that those cells are able to destroy 80% of the
phagocyted bacteria in 15 minutes [95]. Therefore, the rate of change of the population is determined
mostly by the time required for cell migration and antigen recognition. η was found through simulation,
so that the peak level of antigen presentation occurs several days after inoculation [1]. The solution
of (2.3) around at equilibrium (when αA = µAA), a first approximation to the sigmoidal function was
obtained as:
A(t) =
KAA(0)
A(0) + e−ηt(KA −A(0))
(2.14)
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We supposed a APC basal concentration of 1% of the final value and that 95% of the peak is reached
after three days. Substituting these numbers in the last equation, it is found that η = 2.5.
The peak value reached by the population is not easily found in the literature because this model
considers only those cells that have phagocytosed the antigen and presented it to T cells. This varies
according to the antigen being used. Nevertheless, the typical concentration of monocytes is about 1000
cells per ml [1]. We used 5000 [Cel/ml] for the simulations to take in account all presenting cells i.e.
macrophages, dendritic cells and B cells.
αT [Cel/ml day
−1] and µT [day
−1]
At first, there is a very small population of T helper lymphocytes that have a receptor for a peptide
resulting from antigen processing by APCs. It is estimated that in hens there are about 10-100 cells
from a total cell population of 100 million [32] (chapter six). We have assumed that a hen has a total
volume of blood of about 100ml. Therefore, the initial concentration of T lymphocytes may be assumed
as one cell in one ml of blood (100 cells/100 ml).
According to the model, the steady state cell population is:
T¯ =
αT
µT
(2.15)
In mammals, contradictory results about T lymphocyte life expectancy have been found. In [107]
several experiments are discussed measuring the half life of T cells and it is remarked that naive lym-
phocytes survive for days. However, other tests suggest a value of several. We will use life expectancy
for chicken B lymphocytes which is about three days (µT = 0.33).
Using the last value and the steady state equation:
α¯T = T¯ µT = 0.33 (2.16)
σ [ml Cel−1 day−1]
The value of this parameter was obtained from mammal reports. Depending on antigen dose and co-
stimulation level, naive T lymphocytes require between six and 30 hours to start the clonal expansion
[100]. A single dendritic cell can activate 10 to 20 cells per day [97]. Choosing the lower value and a
total volume of blood equal to 100ml a value of σ = 0.001 is obtained.
γT [day
−1]
For mammals, T lymphocytes duplicate 15 to 20 times in the expansion period. As a result, their
concentration increases up to 50000 times [114]. Usually, the peak of lymphocyte population due to the
adaptive response occurs around a week (seven days) after inoculation. It will be assumed that, during
primary response, clonal expansion is responsible for most of the specific T cell population. It will also
be assumed that the initial cell population is just one cell (in accordance with the initial concentration
of lymphocytes having a receptor for the antigen in use) and that the population reaches 99% of the
peak value within seven days. Therefore, under the same assumptions used for the calculation of initial
approximation to η,
γT = −
1
7
ln
(
0.1
0.99 (KT − 1)
)
= 1.3 (2.17)
KT [Cel/ml]
The effector mechanism of T helper lymphocytes is carried out by cytokines that these cells secrete. For
this reason, CD4+ T cell population expansion is lower than CD8+ lymphocytes or plasma cells and it
is about 1000 times the initial concentration. Therefore, KT = 1000.
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α¯B [Cel/ml day
−1] and µB [day
−1]
Values for these two parameters were chosen by a similar argument as the one used for T lymphocytes.
The half life is three days (µB = 0.33) [32] (chapter six) and prior to the inoculation the concentration
of the specific B lymphocyte is 1 [Cel/ml]. Using the steady state solution of the B cell equation, the
parameter value is obtained as:
α¯B =
B¯
µB
= 0.33 (2.18)
βB [day
−1]
After the immunization, the number of B cells for specific antigen increases significantly, from 10 to 100
times the initial value [61]. Using this argument and assuming a steady state condition of the equation
of B cell dynamics, i.e., α¯B + βBBm − µBB¯ = 0, then:
B¯ =
βBBm + α¯B
µB
(2.19)
If the population of B lymphocytes reactive to the inoculated antigen is mainly composed of memory
cells after the primary response, B¯ = B¯m:
βB =
µBB¯ − α¯B
B¯m
= µB −
α¯B
B¯m
= 0.297 (2.20)
ζ [ml Cel−1 day−1]
To the author’s knowledge the kinetics of B lymphocyte activation by T helper cells has not been
reported in the literature. Due to similarity of the dynamical equations for both types of lymphocytes,
we will use the same activation parameter as that used for T lymphocytes, i.e., ζ = 0.001.
γB [day
−1]
Th value for this parameter value was proposed in a similar fashion to the clonal expansion rate of T
lymphocytes. However, two aspects of the equation were considered: the peak of B cell concentration
was 50 times higher than the one for T cells, and the remaining terms of the equation 2.5 affect
the response. Hence, it was necessary to adjust the calculated value to represent typical responses
adequately. Consequently, γB = 2.36.
ψ [ml Cel −1 day−1]
Naive lymphocytes in mammals require a stimulation period between 6 and 30 hours before starting
clonal expansion. Memory cells, on the other hand, respond in 0.5 to 2 hours after a stimulus [100].
This effect has been modeled using three terms in the ODE and the corresponding parameter values
were obtained through in silico experimentation for the lowest ratio of naive to memory cell response
time. A plausible result was obtained using ψ = 2γB = 4.72.
KB and KBp [Cel/ml]
CD8+ T lymphocyte population peaks at about 500.000 [Cel/ml] [114]. It will be supposed that
plasma cells achieve the same concentration. This response occurs with (KB = 45.000). The maximum
difference in magnitude between primary and secondary responses for B cells is about 10 to 100-times
[61]. Therefore, (KBp = 50000).
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Figure 2.3: Contribution of the first term of the memory cell equation to the response. This impulse-like
signal is used in the model to start the memory lymphocyte population growth.
γm [day
−1] and KBm [Cel/ml]
Between 1 and 5% of mammal effector lymphocytes remain as memory cells [114]. On the other hand,
the growing rate have to be established to reach the carriying capacity at the end of the primary
response. Using simulation, a reasonable value for the parameter was found as γm = 1.5× 10
−5. It was
asummed that a ten-fold increase in memory lymphocyte concentration occurs after inoculation [61].
This condition is obtained using (KBm = 10).
φ [mg Cel −1 day−1]
The rate of antibody secretion, for mammals, has been estimated to be in the range 8000 to 20000
molecules per second in a differentiated B cell. We will choose the same value used by Oprea [89] in his
work, i.e., 10000 molecules per second. Adjusting for change of units (secs to days and Daltons to kgs:
1D = 1.66053× 10−27kg). Since a hen’s IgY weights 180kDa approximately [27]:
φ = 2.57× 10−7[mg Cel−1day−1] (2.21)
µIg [day
−1]
The half life of IgYs in serum for 2-9 month old hens was measured in [32] to be 3.3 days. This gives
µIg = 0.303.
r and hBm
These two parameters have no biological meaning; they were included in the model in order to change
the initial value of zero after an inoculation shoot. The contribution of the first term of equation(2.6) to
the derivative is illustrated in figure 2.3, using r = 2000 and hBm = 0.005. The same figure shows the
antigen dynamics. Notice that the contribution of the first term is almost negligible (with a maximum
value of 0.012) and it disappears in a short time compared to the antigen elimination time.
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Figure 2.4: Antigen concentration increase. After the inoculation, antigen is distributed in the individ-
ual’s body producing a raising concentration. After the protein reaches a peak it initiates an exponential
degradation.
2.3 Qualitative responses
The model for the avian immune dynamics was simulated using the platform Simulink R© and the
parameter values described in the last section. The qualitative behavior of the model was analyzed and
its capacity to represent plausible primary and secondary responses was verified. The time evolution of
each model population will be illustrated here. In order to facilitate the observation of different stages
of the immune response namely, presentation, clonal expansion and memory, most of the figures show
two populations that describe two consecutive stages.
Initially, the primary response for each population will be described, then secondary responses will
be commented. Lastly, model responses applying several immunizations and varying the booster day
will be illustrated.
Primary responses
All the simulations presented here used an external input of 1.0 [mg/ml] of antigen concentration
injected on the eleventh day. Figure 2.4 shows a six hour initial increase of antigen concentration
following the inoculation. This is used to represent the pharmacokinetics of the foreign protein as it
diffuses throughout the bird’s body. The concentration reaches a final value very close to one. After this
maximum level, this molecular population is exponentially reduced, which is consistent with mammal
and avian pharmacokinetics. The blue curve in figure 2.5 depicts the antigen dynamics in the primary
response. Two days after the inoculation the antigen concentration is one half of the peak value, and it
is almost zero seven days later.
APC is the next population that changes its state. As shown in figure 2.5, prior to antigen inocu-
lation the concentration of these cells is kept constant at a very low level (one cell per milliliter). The
growth of the APC population begins a few hours after the antigen reaches its peak, and the maximum
concentration is obtained three days after the foreign protein injection. Even though the antigen has
been cleared, there are enough presenting cells to maintain the activation process working. E.g., the
response on day 20. Finally, the population return to its steady state value, one [Cel/ml], without any
lasting effect.
As a result of the increase in the number of APCs, a CD4+ T lymphocyte activation process starts;
figure 2.6 depicts this feature. In steady state (prior to inoculation), the concentration of T cells
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Figure 2.5: Primary responses for antigen and APC populations. The elimination of the inoculated
protein and the growth in the number of cells presenting antigen peptides are showed.
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Figure 2.6: Primary responses for APC and T lymphocyte. CD4+ T cell concentration increase is
due to presentation and clonal expansion processes. After these processes have been concluded, both
populations return to their basal levels.
with the receptor capable of recognizing the specific antigen is very low. About three days after the
first immunological challenge, the increment of the effector T lymphocytes becomes noticeable. This
represents a delay with respect to the APC population response. The carrying capacity is reached around
15.5 days, and this level is maintained for about three days. From this point on, the concentration of T
cells decays in a similar fashion to APCs. When the response is extinguished, this population returns to
its initial value. As explained in the model section, the memory effect in CD4+ T lymphocyte population
was neglected, hence their levels before and after the immune response are exactly the same.
Figure 2.7 shows the dynamics of both lymphocyte populations. The first stage of humoral response
corresponds to B cell activation by antigen and CD4+ T lymphocytes. This event begins about the 15th
day. Subsequently, clonal expansion produces an increase in population size up to the maximum primary
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Figure 2.7: Primary responses of T and B lymphocytes. B cells increase their number after activation
by CD4+ T lymphocytes and antigen recognition. Basal levels for B cells increase as a result of memory
cells.
response concentration (day 17). It is important to emphasize that this population refers exclusively
to mature B cells producing G type immunoglobulins; other isotypes are not included in the model.
Primary response ends about day 35, and due to memory the basal level is slightly higher after the
immunological challenge.
The main objective of this model is to represent antibody production. The dynamics of this pop-
ulation is showed in figure 2.8. Immunoglobulin production is proportional to active B lymphocyte
concentration, and starts at the same time that these cells increase their number. The IgY concentra-
tion peaks around day 20. Since B cells increase their basal level by memory effect, the steady state
solution for the antibody increases as well. In this case, the maximum IgY concentration is relatively
low which is consistent with the fact that primary response B cells produce much more IgM isotype, a
population not included in this model.
The last component of the model is the memory cell population; see figure 2.9. It is assumed
that this variable maintains a constant level after reaching its maximal concentration, as observed in
mammal experimentation. The blue curve shows this feature. However, a single dose was not able to
take the population to the carrying capacity (10 [Cel/ml]) due to the size of the B lymphocyte clonal
expansion was not enough to make that memory cell population reach its peak. Later on, it will be seen
that secondary response quickly increases the memory cell concentration reaching this maximal level.
Almost one month after the inoculation, memory lymphocytes have augmented its number to the value
achieved for the primary response in this simulation. This time coincides with the one mentioned in
[61].
Antibody dynamics has been published for mammals and birds, for example see [1, 90, 91]. Curves
described in these reports were consistent with the qualitative behavior of the model response. Primary
and secondary responses produced by the model required similar times to those established by the
experimental measurements. On the other hand, these typical responses were determined in terms of
the titer instead of the amount of produced protein, hence it can not be directly compared to the
reported data. In the next chapter, measurements of IgY concentrations will be presented and will
corroborate the capacity of the model to represent the immune response dynamics. However, the
qualitative performance of each population described in this section has characteristics that were just
approximations. For instance, some rise times look short taking into account required times for the
intermediate stages of cell activation, migration and maturation.
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Figure 2.8: Primary responses of B lymphocytes and antibodies. IgY production rate is proportionally
to active B cell population.
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Figure 2.9: Primary responses of memory cells and antibodies. After the primary inoculation, memory
cells are produced as a proportion of active B lymphocytes. Additionally, memory cells keep their
number practically constant through the individual’s life.
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Figure 2.10: Secondary response of the antigen concentration. The basal level of antibodies against
protein immunization and the reduction of the time required for generating an immune response resulting
in faster antigen elimination.
Secondary responses
A second set of simulations was obtained, representing two inoculations of the same size (1.0 [mg/ml])
at days 11 and 39. These were also selected for the inoculations in the experimental component of
this thesis, expecting that the primary response would be completely extinguished before carrying out
the booster shot. Consequently, the numerical solution used the same times for the antigen injection
event. During the secondary response, the memory cell population Bm will increase and the terms of
the equation 2.5 that depend on this variable should have a larger effect.
Since the initial antibody concentration is higher in secondary responses, compared to the primary
response, and the antigen is degraded more rapidly, the foreign agent dynamics is significantly modified.
Figure 2.10 shows that, after the second inoculation, the antigen concentration decays at a higher rate.
Whereas antigen lasts for about seven days during primary response, after the booster it disappeared
in only two days. This reduction in the available antigen will practically make the presentation process
stop, and it will cause those terms related to immunological memory to become more important. The
presentation process diminution is clearly observed in figure 2.11, where the two inoculations times are
indicated by red dashed lines. A lower concentration of APCs scarcely activate T lymphocytes which
only reach less than 10% of their carrying capacity.
Figure 2.12 shows the dynamics of IgY concentration. As it was expected, primary response requires
several days to initiate. A delay between the input (day 11) and the response beginning is observed. In
contrast, secondary response starts almost immediately and reaches a peak four days later, compared
to the ten days needed for the first response. Additionally, the maximum antibody concentration is five
times higher than the primary response.
For the set of parameter values proposed in this chapter, the memory cell population did not reach
the carrying capacity in the primary response. Since a fraction of the active B cells differentiate into
memory lymphocytes, the larger cellular expansion of the secondary response forces that population
to rapidly reach the carrying capacity, see figure 2.13. After saturating this population, the dynamics
of memory cells is not related to the antigen booster. Despite the fact that a sudden increase in the
number of memory cells will not be observed in the immune system, the model reflects that a significant
increment on B lymphocyte population size will produce a larger proportion of memory cells reaching
a peak for Bm variable faster, compared to the first antigen dose. After this effect, the steady state of
the equation will not be modified by subsequent inoculations.
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Figure 2.11: Secondary responses of APCs and T lymhpocytes. Secondary response is mainly determined
by memory cells; a significant decrease in presentation activity and scarce naive CD4+ T lymphocyte
activation is observed.
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Figure 2.12: Secondary response of antibody population. The booster response is stronger than the
primary response and it is produced in less time.
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Figure 2.13: Response of memory cells for two inoculations. Memory lymphocyte population reaches its
carrying capacity and afterwards it keeps constant. Secondary response suddenly increases this variable
forcing it to reach its maximal level.
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Figure 2.14: Assessment of variation on inoculation days. Booster shots were carried out from the day
11 to 60. The change form primary to secondary response is clearly observed.
The model of the humoral immune response will be used in this work to define inoculation timetables
in order to maximize the amount of specific antibodies. Figure 2.14 illustrates the model’s performance
under modifications in booster day. In other words, a primary injection is carried out on day 11 and just
one booster is applied from day 11 to day 60. Each curve represents the IgY concentration response in
terms of the combination of initial inoculation and booster. From this graph is recognized that boosters
applied before the memory cell population growth have a little effect in the increment of immunoglobulin
production. Booster shots delivered later than the 22nd day clearly generate secondary responses.
The last figure in this section shows the IgY response when three inoculations are applied on days
11, 39 and 60. In the graph 2.15, after the booster two, identical responses are produced. Since it has
been supposed that memory cell population reaches a maximum and keeps constant, it is expected that
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Figure 2.15: Antibody response for three inoculations. Boosters applied after the second stimulation
produce identical responses to the the secondary.
all booster dose generate exactly the same responses. It has been observed experimentally that the third
humoral response in poultry is slightly higher than secondary [115]. However, this increase has a very
small contribution to the total amount of the produced IgY, then it was neglected.
2.4 Sensitivity analysis
A sensitivity analysis was also carried out in order to establish the effect of parameter variations on
each population included in the model. This analysis was based on the methodology proposed in [69]
that defines the dynamic system as:
x˙(t) = f(x, λ) (2.22)
where λ represents the vector of parameters and f(x, λ) is the function that depends on the states and
parameters and describes the system dynamics. The time derivative of the sensitivity function is:
S˙(t) =
[
∂f(x, λ)
∂x
]
S(t) +
[
∂f(x, λ)
∂λ
]
(2.23)
Sensitivity function is also associated with a defined trajectory that represents any particular response,
for instance a primary response. Equation 2.23 can be numerically solved using a Matlab solver, for
example Dormand-Prince (ode45). In the figures below, the integral of the sensitivity functions (solutions
of equation 2.23) are showed for trajectories produced by primary and secondary responses. It is
important to remark that model’s populations have different orders of magnitude, then integral values
of the sensitivity functions were normalized to the integral of the size of its respective variable to make
them comparable.
Results of this section are organized as follows: the effect of all parameters on each of the populations
composing the model are presented separately. Each figure, from 2.16 to 2.21, shows the integral of the
sensitivity function of each particular population as affected by the parameters. In order to highlight
parameters with greater effect on the model response, the parameters leading to higher sensitivity values
are described first.
The graphical representation of the sensitivity analysis for parameters of the IgY equation is showed
in figure 2.16. The immunoglobulin production rate (φ) is the parameter to which the model is most
sensitive, with a calculated sensitivity of 2.2×106. For the primary response trajectory all variables are
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Figure 2.16: Sensitivity of immunoglobulin equation for primary and secondary responses. The model
is most sensitive to the IgY production rate, with up to five orders of magnitude higher than other
parameters.
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Figure 2.17: Sensitivity of memory cell equation for primary and secondary responses. Memory lym-
phocyte generation rate has a significant effect on whole model dynamics, specially on Bm.
significantly modified when this parameter changes, specially memory cell and antibody populations.
For the booster response, the IgY is the most sensitive population, under variations in φ.
Sensitivities calculated for variations of parameters included on the memory cell equation are pre-
sented in figure 2.17. As expected, the memory cell generation rate (γm) is the parameter most strongly
affecting the dynamics of this population for the primary response with a very high sensitivity value
(1.5×105). This parameter has a significant influence in secondary responses, especially for Bm. In this
case, the calculated value was 3×104. On the other hand, parameters r and hm, that have no biological
meaning and contribute for a very short time in the model’s response, present a very low sensitivity.
This result validates the arbitrary value selection of those two parameters.
Only taking into account parameters included in the T cell equation and for trajectories defined by
primary and secondary responses, T lymphocyte activation rate due to APC (σ) is the parameter that
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Figure 2.18: Sensitivity of T lymphocytes equation for primary and secondary responses. CD4+ T cell
activation rate by antigen presenting cells is the most sensitive parameter for both trajectories.
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Figure 2.19: Sensitivity of active B lymphocytes equation for primary and secondary responses. Primary
trajectory is more sensitive to death and activation rates of this population.
most modifies the response. Figure 2.18 illustrates this feature. In the first inoculation, the dynamics
of memory and T lymphocytes changes more significantly if σ modifies its value. For the booster shot,
CD4+ T cells are the most sensitive population of the model. The rest of the parameters have a small
effect on model response.
Figure 2.19 shows the normalized integral of parameter sensitivity of active B lymphocyte equation.
Death and activation rates have the higher influence in changing model dynamics, particularly for
primary responses. Since memory cell population increase as a result of active B lymphocyte growing,
this variable is the most sensitive to changes in ζ. In addition, it was found that variations in carrying
capacities for primary and secondary responses produce slight modifications in model’s behavior. Clonal
expansion and effector lymphocyte production from memory cells rates also have a very small sensitivity.
Sensitivity results for the parameters of the antigen dynamics equation are presented in figure 2.20.
During primary response, the saturation level of activation function, hAg, is the parameter that has
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Figure 2.20: Sensitivity of antigen dynamics equation for primary and secondary responses. Antigen
elimination rate and saturation level of the activation function are produce the most significant changes
in the model performance.
the highest influence on the population’s behavior, especially memory cells. In addition, this parameter
significantly modifies APC and T lymphocyte dynamics in secondary responses. Even though all popu-
lations are sensitive to antigen elimination rate δAg, the effect is not considerable. The other parameters
of the equations 2.1 and 2.2 have a very low effect on model response. It is important to emphasize that
results of sensitivity analysis described in this paragraph produced small values compared to sensitivities
described above, some of them were different by up to four orders of magnitude.
Variation of parameters included in antigen presenting cell dynamics equation has a very low effect
on the model for primary and secondary trajectories. Results are very similar to those found for the
antigen equation, the sensitivity was very low, see figure 2.21. Regarding to the parameters included
in APC’s equation, only the half life of presenting cells (µA) generates changes in any population. A
remarkable result of this analysis was the scarce sensitivity of model’s variable to carrying capacity (KA)
of this population. The value used for this parameter was arbitrarily selected and the fact that it does
not modify populations’ dynamics lessens the importance of this decision.
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Figure 2.21: Sensitivity of antigen presenting cells equation for primary and secondary responses. Death
rate is the parameter of this cell population with the highest effect on model’s variables.
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2.5 Summary
This chapter presented the mathematical model designed to represent humoral immune response in birds.
This model will be mainly used to describe the IgY production dynamics. Six molecular and cellular
populations that participate in the immune response were included to depict presentation, activation,
clonal expansion and memory phenomena.
This model also includes 28 parameters, three of them without biological meaning. From avian
and mammal immunological reports an initial value parameter set was proposed. Nevertheless, several
parameters could not be obtained from the published literature and ultimately were obtained by means
of simulations. The values chosen were those that made the responses similar to typical ones.
Using these values some simulations were carried out to check the model’s behavior with one or
several immunizations.
Finally, a sensitivity analysis was performed to define which parameters have a higher effect on the
system dynamics. Sensitivity calculations were established independently for primary and secondary
trajectories, although results were very similar for both cases.
Some remarkable results of this chapter are:
• A dynamical model comprised of six differential equations that adequately describes the behavior
of the adaptive immune system in birds was designed. This model includes presentation, activation,
and memory processes.
• The proposed model effectively represents transitions from primary to secondary response allowing
to study the effect of changing time of booster application.
• Even though the immune response includes delays, it was possible to build a mathematical model
based exclusively on differential equations (without delays) and simple functions as mass action,
sigmoid and Hill functions (saturations).
• The initial proposed parameter value set included experimentally established values, mainly for
mammals (mouse and rat) and some found for poultry. However, to the authors’ knowledge several
parameters have not been measured and it was necessary to determine them through simulation.
• Sensitivity analysis allowed to detect the scarce effect of some parameters such as: cellular pro-
duction rates or carrying capacities. Activation, death and, specially, IgY production rates had
very high sensitivities.
• Results of sensitivity analysis confirmed that arbitrary selection of some parameters does not imply
significant differences on model’s response. Therefore, these values will not produce important
changes in parameter estimation and optimization processes.
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Chapter 3
Experimental measurement of the avian
immune response against proteinic antigen
In the previous chapter a dynamical model of the humoral immune response was developed to adequately
represent the published responses. However, some of the proposed parameters were obtained from
reports of mammalian immunology or using simulations. A set of molecular and cellular measurements
from twelve hens (organized in three groups of four) were carried out in order to: characterize the
immune response, contrast the model to a specific response and suggest more accurate values for the
parameters. This chapter describes the experiments and illustrates the results. Immunoglobulin (IgY)
concentration in yolk and plasma were measured as well as CD4+ T and B lymphocyte kinetics in
peripheral blood. The group average and individual responses are presented.
3.1 Experiment description
All the experiments described here were performed with the support of five undergraduate students of
Biology. Four variables were measured in order to characterize the avian dynamical response against a
proteinic antigen, IgY concentration in plasma and yolk and B and T lymphocytes. Measurements were
carried out twice a week and a total of 21 samples were obtained in a period of 81 days. The experiment
was performed with twelve hens divided in the following three groups:
1. Control (birds number: 206, 207, 214 and 226).
2. Birds immunized with 50µg of Leishmania infantum proteinic extract (birds number: 205, 223,
228 and 230).
3. Birds immunized with 500µg of Leishmania infantum proteinic extract (birds number: 203, 219,
220 and 229).
Bird species Gallus gallus, Babcock Brown breed, used in this study were kept in the Avian Produc-
tion Building at the National University of Colombia, in Bogota. Each experimental group composed
of four hens with similar weight were randomly selected from a group of thirty birds.
At the beginning of the project, the techniques required for measuring the immune response were
standardized. Then, the following immunization scheme was applied:
Peripheral blood samples and eggs were collected for eleven days before the first inoculation (three
samples) in order to establish base line values of the experimental measurements. The immunization
consisted of an intramuscular injection of 500µl of antigen (50µg for the group 2, 500µg for the group
3 and vehicle for group 1) sterile PBS mixed with complete Freund’s adjuvant in a proportion of 1:1
(volume to volume). The booster was applied at the day 39th, using half of antigen dose (25µg for the
group 2, 250µg for the group 3 and vehicle for the group 1) diluted in an emulsion of sterile PBS mixed
with incomplete Freund’s adjuvant.
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Methods for antibody measurements
The immunoglobulin (IgY) concentration in peripheral blood and yolk was experimentally measured for
the twelve birds of the study. For both types of measurements the same techniques were used except
for a previous stage of delipidation for yolk antibodies. These data were subsequently used in order
to adjust the model and allowed to check the similarity between the responses of these two sources of
immunoglobulins.
One of the most common methods to find the approximate specific antibody concentration in a
sample, consists in producing serial dilutions of the sample and an immunochemical technique that
identifies its titer. This method supposes an equal protein and antibody concentration for all samples.
If this condition is not achieved some bias would be introduced in the data. It was observed in this
study (data not shown) that the protein levels and the total antibody concentration present significant
variations along the study. During the response, the total IgY level increases by 100% or more of its
basal value and then drops to the initial value. Our experimental design takes into account this variation
since it determines both the net total and specific IgYs in plasma and yolk.
Figure 3.1 illustrates the standardized protocols for quantifying IgY concentrations in plasma and
yolk. Initially, total protein concentration was determined for each sample in order to utilize the
same protein amount (500ng/well) during total IgY level quantification in an ELISA (Enzyme-Linked
ImmunoSorbent Assay) test. Total protein concentration was determined by a Bradford assay (BioRad)
using Bovine Serum Albumin as standard. Then, IgY levels present in 500 ng total protein per well,
was determined employing a direct ELISA using an antibody conjugated to radish peroxidase (Donkey-
anti-IgY-HRP, Gallus Immunotech). A linear detection range for the corresponding standard curve was
between 2 and 60ng of purified IgY and was used to quantify their levels per sample.
After determining the specific value of total IgY for each sample, an indirect ELISA was implemented
using as antigen 300ng/well of Leishmania infantum protein extract. First, antigen was immobilized in
the plate, then the non bound surface was blocked and 500ng of total IgY was added to estimate the
IgY amount specifically bound to the immobilized antigen. This methodology eliminates the typical
measurement error of the systems based on titer identification and produces accurate values of the net
specific IgYs in a sample.
For the case of yolk IgY, the procedure is a modification of the reported by [101]. Briefly, the process
started separating the yolk of the selected eggs using a yolk removing tool, and eliminating traces of
albumen by rinses with distilled water. Approximately 6 ml of yolk were collected from each available
egg. One volume of yolk was diluted with 9 volumes of Tris-HCl 10mM pH 5.00 and Sodium Azide
0.05% and incubated at 4◦C during 16 hours. Diluted yolk suspesion was centrifuged at 10000g, 4◦C
during 25 minutes. Pellet was discarded and the supernatant contained an IgY enriched fraction which
Bradford assay
Total protein
Direct ELISA
Total IgY level
[500 ng protein]
Indirect ELISA
Specific IgY
[500 ng IgY]
(a) Plasma
6 ml of yolk per egg
Dilution in 9:1 of Tris-
HCL
Centrifugation 10000g
Separation
Plasma process
(b) Yolk
Figure 3.1: IgY measurement protocols.
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2 ml of blood
collected
Viability assay via
trypan
Cellular immunophe-
notyping
Diluted 1:2 PBS
centrifuged
Pellet resuspension Flow cytometry
Layered Hystopaque
centrifuged
Washed twice PBS Data analysis
Figure 3.2: Cellular measurement protocol.
Cellular population CD4 FITC CD3 R-PE Bu-1 FITC
CD4+ T lymphocyte + + -
B lymphocyte - + +
Table 3.1: Antibody markers used for each cellular population
was used for all IgYs detection assays using the technique described for plasma immunoglobulins.
Methods for cellular measurements
The immune response was simultaneously characterized in terms of CD4 T and B lymphocytes by
flow cytometry, using the membrane cell markers CD4 and Bu1, respectively. Specific cell levels were
quantified in peripheral blood, throughout the monitoring. It is important to remark that all the
measurements detected circulating lymphocytes positive for the antigens screened and did not determine
unequivocally cell population that bears the specific receptor for the inoculated antigen.
Stages for measuring cellular concentrations are described in figure 3.2. The procedure started
obtaining a volume of 2 ml of peripheral blood from a wing vein and collected into EDTA contain tubes
as anticoagulant. Blood samples were analyzed in laboratory within the next two hours. Separation of
peripheral blood mononuclear cells (PBMC) was performed at room temperature. Briefly, blood samples
were diluted in a proportion 1:2 with PBS and the buffy coat was recovered after centrifugation at 500g
and resuspended in 2ml PBS. Buffy coat cell suspension was then layered onto 2ml of Hystopaque 1077
(Sigma) and centrifuged 500g during 30 minutes at room temperature. Following centrifugation opaque
interface was carefully collected and washed twice at 4◦C with PBS and centrifuged during 10 minutes
at 800g. Finally, pellet was resuspended in 3ml PBS pH 7.2 and cell concentration and viability was
determined via trypan blue exclusion assay.
Mononuclear cell immunophenotyping was carried out with specific antibodies from Southern Biotech.
Antibodies used were as follows: mouse anti-chicken CD-4 Fluorescein (FITC) conjugate (No Cat. 8210-
02) and mouse anti-chicken Bu-1 Fluorescein (FITC) conjugate (No Cat. 8395-02). Finally, mouse
anti-chicken CD3 R-phycoerythrin (R-PE) Conjugate (No Cat. 8200-09) specific marker for CD3. All
monoclonal antibodies used were isotype IgG1κ. Table 3.1 summarizes the markers used for each cel-
lular population. One million cells obtained from the hytospaque separation per sample was used for
each immunostaining. Those cells were incubated with the corresponding set of antibodies in PBS sup-
plemented with 0.5% fetal bovine serum for 30 minutes at 4◦C in the dark. Final incubation volume
was 100µl.
Flow cytometry analyses were performed on a Beckman Coulter cytometer with a 488nm argon laser.
Green fluorescence from (FITC) was detected on the FL1 channel (530/30 nm band pass filter) and
phycoeritrin R-PE was detected on the FL2 channel (585/42 band pass filter). Cells were analyzed with
a minimum of 30000 events. Data were analyzed using FlowJoTM software (TreeStar, Inc., Ashland,
OR).
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3.2 Results of antibody characterization
In this section the analysis of the IgY concentrations detected in yolk and peripheral blood are described.
The preimmune levels are included in some figures and the difference between the measurements and
the basal levels are illustrated. Lastly, a comparison between the response in yolk and in plasma is
presented.
Figure 3.3 shows the responses for the three experimental groups. Each point in the figure was
obtained by the average of the three repetitions of each sample and the average of the four hens in
each group. In the same figure, inoculations are represented by red dashed lines. As expected, primary
response, that includes a few IgYs, it is not clearly observed. On the other hand, secondary response
is very well defined reaching a similar peak concentration (0.45 [mg/ml]) for both experimental groups,
ten days after the booster. This result also represents an important fact, at least qualitatively, antibody
production for groups of 50µg and 500µg antigen doses was almost identical. Observe that, the control
group kept its specific antibody levels very low during the experiment, validating the measurement
technique.
Prior to the primary inoculation three samples were taken in order to estimate the preimmune basal
IgY level. The average of these three data was defined as a base line and will be used to compare the
net response value. Figure 3.4 shows the responses and base lines of each group. Notice that the 500µg
group had higher basal IgY levels compared to the 50µg group, although similar to the control group.
Figure 3.5 illustrates the responses after subtracting their base lines. This graph allows to contrast the
difference between basal levels and the secondary response.
A method to estimate the total performance of each experimental group, in terms of specific IgY yield,
consists in assessing the area under the curve (AUC) of the immune response. Table 3.2 summarizes
the AUCs for the three groups, including raw measured data and IgY concentration after base line
subtraction. The group inoculated with 500 µg antigen produced 33% more antibodies than the second
group. Remarkably, if the basal levels are eliminated, the highest production was achieved with the
lower antigen concentration (group 2).
An unexpected result for the immunized groups was found at the day 53, when an outlier was
obtained. The secondary response peak is clearly defined (day 49) but the next measurement drops
considerably and the following points maintained the trend expected for this response. Therefore,
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Figure 3.3: Specific IgY concentration in plasma for the three experimental groups. The black line
represents the response for the second group, in green for the third and in blue for the control. Red
dashed lines refer to the inoculations. Despite the amount of antigen utilized was ten times more for
one group, the responses were very similar.
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Figure 3.4: Specific IgY concentration in plasma for the three experimental groups including base lines.
Horizontal dashed lines represent preimmune levels of each group and arrows symbolize inoculations.
Control and the third groups showed a higher measurement noise (higher preimmune values).
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Figure 3.5: Specific IgY concentration in plasma for the three experimental groups subtracting base
lines. The red line identifies the zero concentration level and arrows symbolize inoculations. The group
with the lower antigen concentration, had a larger production. Primary response is not distinguishable.
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Control group 50µg group 500µg group
[mg/ml] [mg/ml] [mg/ml]
Including BL 1.4238 2.8975 3.8663
Subtracting BL -0.7429 1.8308 1.3829
Table 3.2: Area under the curve of specific plasma antibodies for each experimental group
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Figure 3.6: Specific yolk IgY concentration for the three groups. The same colors are used here: black
for 50µg, green for 500µg and blue for control. Once again, red dashed lines refer to immunizations.
Even though inoculation affected the laying process generating a small data set, a secondary response
is clearly obtained.
only the datum of the day 53 behaved in a completely different fashion from the presumed curve.
The first plausible explanation was a measurement error, yet data obtained from yolk generated a
similar response and those two types of antibodies were extracted and measured independently. This
phenomenon requires a more detailed study in order to characterize its occurrence. Therefore, in this
thesis that point will be eliminated of the measurement set used for parameter estimation process.
Data obtained for yolk antibodies presented a similar behavior compared to plasma IgYs, see figure
3.6. Secondary responses are clearly distinguished, even though the 50µg group was more affected by
the booster, halting bird’s lying. Therefore, there is no data from day 39 to 53. Still, peak response
of this experimental group was definitely larger than that generated by the group inoculated with the
highest antigen dose.
Base lines for these measurements are presented in figure 3.7. The third group response showed the
highest preimmune IgY levels as observed in plasma. When this background is eliminated a conclusion
about the IgY production can be addressed. The response illustrated in figure 3.8 and the area under
the curve analysis summarized in table 3.3 demonstrate that group two is the most efficient group.
Consequently, the 50µg group produced better results compared to the 500µg group in terms of specific
IgYs, both in plasma and in egg yolk.
According to published reports [38, 101], specific yolk IgY levels present a very similar kinetics to
plasma antibodies, but delayed about seven days due mainly to the required time to accumulate in
yolk, these proteins from the extracellular medium. This study shows two features slightly different.
If the day when the plasma and yolk IgY concentration reach their peaks are considered as reference,
the second group presented a three days delay, see figure 3.9. On the other hand, for the 500µg group
a peak in yolk occurred before detecting the peak in plasma at day 43. However, three days after the
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Figure 3.7: Specific yolk IgY concentration for the three groups including base lines. Dashed lines show
preimmune values and arrows symbolize inoculations. Notice that the third group almost doubles the
preinmune level of the other experimental groups.
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Figure 3.8: Specific yolk IgY concentration for the three groups subtracting base lines. Red line indicates
zero yolk IgY concentration and arrows symbolize inoculations. The group inoculated with 50µg of
antigen yielded 20% more immunoglobulins than the third group.
Control group 50µg group 500µg group
[mg/ml] [mg/ml] [mg/ml]
Including BL 2.1017 5.5417 8.1163
Subtracting BL 0.3600 2.9417 2.4512
Table 3.3: Area under the curve of yolk antibodies for each experimental group
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Figure 3.9: Comparison between specific IgY in plasma and yolk for the 50µg group. The black curve
illustrates the response in yolk, whereas the blue one corresponds to the plasma concentration. Both
responses present similar performances showing a three days delay with regard to the maximum peak.
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Figure 3.10: Comparison between specific IgY in plasma and yolk for the 500µg group. The response
in yolk is drawn in black, while plasma concentration is presented in blue. Except for the day 43, both
responses are similar and showed the same three days delay.
plasma peak another yolk maximum was found, figure 3.10.
A quantitative methodology for determining the similarity between responses in plasma and yolk
could be very useful. Therefore, the linear correlation (that measures whether a signal is proportional to
another one) between those two types of responses was calculated [94]. However, the implementation of
this technique requires uniformly spaced data series and this was not the case neither for yolk or plasma
samples. To solve this issue, the original measurements were linearly interpolated to generate a point
every two days. Figure 3.11 shows the original and the interpolated points for concentrations of specific
IgYs in plasma and yolk for the 50µg group. Observe that, some actual measurements (symbolized in
red) were not included in the new set (interpolated data), since they do not correspond to an uniform
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Figure 3.11: Linearly interpolated measurements of specific IgYs in plasma and yolk for the 50µg group.
Original measurements were represented in red, while the interpolated curve was showed in black. In
this way, each two days a sample was obtained.
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Figure 3.12: Linearly interpolated measurements of specific IgYs in plasma and yolk for the 500µg
group. Original measurements were represented in red, while the interpolated curve was showed in
black. In this way, each two days a sample was obtained.
separation. The same result for the 500µg group is illustrated in figure 3.12. Finally, figure 3.13 contrasts
the yolk and plasma responses for both experimental groups, making more evident the similarity.
Using the interpolated data it was possible to calculate the linear correlation. Numerically, linear
correlation for 50µg group was 0.7321, whereas for 500µg group was 0.8053. Remember that, an index
value near to one represents two proportional signals. Therefore, calculated index values suggest that
responses in both groups were related and the yolk responses follow the plasma ones. Additionally, the
higher value for the linear correlation of the third experimental group could be explained by the absence
of a notorious delay in the yolk response; see figure 3.13.
A better characterization of the delay between yolk and plasma responses would be also desirable.
Utilizing a cross correlation function is also possible to establish numerically the lag between these
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Figure 3.13: Comparison between interpolated yolk and plasma IgY concentrations for both experimen-
tal groups. Plasma points were represented in red and black lines refer to yolk. Similarity between these
two responses suggests that they are proportional.
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Figure 3.14: Cross correlation between plasma and yolk responses for both experimental groups. Red
line represents the highest value for the correlation index. This value occurred with a three samples (six
days) delay for the 50µg group, and with no delay for the 500µg group.
two responses [94]. Figure 3.14 shows the results of applying this function to the interpolated data.
Here, a higher correlation value in a determined position means that displacing the signal that number
of samples produces a more proportional relation between yolk and plasma IgYs. Notice that, 500µg
group had the highest correlation (red line) value on zero displacement , while the 50µg group requires
a delay of three samples (six days) to reach the index peak. However, the difference between the cross
correlation index calculated with a displacement of two or three samples is practically negligible for the
second experimental group. In consequence, the specific IgY concentration in yolk follows the plasma
response with a delay between four and six days, a slightly longer time than that suggested by the
qualitative analysis described above.
To characterize the net increase in antibody concentration, table 3.4 shows the ratios between preim-
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50µg group 500µg group
Plasma 8.2500 3.7852
Yolk 7.6770 2.4471
Table 3.4: Ratio of increase for plasma and yolk antibodies for each experimental group.
Production Reduction Losses
[mg] [mg] %
Raw data 70.03 7.74 11.06
Subtracting BL 41.48 5.02 12.11
Table 3.5: Losses of yolk antibodies due to halt in laying for the second experimental group.
mune levels and peak secondary responses for both experimental groups in yolk and plasma. Since the
second experimental group (50µg) had lower preimmune levels, the increase in the specific antibody
concentration was as high as 8.25 times. On the contrary, high basal levels of the third group suggested
a lower intensity of the secondary response (3.78 times). Conclusively, it is clear that a significant
increase was measured by the proposed technique.
Another criterion for characterizing the performance of the antibody generation using birds, is the
effect of the absence of laying on total IgY production. Since immunoglobulins are collected from the
eggs, pauses on hens’ laying reduce the total antibody yield. Table 3.5 summarizes the total amount
of yolk IgY produced in the experiment described in this chapter and the losses generated by the days
when hens did not lay an egg. In this table, only the results for the 50µg group were mentioned since
this experimental group lacked of some samples (eggs), while birds of the third group had at least an
egg in each day sampled. Taking into account only the processed eggs and assuming a yolk volume of
12 ml, the total immunoglobulin production was 70.03 mg. However, after the booster, and for two
samples, none of the birds of this group laid an egg. The effect of this behavior on the produced IgY can
be quantified interpolating between measurements registered before and after the pause and calculating
the amount of specific antibodies that would be yielded. This calculation suggested a loss in production
of 7.74 mg (11.06%). The same analysis was performed for the data minus the preimmune level; as it
is showed in the table 3.5, the results were very similar to those already commented.
Specific IgY response per hen
Figures presented before correspond to the average IgY concentration dynamics of the four birds of each
group, and allowed to observe some immune response features when a proteinic antigen is inoculated.
Figures 3.15 and 3.16 show individual behavior of each hen and illustrate the variation among birds.
Peripheral blood response is represented in blue and the yolk response in black.
Additionally, table 3.6 summarizes peak values in peripheral blood and yolk and days which these
peaks occur. Notice that, the bird with the highest production in plasma as well as yolk, belongs to the
group with the lowest immunization dose. Hens with the highest antibody concentration in plasma have
also the highest IgY concentration in egg yolk. Except for bird 223, results shown in table 3.6 suggest
that there is a direct relation between IgY production in plasma and in egg yolk. An interesting fact
was that blood peak was very consistent, seven out of eight birds generated the peak ten days after the
stimulus; again bird 223 was the exception for just one sample.
Birds 205 and 230 of the 50µg group generated the highest responses and the hen 228 the lowest.
IgY concentration detected in all birds was higher in yolk than in plasma reflecting the fact that
more antibodies were transported towards the egg than those circulating in peripheral blood. The
yolk responses in all birds followed (except for one outlier) the plasma antibody curve. Notice the
concentration reduction after the peak and a sudden increase after the outlier for all data sets. The
response delay (defined as the time between the peak in plasma and the corresponding maximum levels
in yolk) was the most variable feature in the measurements of this group. Birds 205 and 223 presented
a three days delay in their response, whereas birds 228 and 230 the delay was about seven days. The
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Bird Group Plasma peak Yolk peak Plasma peak Yolk peak
[mg/ml] [mg/ml] Day Day
205 50 0.76 1.08 49 52
219 500 0.76 0.85 49 47
230 50 0.47 0.79 49 61
220 500 0.47 0.69 49 52
229 500 0.43 0.49 49 39
223 50 0.37 0.66 47 52
228 50 0.24 0.42 49 57
203 500 0.22 0.61 49 52
Table 3.6: Comparison among maximal responses in all inoculated hens.
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Figure 3.15: Plasma and yolk antibodies measurement for the first bird group. Yolk response is repre-
sented in black, while the plasma response is symbolized in blue.
latter two were the most affected birds in their laying as a result of the booster which prevented an
earlier detection.
Measurements obtained for the third group reflected higher basal levels than in the observed in the
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Figure 3.16: Plasma and yolk antibodies measurement for the second bird group. Yolk response is
represented in black, while the plasma response is symbolized in blue.
second one, and hindered the comparison between blood and yolk responses. The yolk response delay
exhibited a similar variation to the previous group. Birds 203 and 220 showed a peak in yolk three days
after the plasma maximum; the other two hens presented maximal values before the plasma peak that
could be probably result of measurement noise. In this group the best performance was obtained by the
hen number 219 and the worst by 203, which produced a scarcely perceptible secondary response.
3.3 B lymphocyte response
Average results for B lymphocytes are illustrated in figures 3.17 to 3.19. Similar to immunoglobulin
measurements, a base line was calculated to determine the basal levels of this type of cells which are
included in the graph. Prior to the second immunization, B cell were below 75.000 [Cel/ml], while after
the 50 day reached values about 300.000 [Cel/ml]. Even though it is not possible to claim that this
cell population corresponds exactly to lymphocytes responsible for producing specific antibodies, it is
obvious that after the booster a significant increase in cell concentration is observed. Hence, a secondary
response was clearly detected.
Notwithstanding, B lymphocyte population dynamics was not detectable after the first inoculation,
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Figure 3.17: B lymphocyte average concentration for each group. The black line represents the response
for the second group, in green for the third and in blue for the control. Red dashed lines refer to the
inoculations. Response for both experimental groups were very similar and was detected with four days
delay compared to IgYs.
as in the case of IgYs. Notice that preimmune values are very similar to those generated after the first
inoculation at the eleventh day. The first immune response is mainly composed of IgM isotype (not
measured in this study), which explains the low IgY concentration detected. It was expected that the
behavior of total B lymphocyte population (regardless of their receptor isotype) would show a defined
increment after the first immunization, but that situation was not observed with this experiment.
Secondary responses for both experimental groups were very similar. Maximal detected values were
in the same range and occurred almost simultaneously. The decay trajectory also followed the same
shape for both applied doses, reaching to the basal level about the day 80. Even though the control
group showed a secondary response, its maximal intensity was about half of other groups. This result
suggests that adjuvant (included in the solution applied to birds of the control group) also produces
an expansion of the B lymphocyte population. Hence, the response of the two inoculated groups is
comprised of a component specific for the antigen and a component due to adjuvant. However, this
substance is always added to antigen in order to generate antibodies and its effect should be considered
in the response.
Regarding base lines (figures 3.18 and 3.19) the same pattern observed for IgYs was repeated.
Measurements with the highest basal level corresponds to data obtained from 500µg group; control and
50µg groups registered a basal line half of that in the third group. When this component is subtracted
from the data, it is clear that there is not a significant difference between the immunized bird groups.
This result confirms that the lower administrated dose is enough to stimulate the poultry immune system
with this antigen.
An interesting fact was that variations in B lymphocyte (Bu+) population do not match changes in
specific plasma IgYs. This fact suggests that B lymphocyte activation process, by antigen molecules,
and plasma IgY secretion occur approximately four days before B cell clones enter peripheral blood
circulation and became detectable by our assay.
Lastly, in figure 3.20 a comparison between the B lymphocyte and IgY responses is illustrated. Cellu-
lar measurements are represented in blue, while specific antibody concentrations are in green. Observe
that, in both experimental groups, secondary responses are highly correlated; cellular and molecular
peaks occur nearby and concentration decay takes almost the same time. Then, it is possible to infer
that data obtained for the B lymphocytes correspond to the population responsible for producing IgYs
specific for the inoculated antigen. Therefore, this response can be utilized to modify some parameters
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Figure 3.18: B lymphocyte average concentration including base lines. Dashed lines show preimmune
values and arrows symbolize inoculations. Preimmune level found for the 500µg group was more than
double of the other groups.
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Figure 3.19: B lymphocyte average concentration subtracting base lines. Red line indicates zero B
lymphocyte concentration and arrows symbolize inoculations. If the bias introduced by the base line is
eliminated, a very similar secondary response behavior is observed for both experimental groups.
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(a) 50µg group
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Figure 3.20: Comparison between B lymphocyte response and IgY concentration for both experimental
groups. B cells are represented in blue, IgYs are in green and red dashed lines represent the inoculations.
Similarity between these two responses suggests that cellular measurements correspond to the population
responsible for producing specific antibodies.
of the mathematical model. This figure also suggests that B cell measurements in peripheral blood are
a delayed version of the clonal expansion in germinal centers, since circulating immunoglobulins were
detected first.
3.4 CD4+ T lymphocyte response
Characterized behavior of CD4+ T lymphocytes was less consistent than that obtained for B lympho-
cytes. In figure 3.21 the average of each experimental group is showed as well as inoculation days (dashed
lines). Prior to the first antigen dose, levels of the three groups are very similar to those found in the
secondary peak response. It is important to emphasize that it was possible that a previous immune
response has interfered in the experiment. This result has also consistency with the well known fact
about the lower clonal expansion for this type of cells.
The blue curve in the figure 3.21 shows CD4+ T lymphocyte concentration for the control group;
notice that this group elicited the highest concentration for both primary and secondary responses.
Since the response is independent from the antigen injection, it does not contribute to characterize T
cell dynamics bearing a specific receptor for the interest antigen. In addition, there was no other source
of information that allowed to determine whether T cell measurements correspond to the expected
immune response as occurred for B cells using the IgY data. On the other hand, both inoculated groups
presented a similar response. This pattern occurred in all experiments performed in this thesis.
Maximal responses obtained after the booster presented the same chronological delay observed for B
lymphocytes. The highest levels were reached on day 55, several days after IgYs peaks, indicating that
these cells are only detectable in peripheral blood, some time after plasma cell activation in germinal
centers. However, secondary peaks of T and B lymphocytes took place simultaneously or within a few
days.
Figures 3.22 and 3.23 illustrate base lines of T lymphocyte responses and the resulting data after
subtracting this component. As observed in figure 3.21, control group generated the highest response
and groups two and three behave similarly. In this last measurement the 500µg group exhibited also the
highest basal level. The result of the control group suggests that the adjuvant response is comparable
to the detectable specific response due to the lower expansion of this type of cells.
58
0 10 20 30 40 50 60 70 80
0
0.5
1
1.5
2
2.5
3
x 105
Time [Days]
T 
CD
4+
 L
ym
ph
oc
yt
e 
co
nc
en
tra
tio
n 
[C
el/
ml
]
 
 
Control
50µg
500µg
Figure 3.21: CD4+ T lymphocyte average concentration. The black line represents the response for the
second group, in green for the third and in blue for the control. Red dashed lines refer to the inoculations.
The highest response is yielded by control group; groups 2 and 3 showed a similar kinetics. Preimmune
values were comparable to booster response for groups one and three.
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Figure 3.22: CD4+ T lymphocyte average concentration including base line. Dashed lines show preim-
mune values and arrows symbolize inoculations. The highest preimmune value was obtained for 500µg
group and the lowest for 50µg group, this behavior was observed for all measurements.
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Figure 3.23: CD4+ T lymphocyte average concentration subtracting base line. Red line indicates zero
T lymphocyte concentration and arrows symbolize inoculations. The highest response was achieved by
control group indicating that this response was independent of the antigen.
T and B lymphocyte response per hen
Figures 3.24 and 3.25 illustrate individual cellular response for all birds. In each subfigure T and
B lymphocyte data are presented for each hen belonging to groups two and three. A big diversity is
observed among individual responses; some of them clearly follow a secondary response and the maximal
values of the two populations coincide. On the contrary, other responses elicited sudden increments or
basal levels similar to concentrations found in secondary responses.
In the group immunized with 50µg of antigen, birds 205 and 230, that yielded the highest response,
T cell concentration increase preceded that of B lymphocytes. For instance hen number 205 produced
peaks at days 47th and 53th for cells T and B, respectively. Additionally, both populations initiate
their rising with one day difference. A very similar performance was found for bird 230. Here it is
important, to remark that the mathematical model mimics these results in terms of the two lymphocyte
populations involved in the humoral response. Measurements of remaining birds, 223 and 228, included
some points deviated from the expected curve. For instance, in the data of hen 223 a significant B cell
increment was observed at day 35th without any relation to the administrated antigen dose. The same
situation occurred for bird 228 with T lymphocytes.
Cellular measurements obtained for the group with the highest antigen concentration were similar to
those of the second group. For example, birds 219 and 229 developed a delayed response peak against
booster. Hens 205 and 230 showed the same pattern. Lymphocyte population dynamics for the bird 203
presented different features from the expected, such as: the preimmune concentration was the same size
than secondary response and B lymphocytes measurements exhibited an outlier after booster response
(day 56). Finally, measurements of hen 220 included a point that does not correspond to expected
curve and represents a second increment in T lymphocytes concentration after booster. If this point is
neglected, the response matches with the expected behavior of the two populations.
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3.5 Summary
This chapter presented an experimental set performed using twelve hens in order to characterize the
dynamic behavior of the immune response against a proteinic antigen, in this particular case Leishmania
infantum proteinic extract. Three experimental groups inoculated with different antigen amounts were
utilized in this study: 1) control group, 2) 50µg and 3) 500µg. For the three groups peripheral blood and
yolk IgY concentrations were measured as well as CD4+ T and B lymphocytes. The experimental design
allowed to quantify concentrations of specific IgYs in [mg/ml], instead of just the titer, making possible
to employ this numerical data in the parameter estimation process described in the next chapter.
Results showed that the second group (50µg), with ten-times lower antigen dose, yielded more specific
antibodies. This feature was determined by an area under the curve analysis of the responses subtracting
base lines (preimmune measurements average). As it is reported in the literature, plasma and yolk IgYs
responses are very similar except for a delay due to the time required to transport proteins from the
blood toward the egg. In this case the average time delay was three days. Secondary responses were
clearly defined, whereas responses against the first immunization were not observable. This behavior
was expected since primary response is mainly composed by IgMs.
CD4+ T and B lymphocyte measurements suggest a saturation effect of the antigen concentration,
since groups two and three generated similar responses despite the ten-times difference between antigen
dose. The model presented in the previous chapter mimics the measured kinetics for these two types of
cells.
From the experimental stage of this thesis some contributions can be highlighted:
• The most used methodology to measure antibody concentrations is based on titer quantification
using serial dilutions. In this thesis measurements were obtained in terms of net values (mg/ml)
rather than relative ones (titer). With known net IgY values, parameter estimation process was
facilitated.
• A similar total specific antibody production was obtained for both experimental groups, both
in blood and in yolk. In fact, the group inoculated with the lowest antigen dose yielded 30%
more antibodies than the group injected with 500µg of antigen, after normalization subtracting
preimmune levels.
• As mentioned in published reports, IgY measurements in peripheral blood and yolk are similar
except for a delay. Using average values of humoral response this time was established in three
days for both groups.
• Employing flow cytometry the entire kinetics of the immune response for CD4+ T and B lym-
phocyte concentrations in peripheral blood were characterized. Peaks values corresponding to the
secondary response will be used to adjust some of the initial guesses of the model parameters.
• Data of T and B lymphocyte dynamics confirmed consecutive responses, T cells increased their
number before the B cell concentration increment. This feature was observed in several hens.
However, T lymphocyte measurements were less consistent with the expected response, probably
due to the their lower clonal expansion.
• Values of cellular concentration were delayed with respect to IgY concentration rising, which
suggests that cellular kinetics in peripheral blood are detectable some time after clonal expansion
in germinal centers.
• An unexpected result of these experiments was the outlier presented after secondary response
peak. A sudden fall in IgY concentration was observed between the maximal point and the third
datum after the booster. This behavior was clearly identified in plasma for all hens and in yolk
for some birds.
• In addition to characterization of immunoglobulin and lymphocyte dynamics, an antibody pro-
duction against a Colombian strain of Leishmania infantum was successfully achieved. To the
best of the authors’ knowledge this specific parasite detection tool had not been produced.
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Chapter 4
Parameter estimation for the model of the
avian immune response dynamics
This chapter presents the results of the parameter estimation process for the avian model introduced in
the second chapter. The estimation process was carried out using plasma immunoglobulin measurements
for each experimental group and for the two birds with the highest response from each group. Here,
some aspects of the parameter estimation are established, such as: choosing an estimation methodology,
selecting the parameters to be estimated and the optimization algorithm employed to solve the least
square problem. In addition, the sensitivity of the algorithm regarding the initial parameter guess, was
analyzed. Finally, the estimated values for the four data sets are compared and some conclusions are
obtained.
4.1 Modification of some parameters from experimental results
The parameter estimation process consists of determining those values that minimize the difference
between measurements and model output. The methodology to fit the model response to a particular
set of data is based on setting an optimization problem whose objective is to minimize some error
function. The most common error function is the point-wise difference between the measurement and
the solution to the differential equation that define the system dynamics, squared. This problem is
known as non-linear least squares (NLS) due to the fact that the relationship between the model and
the parameters is nonlinear. This is the case of the current model. In order to solve this problem, several
solution approaches have been proposed, all of them based on an iterative scheme. A disadvantage of
these techniques is that they require an initial point (parameters initial values) near the estimated values.
Using the information obtained in the experimental stage, some improved guesses can be proposed for
those parameters.
Experimental data presented in the previous chapter were organized as cellular and antibody mea-
surements. Specific immunoglobulin concentrations in peripheral blood will be used to define the op-
timization problem that allows to tune the model to follow particular immune responses against the
inoculated antigen. The information obtained from CD4+ T and B lymphocyte dynamics can not be
employed to adjust the model since these measurements do not correspond exclusively to those popula-
tions that bear the specific receptor for the injected antigen. Moreover, T cell population did not show
a relation between the inoculated protein and the response.
Nevertheless, B cells exhibited a behavior more consistent with the expected kinetics, see figure 4.1.
Results illustrated in that graph suggested a change in some of the initially proposed parameter values.
The carrying capacity for the secondary response of this population has been assumed about 5×105 and
measurements indicated a peak of 250.000 [Cel/ml]. Since this value is established from the expression
KBp+BmKB, therefore KB = 20000. On the other hand, the observed decay time was higher than the
initial guess, (given by 1/µB = 1/0.33). A death rate of µB = 0.09 corresponds more adequately to the
observed time for both experimental groups.
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Figure 4.1: B lymphocyte average concentration, subtracting base line. The highest levels is about 220
thousand cells per mililiter and it is similar for both groups.
In addition, as discussed in the previous chapter, the experimental results proved that there is no
significant difference in the response with inoculations of 50 or 500µg of antigen. Therefore, it will be
assumed that both groups had the same concentration input to the model (1 [mg/ml]). This value was
determined from the third group: 500[µg] of protein diluted in 500[µl] of PBS and Freund’s adjuvant,
so the antigen concentration is 1[µg/µl] or in the model’s units, 1 [mg/ml].
4.2 Selection of the parameters to be estimated
The dynamical model proposed to represent the avian humoral response, described in chapter two,
includes 28 parameters, while the experimental measurement set is only comprised of 21 points. Hence,
it is necessary to select a parameter subset in order to make the estimation process feasible. Several
questions have to be considered for implementing this procedure: 1. How many parameters should be
included in the estimation algorithm to fit the model adequately? 2. Which parameters should be
estimated in order to obtain the best results? and 3. What optimization algorithm should be used to
solve the nonlinear least square problem that defines the estimation process?
The first two questions were answered by using a Monte Carlo-based random search method. The
strategy consisted in randomly selecting sets of parameters with varying numbers of members and
trying to solve the optimization problem for the optimum values for these parameters; all the remaining
parameters are fixed at their original value. Then, the fitting error was used as a performance index
that qualifies the estimation success for a given parameter subset. The answer to each question required
massive sets of estimations.
However, this approach required to determine the optimization algorithm for solving the NLS prob-
lem. In other words, the third question had to be answered while dealing with the first two. Four
possibilities were taken into account: trust-region [9, 99], genetic algorithms (GA) [47], Levenberg-
Marquardt (L-M) [76] and simplex Nelder-Mead [71]. Initially, the algorithm’s capacity for solving the
NLS problem, including only B cell and IgY equation parameters was assessed. In this way, it was
determined that the simplex Nelder-Mead algorithm was the only one that successfully converged to an
adequate solution. This will become evident in the estimations presented throughout the next sections.
Therefore, the Monte Carlo analysis used to select the parameters was carried out exclusively with this
algorithm.
In order to facilitate the reading of the results presented ahead, table 4.1 enumerates model param-
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Number Parameter Number Parameter
1. δAg 15. βB
2. δIg 16. ζ
3. hAg 17. γB
4. b 18. ψ
5. αA 19. KBp
6. KA 20. KB
7. η 21. µB
8. µA 22. γm
9. αT 23. KBm
10. σ 24. φ
11. γT 25. µIg
12. µT 26. n
13. KT 27. r
14. α¯B 28. hBm
Table 4.1: Model parameters
eters. From this point, each parameter will be called either by its name or by the number defined in
the table.
The number of parameters required to adjust the model output to the experimental data was obtained
performing massive estimations. Initially, three different parameters were randomly selected for inclusion
in the estimation process. Then, the optimization problem was solved using the simplex Nelder-Mead
algorithm. The squared sum of the point-wise difference between measurements and model response was
calculated as a criterion to detect a set of parameters that enables an effective estimation. This procedure
was repeated 500 times. Finally, the minimal and maximal error were calculated to characterize the
effectiveness of using the number of parameters being tested.
The same approach was repeated selecting up to eight parameters. Figure 4.2 shows the results
using measurements for both experimental groups. Squares represent the least error and the triangles
the highest one; results are symbolized in red for the 500µg group and in blue for the 50µg group. Notice
that, the maximum and the minimum values remain practically unchanged in all cases. A conclusion
that can be addressed from this experiment is that the estimation process for this model is almost
independent of the number of parameters included. This also means that the estimation depends more
strongly on which parameters are used. In the end, five parameters were included giving more flexibility
to the process. Higher numbers required much longer computing times.
Following a similar approach to the one discussed above, it was determined which parameters would
be used in the model tuning. In this case, 1000 estimations were carried out using random sets of
five parameters (as explained above) and calculating the error between the model output and experi-
mental data. Figures 4.3 and 4.4 summarize the results for the second and third experimental groups,
respectively. Estimation errors were sorted from lowest to highest and a line segment is drawn over the
corresponding numbers of the parameters being estimated in that case. For instance, notice that for
both groups, parameter number 25 (IgY degradation rate, µIg) appeared in all estimations with a small
error. The carrying capacity (number 20) and the death rate of B lymphocyte population (number 21)
were also often found in low error tunings. Observe that these parameters (20 and 21) do not show
up for cases at the top of the figure. The remaining parameters are distributed along the graph, this
indicates that they were not determinant in achieving an adequate estimation.
One of the better results was obtained when including the antigen degradation rate δAg and the
saturation level of the activation function hAg in the estimation process. Since the initial guesses of
these two parameters were established by simulation and the sensitivity analysis determined that they
had a significant influence in every population variation, they were included in the estimation procedure.
Memory cell production rate (γm) appeared in both low and high error results. However, it was chosen
for the estimation process since its initial value was established through simulation, and because it
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Figure 4.2: Maximal and minimal error using a different number of parameters in the estimation.
Squares represent the lowest error and triangles the highest. Notice that the variation on the amount
of parameters included in the process do not change the error level.
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Figure 4.3: Results of 1000 estimations using five parameters for the 50µg group. Each row represents
one estimation with a different set of parameters, organized from lowest to highest adjust error. Clearly,
some parameters generate a response more similar to experimental data.
presents a high sensitivity as explained above. In addition, it is crucial in determining the time required
for memory generation.
The antibody production rate (φ) could also have been used in the estimation. This rate presented
the highest sensitivity of all model parameters and it was also among the parameters that produced
the best model fits. However, some preliminary experiments showed that using this rate the algorithm
converged to greater values of φ, resulting in reduced memory rate and generating secondary responses
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Figure 4.4: Results of 1000 estimations using five parameters for the 500 µg group. The results were
very similar to those obtained for the second group.
with long delays. This scenario did not match the experimental measurements. In summary, the
parameters used in the estimation process were: antigen degradation rate (δAg), saturation level of
activation function (hAg), carrying capacity of the B lymphocyte secondary response (KB), memory
cell generation rate (γm) and immunoglobulin degradation rate (µIg).
4.3 Estimation results for each experimental group
This section presents the results of the estimation process using the data of serum IgY concentration
of both experimental groups. In all cases, the Simplex Nelder-Mead algorithm was used to solve the
nonlinear least square problem and the five parameters selected in the last section were estimated. The
identification process was performed both for the raw data and also for the figures resulting from the
measured minus the base line or preimmune level. Finally, the model parameters were adjusted to
reproduce the measurements of the bird with the highest response of each group. It is important to
emphasize that an outlier in antibody concentration was found on day 53. This point was eliminated
from the set of the data used in the estimation to avoid a displacement of the response curve towards
a lower level IgY concentration.
The parameter estimation algorithm was implemented utilizing the Matlab’s SimBiology toolbox
[78], while analyses to determine optimal inoculation timetables, presented in the next chapter, will be
performed using the simulation platform Simulink. Each one of these computational tools (SimBiology
and Simulink) employs different algorithms that numerically solve the differential equations of the model.
Small differences may be introduced by the numerical solvers. Therefore, in order to contrast the results
and determine whether some differences occur, in what follows both responses, using SimBiology and
Simulink, are presented.
Particularly, for the set of simulations performed on the Simulink platform, the solver based on
trapezoidal rule (ode23t) for stiff equations and solver Dormand-Prince (ode45) were tested. There
was no perceptible difference. On the other hand, for SimBiology tool, the suite SUNDIALS [57] was
employed due to it is the only one that allows to include events (that represent inoculations) on the
simulation.
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Figure 4.5: Comparison among algorithms for parameter estimation using the average data of the 50µg
group. Only the simplex Nelder-Mead algorithm converged to an adequate response.
Results of parameter estimation for the 50µg group
The first measurement set was obtained from the pointwise average of specific antibody concentration of
birds 205, 223, 228 and 230. These hens were inoculated on the eleventh day with 50µg of antigen and
with a booster of 25µg on day 39. As it was discussed in the last section, four algorithms were used to
solve the least square problem: trust-region-reflective, genetic algorithms (GA), Levenberg-Marquardt
(L-M) and simplex Nelder-Mead. Figure 4.5 illustrates the results using these four solving approaches
for the second experimental group. Inoculations are indicated as red dashed lines in that figure. This
result shows that only the simplex Nelder-Mead algorithm was effective to adjust the model. These
curves were obtained with the same initial values for all parameters and excluding the outlier of the day
53.
The curve generated by the model using the parameter values obtained with the successful algorithm
is presented in figure 4.6. In this graph the model responses using both Matlab tools are showed. Observe
that the black and green curves are identical.
The same procedure described above was employed to tune the model using data of the 50µg group,
subtracting the base line level. In this way, only values above this threshold were considered. Results
for the four algorithms are presented in figure 4.7. The algorithms’ performance was, basically, the
same obtained for the previous case. In particular, the response generated with parameters using GA
was very poor, and it did not follow the typical IgY production. Once again, the Simplex Nelder-Mead
algorithm produced the best adjustment; see figure 4.8. As in the previous case, there was no difference
between numerical solvers employed. Using the data minus the basal level, the primary response could
not be observed (except for one point, all data were zero). Therefore, there was not any information to
tune this stage of the immunological response.
Table 4.2 summarizes the results of the parameter estimation process using the raw measurements
and those obtained after subtracting the base line. This table also includes the initial guesses used in
the estimation. Notice that, the algorithm converged to values near to the starting points and they
were similar for both cases. After subtracting the base line a lower concentration peak was achieved
and the carrying capacity of B cells was also reduced. The differences between the estimated values for
the remaining parameters were: 9% for hAg, 10% for γm, and 13% for µIg. The parameter with the
biggest change, between raw data and adjusted data, was δAg with the 17%. These results show that
modifications on the maximal level of the secondary response may produce a significant change in the
estimated values.
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Figure 4.6: Model responses obtained employing both computational tools (Simulink and SimBiology)
using parameter values adjusted for the data of the first group. Both curves are identical.
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Figure 4.7: Comparison among algorithms for parameter estimation using the average data of the
50µg group and subtracting the base line. The effectiveness of the simplex Nelder-Mead algorithm is
maintained.
71
0 10 20 30 40 50 60 70 80
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
Time [Days]
Ig
Y 
co
nc
en
tra
tio
n 
[m
g/m
l]
 
 
Measurement
SB Model
SL Model
Figure 4.8: Model responses obtained employing both computational tools (Simulink and SimBiology)
using parameter values adjusted for the data of the first group subtracting the base line. Responses
generated for both simulating platforms are practically the same.
Parameter estimation for bird 205
The estimation process performed using the measurements of the first experimental group showed that
this procedure is sensitive to the size of the achieved peak of the secondary response. In order to
characterize in more detail this feature, the algorithm’s performance using data of the bird 205 only,
the one that yielded the highest IgY response, was assessed. Figure 4.9 illustrates measured and the
simulated points when utilizing the four algorithms mentioned. In this case, as before, only the model’s
response obtained by the simplex method followed the experimental data; see figure 4.10.
The adjustment of model’s response using this measurement set was achieved introducing big changes
in the parameters, see table 4.3. For instance, the secondary response carrying capacity increased more
than five times, from 20.000 to 107.388. On the other hand, the memory lymphocyte generation rate
decreased by one order of magnitude. It was established experimentally that the B cell concentration
for this bird reached a maximal value of 6×105 (KB = 60000), three times the initial guess. Therefore,
the significant variation found by the estimation agrees with cellular measurements. The reduction in
γm value implies that the secondary response will take more time to occur producing a delay in the
optimal inoculation timetable. Since the parameter estimation is based on solving iteratively a least
squares problem, it is necessary to start near to the real values. This could be a very difficult task to
achieve due to variations among individuals.
Parameter Initial guess Estimated value Estimated value BL
δAg 0.5 0,4858 0,5727
hAg 0.1 0.1124 0.1175
γm 1.5e-5 1.548e-5 1,404e-5
KB 20000 28102,26 23789,27
µIg 0.303 0,0871 0,0990
Table 4.2: Estimated values for parameters using data of the 50 µg group
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Figure 4.9: Comparison between solution methods of the least square problem using the data of the bird
205. The response generated by the values obtained with the simplex Nelder-Mead algorithm adequately
follows the experimental data. No other algorithm is capable of reproducing the measurements of this
hen.
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Figure 4.10: Model responses for both simulation platforms using the measurements of the bird 205.
The peak IgY concentration of this hen was the highest of the group. The model tuning was successful,
even though the estimates differed from the group values.
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Parameter Initial guess Estimated value
δAg 0.5 0,0863
hAg 0.1 0.0726
γm 1.5e-5 6,932e-6
KB 20000 107388,56
µIg 0.303 0,1735
Table 4.3: Estimated parameters using the experimental data of the bird 205
Variation in the initial guesses of the whole set of parameters for the 50µg group
The estimation results for the 50µg group, presented in the last section, depend on the initial guesses
selected for all model’s parameters including those that are going to be tuned. With the purpose of
assessing the effect of varying initial conditions, 5000 estimations were carried out selecting random
values for sets of five parameters. All model parameters can be included in these sets, except those that
are biologically meaningless. For the parameters in the chosen set, initial values are given random values
in an interval ±20% around the nominal value. The results were organized in histograms presenting the
frequencies of the estimated values. In each figure, the nominal value found in the previous section is also
indicated. In the following figures, some estimated values are shown as zero; this condition represents
those cases when the algorithm did not converge.
The two histograms presented in figure 4.11 show the frequencies of the estimated values for δAg
and hAg. The antigen degradation rate has a well defined trend towards a central level that is slightly
displaced towards a higher value. In contrast, this deviation seems to be compensated by the mean level
of the saturation function that moved towards a lower level. Remember that in the model equations the
immune response is modulated by an activation function (eq. 2.2) that depends on antigen concentration
and the saturation level hAg. Hence, variations in these two parameters will produce changes associated
with starting and ending the response. An interesting result about hAg was the bimodal distribution
of estimated values as illustrated by its histogram. There was a set of estimated values around 0.11
and another one around 0.04. Since a lower than nominal value for this parameter implies an activation
function that saturates in a shorter time, thus the generated response using any of the two values will be
very similar. Higher than nominal values for this parameter could have been more troublesome, implying
slower saturation, leading to lower growth rates for the other population. In conclusion, modifications
below ±20% in all model parameters mantain the estimated values of the two parameters related to
antigen elimination and saturation level near the nominal case.
Estimated values for the carrying capacity KB and memory cell production rate γm were centered
around the nominal values, as it is presented in figure 4.12. For γm more than the 50 % of the estimations
were found within ±10% of the nominal value. On the other hand, the results for KB showed a low
dispersion, 72% of the values were closer than 6% to the nominal value and 36% of the cases were closer
than 2.5% to the value obtained without any modification of the initial guesses. These two parameters,
that directly participate in memory generation and hence determine the optimal inoculation times,
presented only a small variation with respect to the value estimated in the nominal case.
The initial immunoglobulin degradation rate was 0.303 [day−1]. The estimations showed that the
algorithm mainly converged to 0.087, found in the nominal case. This was the parameter with the
lowest sensitivity to variations in the values used as starting points for the algorithm; see figure 4.13.
The error in the curve fitting was also calculated and a histogram was drawn. Results showed that
almost 80% produced a response with the same error as in the nominal case and 20% achieved a slightly
better adjustment. This behavior allowed us to infer that changes below ±20% in the initial guesses do
not modify the model tuning using the measurements of the 50µg group.
The analysis presented above was obtained taking randomly five parameters and modifying their
value up to 20%. In order to verify the previous results, the interval for value parameter change was
widened to ±50% and 1000 estimations were carried out. Histograms presented in figures 4.14 to 4.16
show that features observed in parameter variations up to ±20% were maintained. For example, antigen
degradation rate, δAg, had the same central value, but presented a higher dispersion; some unfeasible
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Figure 4.11: Variation of the estimated values of the parameters δAg and hAg when the initial guesses
are modified using 50µg group data. The estimated values cluster around the nominal levels, except for
a second set around a lower saturation level. Values equal to zero symbolize when the algorithm did
not converge.
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Figure 4.12: Variation of the estimated values of the parameters γm and KB when the initial guesses
are modified using 50µg group data. The largest frequency is around the nominal values.
results were even negative. The saturation level presented the same two cluster points discussed in the
previous estimations.
The estimation process in the present case, with variations of ±50% in the remaining parameters:
γm, KB and µIg, had a performance that is, basically, identical to that achieved for changes of 20%.
Notice that in figures 4.15 and 4.16 there was a trend towards the central value found in the nominal
case. In addition, the carrying capacity of B cells and the IgY degradation rate presented a very low
variation. Finally, the total estimation error was kept at the same level. It increased, only slightly, for
30% of the cases.
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Figure 4.13: Variation of the estimated values of the parameter µIg when the initial guess is modified
using 50µg group data. The IgY estimated value coincides with the nominal case for almost the 50% of
the tested conditions.
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Figure 4.14: Variation of the up to 50% in the initial guesses of the parameters δAg and hAg using the
data of the 50µg group. Even though a larger dispersion is observed, histograms were centered around
the same values found in the case of 20% variation. Values equal to zero symbolize when the algorithm
did not converge.
Results of parameter estimation for 500µg group
For the third experimental group, composed by birds 203, 219, 220 and 229, and inoculated with ten
times more antigen (500µg and booster of 250 µg) the same procedure described above was applied.
As it was mentioned at the beginning of this chapter there was not a significant difference between the
responses of the two experimental groups. Therefore, the same input (1 [mg/ml] of antigen) was used
for the estimations described below. For this group the outlier of the day 53 was also removed from the
measurement set. Estimation results are presented with the same format of the last section. Results
using four optimization algorithms, subtracting base lines and adjusting the model with the data of the
bird with the highest response in the group will be illustrated.
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Figure 4.15: Variation of the up to 50% in the initial guesses of the parameters γm and KB using the
data of the 50µg group. In most of the cases the estimated values were around the nominal value.
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Figure 4.16: Variation of the up to 50% in the initial guess of the parameter µIg using the data of the
50µg group. Once again, IgY degradation rate and the tunning error were maintained constant for most
of the cases.
In the previous estimations, it has been determined that methodologies based on trust-region-
reflective, GA and Levenberg-Marquardt algorithms were unable to obtain an adequate adjustment.
Using the data for the third group, this conclusion was confirmed; see figure 4.17. Particularly, the
trust-region algorithm did not converge, so it was not presented in the figure. Once again, only the
simplex Nelder-Mead algorithm performance agreed with the results found for the 50µg group.
The detailed response for this set of measurements, utilizing Simulink and SimBiology platforms, are
illustrated in figure 4.18. As it was discussed in chapter three, the present experimental group presented
a higher preimmune level that seemed to hid the primary response. This feature is observed in the model
response, where the primary curve was below all measurements. Additionally, after the booster this
group presented a maximal increment, then a sudden reduction and a sequence of practically constant
values. This trajectory forced the algorithm to produce a response that is far from the peak measured
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Figure 4.17: Comparison among optimization algorithms using the average data of the 500µg group.
The methodology based on the trust region did not converge and responses produced by GA and L-M
were not satisfactory.
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Figure 4.18: Responses of the tuned model using Simulink and SimBiology for the average measurements
of the 500µg group. There was no perceptible difference between the two simulation platforms.
for this group. Lastly, in terms of the numerical integration of the differential equations, there was not
a significant difference between the two computational tools.
In the next test, parameters were tuned using the average data of the 500µg group and subtracting
the base line. Figure 4.19 shows the model responses obtained for all the algorithms used. Figure 4.20
illustrates the curve obtained, using the simplex method, exclusively. This response was very similar
to the one obtained with the raw data except for the peak reached after the booster. However, this
significant reduction in the maximal IgY concentration caused numerical issues. The difference between
the responses produced by each solver was considerable in primary and secondary responses.
Initial guesses for parameter values and the estimated values for the raw data and data adjusted for
basal levels are gathered on table 4.4. Comparing the results for both estimations, some conclusions can
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Figure 4.19: Comparison among optimization algorithms using the average data of the 500µg group and
subtracting base lines. The maximal level reached by the model’s response was significantly lower than
the case with the raw data. As expected, only the simplex Nelder-Mead algorithm produced a good fit.
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Figure 4.20: Response of the model with parameters estimated using data of the 500µg group and
subtracting base line. The curve generated by the model do not reach the secondary peak due to the
set of values that are next to the maximum are significantly low and force to the algorithm to drop the
response.
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Parameter Initial guess Estimated value Estimated value BL
δAg 0.5 0,4189 0,7007
hAg 0.1 0.1308 0.1055
γm 1.5e-5 1,656e-5 1,749e-5
KB 20000 18712,66 17895,67
µIg 0.303 0,0579 0,1104
Table 4.4: Estimated parameters for the 500µg group
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Figure 4.21: Comparison among the optimization algorithms to estimate parameters using data of the
bird 219. For all sets of measurements tested, the model could not be tuned using a other algorithm
than simplex to solve the least squares problem.
be drawn. For instance, the most significant change in the estimated values of this group occurred for the
antibody degradation rate whose value was doubled. The antigen elimination rate also increased its value
by 67%. The modifications in these values were the result of a reduction of about 60% in the maximal
IgY concentration of the secondary response. The remaining parameters KB and γm presented only
slight variations. The carrying capacity KB saw its value reduced by 4% and the memory cell generation
rate increased by 5%. The later value suggested a scarse modification in the time required to develop
the immunological memory.
Parameter estimation for bird 219
Measurements of bird 219 were the highest of the group and very similar to those of the hen with
the highest response of the second group (bird 205). Figure 4.21 illustrates the results for the four
optimization algorithms. As before, the simplex Nelder-Mead algorithm is capable of converging to a
solution that follows the data, as this fact was corroborated once again by this experiment. Similarly,
it was established that the least square problem formulated to estimate parameters of this model can
not be correctly solved with any of the other tested techniques.
Parameter estimation using the data set of bird 219 was comparable to the group average; see figure
4.22. Since, after the peak (day 49) measurements were below one half the maximum concentration,
the model fit produced a trajectory that did not reach that peak. This feature was also observed in
the group average. Therefore, the estimated values did not differ from those found for the 500µg, table
4.5. Finally, the effect of using the two numerical solvers was assessed. There was not a significant
difference, as it was presented at the same figure.
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Figure 4.22: Responses of the model tuned with the estimated parameters using measurements of the
bird 219. The curve was very similar to that produced for the third group. There was no differences
between the two numerical solvers.
Parameter Initial guess Estimated value
δAg 0.5 0,4591
hAg 0.1 0.1101
γm 1.5e-5 1,549e-5
KB 20000 32019,43
µIg 0.303 0,0557
Table 4.5: Estimated parameters for the model using the data of the bird 219
Variation in the initial guesses of the whole set of parameters for the 500µg group
In the last set of experiments described in this chapter, the effect of varying the initial guesses for
all parameters of the model in the estimation results was assessed. The methodology employed was
identical to that described for the same analysis using the data of the second group. Five thousand
estimations were carried out selecting in random fashion groups of five parameters and then randomly
modifying their values up to ±20%. For parameter selection and value changing a uniform probability
distribution was used. Frequency histograms for the estimated parameter values are presented in the
next figures, where the nominal (without variation) value was also indicated as a red line.
In the figure 4.23 frequencies of antigen elimination rate and the saturation level of the activation
function are showed. The variation range of the estimated values was larger than that observed for the
50µg group. For instance, for δAg even negative values (the lowest was −0.8) were achieved, while the
minimum value of this parameter for the second group was 0.2. On the other hand, some features were
maintained the same. For instance, in both groups the most frequent value of the antigen degradation
rate was higher than the obtained for the nominal case. In particular, for 500 µg group, nominal estimate
was 0.418 and the most frequent was 0.55. For the parameter hAg the algorithm converged around two
values, but a larger number of cases around the initial guess 0.1, and centered lower than the nominal
case. This qualitative behavior was also observed for the estimations of the second experimental group.
This result is explained by the opposite effect of these two parameters in the activation function; if the
degradation rate of the inoculated protein is increased, the saturation level is reached more rapidly.
Estimated values for the memory cell generation rate and the carrying capacity of the B lymphocytes
are illustrated in the figure 4.24. The result for γm was consistent with the value found when none of
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Figure 4.23: Variation of the initial guesses of the parameters δAg and hAg using the data of the 500µg
group. A higher dispersion in the results was obtained compared to the estimations of the second
group. However, the trend to the nominal value was maintained. Values equal to zero symbolize when
the algorithm did not converge.
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Figure 4.24: Variation of the initial guesses of the parameters γm and KB using the data of the 500µg
group. The results for both parameters were centered around the nominal values. The memory cell
generation rate was mainly maintained near to the nominal case.
the initial guesses was changed; 28% of the estimated values differed from the nominal value by less
than 7%. Since this rate determines the time required to increase the memory cell population, a value
less sensitive to parameter variations is desirable in order to design a booster schedule with parameter
uncertainty. Regarding the carrying capacity KB, the estimations were similar to those obtained using
data of the 50µg. The variability was low, as 38% of the results matched with the nominal value (below
8% of difference).
As it was observed in the analysis performed for the second experimental group, the IgY decay rate
and the fitting error showed the lowest variation level when the initial guesses of the model parameters
are modified; see figure 4.25. For more than half the cases (55%), the estimated value for δIg was about
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Figure 4.25: Variation of the initial guesses of the parameter µIg and error using the data of the 500µg
group. The estimated value for IgY degradation rate was very consistent for 5000 cases assessed. The
error value was mainly centered around the nominal value.
the 9% of the nominal result. For about 40% of the results, the error was the same calculated for the
50µg group; in very few cases the reponse produced by the model was inadequate (error 0.7). Finally,
in other cases the error was slightly better or worse.
In the last part of this section, the range of variation of the parameter values used in the first iteration
was widened to ±50%. In this way, a more stringent condition was imposed upon the estimation process.
The results obtained with this experiment did not differ from those described above. Estimates of the
antigen elimination rate and the saturation level are presented in figure 4.26. It follows a similar
pattern of variations as it was observed for the ±20% case. Estimated values for memory lymphocyte
generation rate, γm, were also centered around the nominal value and produced maximum and minimum
values similar to those found before; see figure 4.27. For this parameter, 17% of the estimations had
a difference smaller than 4.5% from the nominal value and 35% of the results were closer than 12% to
the case without variation. Even though the estimation results of B lymphocyte carrying capacity had
a larger dispersion, the modal value was obtained very close to the nominal case (37% of the estimated
values were found within an error interval of 7%). The IgY degradation rate and the fitting error did not
present a considerable change despite a wider range in the initial guesses; see figure 4.28. Numerically,
60% of the results differed by less than 10% from the nominal value.
4.4 Comparison among the estimated values
Table 4.6 gathers the estimation results, using the simplex Nelder-Mead algorithm, for both experimental
groups and for the two individual hens, described above. The numerical estimates obtained for these
parameters had different levels of variation. In particular, the results of bird 205 differed significantly
from the other three sets of estimated values. This fact was remarked in the section that described
the model parameter values for those measurements. Except for this case, the differences among the
regarding estimated values were small.
For the antigen elimination rate the largest difference was observed between the groups with a value
of around 15%. A very similar range (about the 16%) of variation was obtained for hAg. The rate of
memory lymphocyte generation (γm) showed a maximal variation of 7%, a result that suggests a very
similar optimal inoculation timetable for both experimental groups and emphasizes the scarse difference
between the two immune responses yielded with the two antigen concentrations used in this thesis. On
the contrary, the estimated values for the carrying capacity (KB) were significantly different between
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Figure 4.26: Variation of the up to 50% in the initial guesses of the parameters δAg and hAg using the
data of the 500µg group. The estimated values for both parameters were dispalced from the nominal
value. This result was consistent with the behavior observed for the 50µg group. Values equal to zero
symbolize when the algorithm did not converge.
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Figure 4.27: Variation of the up to 50% in the initial guesses of the parameters γm and KB using the
data of the 500µg group. Even thought the dispersion of the results was larger than the 20% case, the
estimates were around the nominal case.
groups (50%). It was expected that the amplitude differences in terms of IgY concentrations, as it
was observed for both groups, implied changes in B cell peaks. Finally, the estimated value of the
IgY degradation rate, µIg, was 56% higher for the second experimental group compared to the tuned
parameter of bird 219. This result was related to the fact that the last measurement of bird 219 almost
doubled the level of the 50µg group, implying a longer time required for protein degradation.
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Figure 4.28: Variation of the up to 50% in the initial guesses of the parameters µIg and fitting error
using the data of the 500µg group. For all estimations performed, the highest frequency in the estimated
value of the IgY degradation rate was around the nominal value and with a low dispersion.
Parameter Initial guess 50µg group 500µg group Bird 205 Bird 219
δAg 0.5 0,4858 0,4189 0,0863 0,4591
hAg 0.1 0.1124 0.1308 0.076 0.1101
γm 1.5e-5 1.548e-5 1,656e-5 6,932e-6 1,549e-5
KB 20000 28102,27 18712,66 107388,56 32019,43
µIg 0.303 0,0871 0,0579 0,1735 0,0557
Table 4.6: Summary of the estimated parameter values
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4.5 Summary
The methodology and results of parameter estimation were presented in this chapter. In all cases,
plasma measurements described in the third chapter were used to tune the model parameters. Since
the measurement set was smaller than the number of parameters, it was necessary to select a parameter
subset to define a feasible least square problem that can be solved to determine the optimal parameter
values. To determine how many and what parameters to estimate, a Monte Carlo approach was em-
ployed. Additionally, several optimization algorithms were tested and it was established that the only
one that was consistently successful was the simplex Nelder-Mead method.
The estimation results for each experimental group and for one bird of each group allowed to em-
phasize the similarities and differences among the obtained values. Tuning of the response curve when
the preimmune level (basal line) is subtracted was also explored. In addition, the effect of varying the
initial guesses for the whole set of parameters on the estimated values was also characterized.
Some results of this stage are enumerated as follows:
• The number of parameters included in the estimation process does not determine the success in
fitting the model to the experimental data. There were not significant differences between the
errors calculated for estimations using any number from three to eight parameters.
• Parameters included in the estimation should be carefully selected in order to obtain a successful
fit. The IgY degradation rate (µIg), memory cell generation rate (γm) and the B lymphocyte
carrying capacity (KB), were the most important parameters to fit the model to the immune
response measurements.
• Four optimization algorithms were tested for solving the nonlinear least squares problem. Only
the simplex Nelder-Mead produced a consistent response. The remaining algorithms either did not
converge or produced responses qualitatively different from the experimental humoral response.
• When base lines were subtracted from each group measurements, the parameter estimation process
was also successful. Results showed that estimations differed very little from the values estimated
from the raw data.
• Parameter estimation and optimal timetable assessment (as described in the next chapter) were
implemented with two different computational tools that used two different numerical solvers.
Comparison between the two solving methodologies showed no significant differences.
• The parameter estimation process for bird 205, the hen with the highest production peak, was not
consistent with the two numerical solutions. In addition, the estimated values were very different
to those obtained using other data sets and the algorithm converged to points far from the initial
guesses. The B cell dynamics for this hen showed a concentration peak much higher than that
initially assumed. This feature emphasized the well known fact that it is necessary to propose
initial values close to the tuned ones in order to obtain an effective fit.
• The analysis of the effect of variations in the initial model guesses showed that modifications as
large as 50% produced considerable differences in the estimated values, but with a clear trend to
approach the nominal value. Furthermore, there was not a significant change in the frequencies of
the estimated values when the variation range was widened from 20% to 50%.
• Estimated values found using data for the two experimental groups and bird 219 were similar,
showing differences of about 15%. The memory cell production rate, that chacterizes the transition
from primary to secondary responses, had a maximal difference of 7%. This result suggests a
similar optimal inoculation timetable for all hens when this particular antigen is used. The B
lymphocyte carrying capacity of the secondary response presented the maximal variation (50%);
this result makes sense, since the variation on peak levels among responses were considerable and
the rate of IgY production was fixed. Then, the only option was to modify, also considerably, the
value of this parameter.
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Chapter 5
Optimal inoculation timetables for the
model of the avian immune response
In this chapter the constrained binary optimization problem that describes the selection of the immu-
nization days to maximize the IgY production is introduced. The definition and characteristics of the
problem are presented and the solutions for several cases are illustrated. Initially, the simulation results
for several booster inoculation times are showed. For all cases, the first inoculation is administered at
the eleventh day and a booster was simulated at several times ranging from day 11 to day 70. Using
the tuned model, the simulated response for each booster time selection is assessed in terms of its peak
response or the total antibody concentration yield. In this way, an optimal booster day was determined.
The effect of modifying parameter values in establishing the optimal day was also analyzed. Subse-
quently, a generalization of the problem, involving any finite number of booster shots, is solved using a
genetic algorithm approach. Two particular cases, for two and four boosters were studied. In addition,
the algorithm sensitivity to variations on estimated parameters is assessed. An experimental verifica-
tion of the model prediction is obtained measuring specific IgY response when an optimal timetable is
applied. Finally, some conclusions of this stage are enumerated.
5.1 Definition of the optimal inoculation problem
The main objective of this thesis was to design a methodology that allowed to define an immunization
scheme that maximized the specific immunoglobulin production. The dynamics of the immune response
was characterized using six differential equations and 28 parameters. This model permits the evaluation
of the system performance when diverse inoculation schedules were applied. Using this tool is it possible
to calculate the total IgY concentration produced as the numerical integral of the variable Ig and utilize
this value as the objective function of an optimization problem. Since the proposed model is nonlinear,
this becomes a nonlinear optimization problem. In addition, the definition of the optimization problem
requires other conditions. These will be discussed below.
Figure 5.1 illustrates the optimization problem that represents the selection of a set of days for
administering the antigen doses. Red points symbolize days when a booster shot is applied, while
black nodes refer to the opposite case. A finite time horizon (n possible days for selection) will be
established as the last day available for applying a booster. Notice that, every branch of the decision
tree is comprised of a sequence of days that may include several inoculations. Therefore, there is a finite,
although usually very large, set of possible day combinations for administering the stimuli. In other
words, the decision to be made in this problem is whether to inoculate or not on one specific day, until
day n. This feature makes the optimization problem a binary one. On the other hand, the number of
boosters that can be applied to a bird are severely limited. This constraint makes some branches of the
decision tree shorter than others, because the time required for administering consecutive inoculations
is lower (there in not enough inoculations to reach n). If too many immunizations are administered,
the protein can be wasted (in much of the cases it is extremely expensive or difficult to obtain) or the
bird could be hurt hampering its capacity to lay eggs. Obviously, this situation would worsen the IgY
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Figure 5.1: Description of the optimization problem for determining the inoculation timetable. For each
day a decision has to be made about either applying or not a booster. In addition, the total number
of inoculations that can be administered a hen is severely limited. The objective function is the total
concentration of the yielded IgYs.
production. In summary, the optimization problem defined here, can be categorized as a constrained
nonlinear, binary programming one.
An optimization problem with these conditions is not easy to solve. Some of the proposed techniques
to deal with integer programming problems are based on building a tree, where each node represents
a subproblem that allows variables to take real values. By solving those subproblems, it is possible to
establish bounds that allow to eliminate branches and reduce the computational burden associated with
solving many subproblems. This technique is known as branch and bound. However, this approach
requires a convex objective function, and that condition is not guaranteed in this particular case. Other
solving methodologies for integer (or binary) problems are based on heuristic algorithms inspired in
nature phenomena. In this work, a genetic algorithm was employed to select the day set that maximizes
the total antibody production. This type of algorithm can be easily used in binary problems, since it
is only necessary to force that the related operations (crossing, selection and mutation) produce integer
results.
5.2 Maximal response with one booster
In the first analysis, the responses of the tuned model for each experimental group depending on the
day of the booster application was assessed. Initially, the effect of an inoculation of 1 [mg/ml] at the
eleventh day and a booster shot of 0.5 [mg/ml] was simulated. The time chosen for application of the
booster was varied from the eleventh day to the seventieth day.
Since it has been assumed that the memory cell population maintains its concentration after reach-
ing its carrying capacity, the secondary responses will be very similar from the day that the memory
population reaches its peak. This behavior was observed in the qualitative analysis presented in chapter
two. This characteristic means that, for the whole set of possible booster days there are many similar
maxima (they differ by less than 1%), therefore the first one was defined as the peak response.
Results for the model tuned with measurements of the 50µg group
Figure 5.2 illustrates the responses of the tuned model using the measurements of the second experimen-
tal group. On this graph the progressive transition from the primary to the secondary responses (black
curves) was observed. This change is related to the increase of the memory lymphocyte population.
The first peak response (blue curve) occurred when a booster shot was applied at the 28th day (dashed
red line). This result suggests that it is possible to produce a secondary response 17 days after the first
inoculation.
The progressive transition from primary to secondary responses is also observed in terms of the
maximal reached values, figure 5.3. After day 28 all peak concentrations are practically the same,
except for the boosters applied after the day 65 that have not reached their peak level. Notice that, the
more significant changes are observed between days 20 to 26 when the primary response is decaying.
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Figure 5.2: Responses of the model tuned with 50µg group data, in terms of IgY concentration. In this
experiment the booster day varied from the day 11 to the day 70. The blue curve represents the first
maximum response when the booster is administered at day 28.
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Figure 5.3: Maximum levels reached by each response with one booster for the model tuned with the
50µg group data. The transition from primary to secondary response follows the function that describes
the memory lymphocyte dynamics. After the day 65 the response could not reach its maximum value.
The system performance under varying booster times can also be quantified using the total antibody
yield as an index. The accumulated IgY concentration for sixty days of production from the booster
application is illustrated on figure 5.4. On this figure, the time axis corresponds to the day when the
second inoculation was administered. On the figure two points have been represented in red that refer
to the highest yield and the first maximum. Notice that, if the booster is applied at day 35, the total
concentration yielded is the highest, but the result of the day 31 (in red) is slightly different (less than
2.5%).
In the next test, the effect of varying parameter values to determine the optimal day for booster
application was analyzed. Figure 5.5 shows the optimal day for a second inoculation (z-axis), as a
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Figure 5.4: Accumulated total production for 60 days of the model tuned with the 50µg group data.
Even though the maximum production is obtained at day 35, the difference to the result of the day 31
is less than 2.5%.
function of modifications in the parameter values (except for the three parameters that are biologically
meaningless). The modification range was established in the ±40%, and in all cases just one parameter
was changed at a time. This figure has a constant region that suggests the same day (28) for booster
administration despite of parameter modifications. However, some increases and reductions in the
selected day were observed. Particularly, two very significant increases were observed when two the last
parameters were reduced.
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Figure 5.5: Variation of the optimal day depending on the parameter values for one booster. The model
was tuned with the measurements of the 50µg group. The selected day is maintained constant in most
of the cases, except for some parameters included in the equation of the B lymphocytes and memory
cells.
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Figure 5.6: Level contours of the variation on the optimal day as a function of parameter value modi-
fications for the model tuned with the data of the 50µg group. The biggest change is produced as the
result of modifying the memory lymphocyte generation rate or the primary response carrying capacity.
In order to facilitate the interpretation of these results a level contour figure was built, see 5.6.
This graph shows that an increase in the first parameter (antigen elimination rate δAg) produces a
slight reduction in the optimal day. Changes in parameters 19 (KBp) and 22 (γm) generated the larger
modifications; with the memory cell generation rate at 60% of its nominal value the optimal day was
displaced by almost a month towards the day 60. This result was not reasonable, since it did not match
the measured response.
Figure 5.7 shows the responses that are produced when KBp and γm values are modified. Changes in
the value of the primary response carrying capacity modify the required times to increase the memory
cell population. Therefore, secondary responses appear in some cases sooner than before and in other
instances they appear later, depending on the direction of the parameter change. As a result, the
optimal inoculation day is also modified. On the other hand, for the case of variations on the memory
cell production rate the optimal day changes progressively. These two figures show that values that
considerably differ from the tuned ones do not produce typical responses as those measured in this
thesis. Hence, it is not reasonable to suggest optimal days as late as 45 days after the first inoculation.
In the previous chapter, the effect of varying the initial guesses of the parameters in the estimation
algorithm was assessed. For that analysis, 5000 estimations were carried out and the optimal inoculation
days were computed for each case. Figure 5.8 show the frequencies of the selected optimal days for
the model tuned with the values of the 5000 estimations mentioned before. In a darker tone it was
represented the day with the highest frequency. It corresponded to the same day obtained for the
nominal case (day 28th). This result matched the feature observed for the parameters: the estimated
values tend to cluster around the nominal value. Another interesting fact determined by this experiment
was that more optimal responses were found between days 24 and 27 than between days 29 and 32. Even
though the initial guesses varied by ±20%, in most cases the optimal day occrured by the day 28th.
Consequently, all experiments suggest that a secondary response can be achieved by an inoculation
applied on day 28th. This is eleven days before the day selected from an empirical scheme for the
experiments described in this thesis.
Results for the model tuned with measurements of the 500µg group
Following the same procedure described above, the behavior of the model, tuned with the values esti-
mated for the 500µg group, when the booster days were modified was analyzed. The first immunization
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Figure 5.7: Responses of the tuned model modifying the two parameters with the highest effect on the
optimal day selection. Big changes in KBp and γm produce responses that considerably differ from the
experimental measurements and suggest booster times unreasonable.
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Figure 5.8: Histogram of the optimal day found using the 5000 set of parameter values estimated in the
chapter four for the 50µg group. The highest frequency was found in the day 28, the same obtained for
the nominal case.
was applied at the eleventh day and the time of the booster application was varied from day 11th to
70th. The same concentrations were simulated: 1 [mg/ml] and 0.5 [mg/ml] for the first inoculation
and the booster, respectively. Figure 5.9 illustrates the IgY responses generated by the model. Once
again, the blue line represents the first peak which was obtained with a booster applied at day 28. This
result coincides with the optimal day found for the second experimental group suggesting that 17 days
are enough to produce secondary responses with this breed of bird and this type of antigen. Figure 5.10
shows the maximum values reached for each response as a function of the booster day. Clearly, it is
observed the transition from the primary response to the secondary response and the latter days where
the peaks were not reached.
The total IgY production for 60 days after applying one booster is showed in figure 5.11. The result
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Figure 5.9: Model responses in terms of IgY concentration varying the booster day. The model was
tuned with the parameters estimated for the 500µg group. The blue curve represents the first maximum
response when the bird was immunized for the second time at the day 28. This is the same optimal day
obtained for the second experimental group.
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Figure 5.10: Maximum levels reached for each response varying the booster day for the model tuned
with parameters of the 500µg group. The maximum concentration was approximately constant after
the inoculation at the day 28.
was similar to that obtained for the second experimental group, since the maximum value was found some
days after the first secondary peak (day 28). The largest production was yielded with an inoculation
at day 47, 19 days after the first secondary response. However, the accumulated concentration with an
inoculation at the day 30 differed from maximum by less than 2.5%.
The effect of varying the values of the model parameters on the selection of the optimal booster
day is presented in figure 5.12. The result is practically the same as it was obtained for the second
experimental group. Changes as large as 40% did not significantly modify the selected day, except for
the primary carrying capacity (KBp) and memory lymphocyte generation rate (γm). In particular, if
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Figure 5.11: Accumulated total production during 60 days for the model tuned with parameter values
of the 500µg group. The maximum production was generated by the booster applied at day 47, 19 days
after the first secondary peak. However, the total production obtained administering the booster at day
30 only differ from the maximum in less than 2.5%.
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Figure 5.12: Variation of the optimal day as a function of changing parameter values. The model was
tuned with the parameters of the 500µg group. The result of the experimental group was similar to the
second one; the optimal day was maintained constant except for three parameters.
values of these two parameters are reduced, a delay up to 40 in the optimal day for a booster application
may result. Variations on antigen elimination rate change the optimal solution only a couple of days.
Visualization of the changes in the optimal day was facilitated using a level contour graph, see figure
5.13. The blue tone that was present in the most part of the figure refers to the nominal day (28). An
increase in the selected day was observed when the parameter 22 (γm) changed. This result is consistent
with the purpose of this parameter, since it determines the required time to develop the immunological
memory.
Figure 5.14 presents response curves produced by each optimal day, when the values of the parame-
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Figure 5.13: Level contours for the variation on the optimal day as a result of changes in the parameter
values. The model was tuned with the measurements of the third experimental group. Memory lympho-
cyte generation rate and the primary response carrying capacity significantly modified the selected day
for the maximum production. Nevertheless, some responses do not match the experimental responses.
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Figure 5.14: Responses of the tuned model modifying KBp and γm. Significant changes were observed
on the optimal day selection. However, exactly as the second experimental group, some responses
considerably differ from the experimental measurements and suggest very delayed booster times.
ters KB and γm were modified. The results were very similar to those commented for the 50µg group. A
reduction in the values of these two parameters implies a larger time for increasing memory cell popula-
tion and very delayed secondary responses that do not coincide with experimental data. In conclusion,
variations as large as 40% on the parameter values do not considerably modify the selected day for
appliying a booster. Even though a significant change was observed by the effect of the parameters KB
and γm, those responses were not reliable and were not used for the optimal timetable design.
In the last experiment of this section, the frequency of each optimal day was established using the
5000 estimated parameter sets presented in the previous chapter. The histogram is showed in the figure
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Figure 5.15: Histogram of the optimal day for the model tuned with the parameters of the 500µg group.
The highest frequency was found three days before the nominal day (25). However, in most of the cases
the optimal day was obtained before the day 28.
5.15. In a darker blue it was represented the optimal day for the nominal case (28). Here, the highest
frequency occurred in the 25th day instead of the nominal day as it had been found for the second
group. However, more than 36% of the results were within the interval 25th to 28th day, and 52% of the
optimal inoculation days occured before the 28th day. This suggests that there is a large probability of
obtaining a secondary response in this period.
Genetic algorithm solution to the optimal day for one booster
Up to this point, the strategy to determine the optimal day consisted in simulating each possible
combination of primary inoculation and a booster and calculating the peak response or the total yielded
concentration. This approach could not be used if the number of stimuli increase, since the number of
possible combinations will be huge requiring unfeasible computation times. Therefore, another technique
was used in order to generalize the procedure of selecting several booster times. As it was mentioned
in the first section of this chapter, an approach based on genetic algorithms was proposed to solve the
constrained binary programming problem. This tool was utilized to determine the booster day that
produces the maximum total IgY concentration.
It is important to emphasize that this heuristic algorithm initiates with a random population of
possible solutions that might influence the convergence value. In order to overcome local minima,
several initial populations must be tested. Figures 5.16 and 5.17 illustrate the results of the GA using
one hundred random initial solution populations. These figures show that algorithm convergence is
highly sensitive to the initial set of solutions. Notice that, results were obtained almost for all days,
from 14 to 70, but with a significant differences in their objective function values. As expected, it is
necessary to offer some variability to the algorithm in order to obtain a global maximum. Selected
booster days for 50µg and 500µg group were 29 and 30, respectively. However, the total IgY produced
if the booster is applied two days after or before of these days is practically the same.
In summary, all experiments suggest that the second immunization should be applied between 17
and 20 days after the first inoculation. All tests performed for both experimental groups lead to that
conclusion. On the other hand, the capability of the GA of solving the binary programming problem
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Figure 5.16: Solutions of the genetic algorithm using one booster and the model tuned with the param-
eters of the 50µg group. The algorithm convergence strongly depends on the random initial solution
population. The maximum concentration was obtained with the day 29 (red point).
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Figure 5.17: Solutions of the genetic algorithm using one booster and the model tuned with the pa-
rameters of the 500µg group. The maximum concentration was produced with a booster at day 30.
However, differences were small compared to the IgY yielded two days earlier.
was checked by an alternative solution method based on massive simulations. In the next section, an
experiment to verify in vivo the selected optimal day will be described.
5.3 Maximum humoral response using two boosters
The next step in the analysis of the optimal inoculation timetables is to assess the model performance
with two boosters. This section presents this particular case. The two days that maximize the total
IgY concentration were determined using the GA approach with 100 initial populations. Once again,
the process was performed for both experimental groups.
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Figure 5.18: Results of the genetic algorithm for selecting two boosters that maximize the total anti-
body production. The model was tuned with the parameters of the 50µg group. One hundred initial
populations were utilized to give diversity to the algorithm. Red points represent the convergence values
and interpolating them, the surface was built.
Selected days using two boosters for the model tuned with the measurements of the 50µg group
are presented on figure 5.18. Red points symbolize algorithm convergence values; the surface was built
interpolating these 100 solutions. Some times the algorithm converges to solutions very far from a global
maximum. For example, see the point with the first inoculation at 23, and the second at 78. It is also
clear that many solutions lay on a flat region of the figure what means that there are many booster
combinations that produce almost the same total production. In this case, the requirement of many
initial conditions for obtaining a successful solution was confirmed.
The interpretation of these results can be facilitated using a level contour graph. Figure 5.19 shows
the total antibody concentrations reached for the tuned model using as input stimuli the solutions
obtained by the GA. The flat region observed in the figure 5.18, depicts a similar total production that
was obtained when the first booster was applied between days 24 and 35 and the second one between 38
and 50. Even though the results inside this region are not exactly the same, they produce similar total
IgY concentrations. Notice that, few days after the first inoculation (less than day 22) there was not a
solution for the first booster, as well as day 32 for the second. For all possible solutions, the highest IgY
production was reached with the combination: the first booster at day 29 and the second at day 41.
Figure 5.20 represents the level contours of the solutions found by the GA for the third experimental
group. The results were very similar to those obtained for the another experimental group. The first
booster should be applied between days 24 and 35 and the second between 37 and 50. The highest
production was achieved by boosters at days 29 and 45.
Sensitivity analysis of the optimal trajectory for two boosters
The methodology described in the second chapter to calculate the model sensitivity regarding to pa-
rameter variations, was also used here to determine the effect of varying some parameter values on the
optimal trajectory. The integral of the sensitivity function was normalized using the total population
size to make comparable the results of each variable. In this analysis the model was tuned for the 50µg
group and two boosters were applied at days 29 and 41.
The calculated sensitivities for the parameters related to the equations of antigen and antigen pre-
senting cells are illustrated in figure 5.21. Results presented in this figure show that the sensitivity of
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Figure 5.19: Level contours of the GA solutions for two boosters for the model tuned with parameters
of the 50µg group. The region limited by days 24 to 35 for the first booster and by 38 to 50 for the
second one produced the highest IgY total concentrations.
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Figure 5.20: Level contours of the GA solutions for two boosters for the model tuned with parameters
of the 500µg group. The results were similar to those obtained for the second experimental group. The
region limited by days 24 to 35 for the first booster and by 37 to 50 for the second one produced the
highest IgY total concentrations.
this set of parameters is very low, even lower than that calculated for secondary response trajectory and
using the initial guesses. The greater value was obtained for the death rate of APC.
Figure 5.22 depicts the sensitivities of the T and B lymphocyte populations. Results did not differ
from those found in the second chapter, where the higher sensitivities were obtained for the activa-
tion rates σ and ζ, respectively. In the optimal trajectory analyzed here, variations of these thirteen
parameters did not imply significant changes in the response of the model.
In contrast to the previous results, variations on the parameters of the memory cell and immunoglob-
ulin equations produce big changes in the model response. These results are presented in figure 5.23.
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Figure 5.21: Sensitivity of the equations of the antigen and antigen presenting cells for the two boosters
optimal trajectory. In general, the sensitivity of the whole set of parameters was low. Changes in the
death rate of the APC modifies more considerably this population.
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Figure 5.22: Sensitivity of the equations of the T and B lymphocytes for the two boosters optimal
trajectory. Results were very similar to those described for the case with a single booster. The CD4+
T activation rate was the parameter with the highest sensitivity.
The memory cell generation rate presented a high sensitivity with an accumulated value about 104 for
the Bm population. This behavior was observed in all sensitivity analyses and it mainly reflects the
effect of the first immunization. Finally, the the IgY production rate (φ), showed the greatest sensitiv-
ity of all model parameters in the optimal trajectory. However, it is important to emphasize that this
parameter modifies the concentration peak but it maintains the response shape.
The tests described above showed that the normalized integral of the sensitivity function was smaller
for all model’s populations compared to the values calculated for the secondary response trajectory. This
results suggest that including more inoculations do not increase the model sensitivity.
In the analysis of the effect of parameter variations on the optimal day for applying a single booster, it
was determined that memory cell generation rate (γm) was the parameter that modifies more drastically
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Figure 5.23: Sensitivity of the equations of the memory cells and immunoglobulins for the two boosters
optimal trajectory. Changes in the IgY production rate generate the greatest variations on the model’s
response.
the result. In order to characterize the effect of varying this parameter on the total IgY concentration
yield, the optimization problem was solved using 70% and 130% of the estimated value of this rate.
Figure 5.24 shows the level contours when the lowest value was utilized. It is clearly observed that
maximum levels were displaced from the center found in the nominal case. Since this reduction in the
parameter value implies a larger time for reaching the carrying capacity of the Bm population, it is
reasonable to infer that a delay in the optimal days was suggested. For the second case, γm equal
to 130% of the nominal value, the results showed that the center was moved to the left (less time to
apply the boosters) only a couple of days. The graph that descibes this result is very similar to the one
presented for the first case and it is not included here. It is important to remark that in the case of a
single booster the same behavior was observed.
All sensitivity analyses performed in this project showed that, independently of the chosen trajectory,
the most sensitive parameter of the model was the IgY production rate (φ). In the following test, the
optimal timetable was determined for the model tuned with parameters of the second group, except
for φ which was given values of 50% and 150% of its nominal value. Figure 5.25 illustrates the level
contours for the 100 solutions obtained with the GA. Even though the peak concentration droped
(approximately to 50%), the region for the optimal inoculation was practically the same. Antigen doses
should be administered between days 22 and 35 for the first booster and between 34 and 50 for the
second one. The results of changing this rate to 150% were very similar to those described here, except
for the maximum antibody concentration reached.
Table 5.1 summarizes the optimal days calculated for all scenarios discussed in this section. Prob-
ably the most significant feature observed in these solutions was that the day determined for the first
booster coincides with that found in the analysis of a single booster, day 29. Only when the memory
cell generation rate was modified, the selected day for the first booster was also changed (twelve day
delay). However, it is important to emphasize that in this condition the model response does not rep-
resent adequately the experimental measurements. If the results obtained by using a value for γm very
different of the nominal value were not taken into account, the optimal days for the second booster
were obtained between days 41 and 45. This interval was consistent with the regions determined by
the genetic algorithm in the nominal case and suggest an option to design the inoculation timetables
despite uncertainties in some parameters.
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Figure 5.24: Level contours of the genetic algorithm for selecting two boosters using the model tuned
with measurements of the 50µg. In this condition the value of γm was reduced to 70%. The results
suggest that the first booster should be delayed due to the greater time required to develop the memory
cell population. Notice that, the center of the figure was displaced to a greater day compared to the
nominal case.
Group Parameters First immunization Booster
50µg Nominal 29 41
500µg Nominal 29 45
50µg γm at 70% 41 53
50µg γm at 130% 27 41
50µg φ at 50% 29 43
50µg φ at 150% 29 44
Table 5.1: Summary of the selected days for applying two boosters in order to maximize the antibody
production. The results of varying the two parameters with the highest sensitivity are presented.
5.4 Mid-term production using four boosters
The methodology described in this chapter can be used to determine the optimal booster combination
that maximizes the total IgY concentration using any finite number of inoculations. In this section,
a final example using four boosters was analyzed. The time horizon was established in five months
(150 days) and the model was tuned with the parameters of the 50µg group. An empirical schedule
might consist on applying antigen doses distributed along the five months i.e., the inoculations would
be administered at days 11, 39, 69, 99 and 129. On the other hand, with the approach based on GA
the selected days were: 30, 48, 67 and 82.
The contrast between the responses applying the empirical scheme (blue curve) and the solution
obtained by the GA (black curve) is presented in figure 5.26. The result obtained with the algorithm
suggests that it is possible to reach a higher production in less time. The area under the curve index
can be used again to quantify the performance of each timetable. For the empirical schedule the AUC
was 205.57, whereas for the optimized timetable was 236.88. This difference represents an increase of
15% in total IgY yield. Notice that, the day determined for the first booster coincided with the previous
results.
Probably, a more interesting feature about the optimal response was that it ends much earlier than
the response generated by the empirical scheme. Figure 5.27 illustrates the timetables performance, if
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Figure 5.25: Level contours of the genetic algorithm for selecting two boosters using the model tuned
with measurements of the 50µg. In this condition the value of φ was reduced to 50%. Even though the
peak concentration was lower than the obtained for the nominla case, the region for optimal inoculation
was practically the same.
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Figure 5.26: Responses of the model tuned with the measurements of the 50µg group applying four
boosters. The blue line corresponds to the empirical schedule, while the black one represents the
optimal immunization timetable. Theoretically, it is possible to achieve an increase of 15% in the
antibody production using the optimized timetable.
only the first three months are taken into account. For the optimal timetable the four boosters were
administered, while only two have been applied for the empirical case. In addition, the area under the
curve for each scenario was drastically different; 93.60 for the empirical against 209.59 for the optimal.
The latter production was even bigger than the total yield for monthly immunizations. On the other
hand, the difference between five and three months of IgY the production was about 13%, but the three
month solution implies lower costs of bird feeding and keeping.
In the following test, the total IgY production was quantified applying four boosters on the same
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Figure 5.27: Responses of the model tuned with the measurements of the 50µg group applying four
boosters. Only the performance for 90 days was illustrated. In this case, the total IgY production of
the optimal schedule doubled the empirical one.
days defined above (30, 48, 67 and 82) to the model tuned with the parameters of the 500µg group.
Figure 5.28 shows the performance of the IgY concentration in the first 90 days. Even though the
parameter values used in this simulation did not correspond to the estimated ones of this experimental
group and the timetable was not designed specifically for this case, the increase in the total IgY yield was
noticeable. Using the AUC performance index, it was determined that the empirical schedule produced
91.50, while the optimized timetable generated 204.16. This result suggests that even for the case when
the timetable was not obtained for the model tuned with the specific parameters (but similar ones),
an increase in the total production can be achieved. Notice that, the improvement in the antibody
production is obtained due to a reduction in the time required between consecutive boosters.
The estimation results using the measurements of bird 205 were presented in the chapter four.
There, it was commented that the algorithm converged to points that significantly differed from the
initial guesses and the other estimates. In order to assess the performance of the optimal timetable,
the model tuned with the parameters of bird 205 was simulated. Once again, boosters were applied at
the same times and the total IgY production was quantified using the AUC index. Figure 5.29 shows
the responses obtained with the empirical and optimized timetables. Since the value of the memory cell
generation rate was lower for this case, the first booster was applied and a secondary response was not
produced. The results of area under the curve for responses generated with this parameter set were:
470.32 and 442.64 for the empirical and optimal schedules, respectively. It is clear that the second
immunization did not contribute to increase the total IgY production. On the contrary, the second
inoculation is a waste of antigen. However, it is important to remember that parameters obtained for
the measurements of the bird 205 were significantly different from the other estimates. Consequently,
if estimated parameters significantly differ from the initial guesses or the group estimates, predicted
responses could produce delayed secondary responses that not correspond to the actual behavior.
Even though the optimal timetable did not offer a production advantage compared to the empirical
schedule when the five months of the experiment are taken into account, the total IgY concentration
for both schemes in 90 days are very different; see figure 5.30. The AUC of the response applying
boosters on days 39 and 69 was 207.33, whereas for the selected days (30, 48, 67 and 82) was 408.74.
Consequently, a timetable that suggests the boosters application sufficiently closer (but that produce
different responses), could significantly increase the total IgY production, even if there is some variation
on the parameter values.
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Figure 5.28: Responses of the model tuned with the measurements of the 500µg group applying four
boosters. Days selected for this simulation were the same determined for the second experimental group.
Only the first 90 days are presented in the figure. Even though the timetable was designed for slightly
different parameter values, an improvement in the IgY production was achieved.
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Figure 5.29: Responses of the model tuned with the parameters of the bird 205 applying four boosters.
Since the time required for developing the immunological memory is greater for this case, the first
booster do not produce a secondary response and the total production is lower than that obtained with
the empirical timetable.
5.5 Experimental evaluation of the optimal day for one booster
In order to verify whether predictions obtained with the model would coincide with the behavior of
the immune system, a second experiment in vivo was carried out. In this assay, a group of hens was
inoculated following the optimal schedule determined for the case of one booster. Results described in
the second section of this chapter showed that a secondary response could be obtained if immunizations
were applied on days 11th and 28th. However, sensitivity and total production analyses suggested
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Figure 5.30: Responses of the model tuned with the parameters of the bird 205 applying four boosters.
Only the response for the first 90 days was represented. The application of closer boosters may generate
an advantage in the IgY production.
slight variations about the day of booster administration. Therefore, it was decided to wait one day
and immunize birds on days 11th and 29th. The same antigen concentrations (50µg and 25µg for
booster) utilized for the second experimental group were applied here. In this experiment, only the IgY
concentration in yolk was measured.
Eight hens organized in two groups (fourth and fifth) were used in this test:
4. Control (birds number: 204, 212, 213 and 217).
5. Birds immunized with 50µg of Leishmania infantum proteinic extract (birds number: 201, 208,
211 and 225).
The model predicted that a secondary response should be obtained, if the booster was applied
eighteen days after the first inoculation. Figure 5.31 illustrates that the expected response, in fact
occurred. Even though this experiment did not allow to verify the effect of varying the booster day, it did
demonstrate that a shorter inoculation time produces the same response than that obtained immunizing
ten days later (remember that following the empirical schedule, inoculations were administered on days
11th and 39th). This was a very significant result, since the reduction in the time employed for producing
specific IgY implies a reduction in the costs associated with bird keeping. On the other hand, the
measured response corroborated the model capacity of representing the immune system dynamics.
Three out of the four hens of the group showed a well defined secondary response with peak con-
centrations very similar to those registered in the second chapter. Bird 208 halted its laying a couple of
days before the booster, hence there was not a measured response for it. Figure 5.32 shows individual
measurements for the control group. Once again, these data corroborated the measurement technique.
The area under the curve index permitted to quantify the total specific IgY production per bird
using the optimal schedule. Table 5.2 summarizes the results for each bird and the average of the
control group. For comparison purposes the values calculated for the second and third experimental
groups (presented in the third chapter) were also included. Notice that, the highest productions were
obtained with the optimal schedule. Even though variations on the preimmune levels affect the total
value registered, it is clear that the total concentration is higher than that produced using the empirical
timetable.
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(a) 201
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(b) 211
0 10 20 30 40 50 60 70
0
0.2
0.4
0.6
0.8
1
Time [Days]
Ig
Y 
co
nc
en
tra
tio
n 
[m
g/m
l]
(c) 225
Figure 5.31: Yolk antibodies measurement for the bird group inoculated using the optimal timetable.
Group number Measurements Including BL Subtracting BL
2 50µg group 5.5417 2.9417
3 500µg group 8.1163 2.4512
4 Control 1.2763 0.2347
5 201 6.2705 3.3003
5 211 3.9749 1.2826
5 225 9.0122 5.5448
Table 5.2: Area under the curve of yolk antibodies for each experimental group using the empirical and
the optimized timetables
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(a) 204
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Figure 5.32: Yolk antibodies measurement for the control bird group inoculated using the optimal
timetable.
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5.6 Summary
This chapter presented the design of optimal inoculation timetables based on a mathematical model
of the avian immune response and on the use of genetic algorithms and massive simulations. The
methodology for solving the constrained nonlinear binary optimization problem that represents the
selection of inoculation days was also discussed. The purpose of the optimization was to maximize the
total IgY production. This problem was solved for the model tuned with several sets of parameter
values. The performance of the optimized schedules were tested for both experimental groups subject
to one, two and four boosters. In addition, an experimental verification of the model predictions was
discussed.
In the simplest scenario, when a single booster was applied, the day that generates the first secondary
response and the maximum IgY production was determined. This result was obtained using GA and
through massive simulations testing all possible combinations. Additionally, the frequency distribution
of the optima day for administering the booster was characterized for the 5000 parameter estimations
presented in the fourth chapter. For the case of two boosters, the sensitivity of the optimal trajectory
was calculated and the effect of varying some parameter values was assessed. Subsequently, the optimal
timetable, using four boosters, was designed for the model tuned with the parameters of the 50µg
group. The same days selected for this case were simulated for the model with the parameters of the
500µg group and bird 205. This experiment showed that timetable was successful for increasing the IgY
production, even if small variations of parameter values are considered. Finally, an in vivo experiment
using eight hens was performed to corroborate whether the model predictions about the optimal day for
one booster were correct. The results showed that a significant reduction on the time required to apply
a booster can be determined using the proposed model and the optimizing technique. In this way, the
effectiveness of the methodology designed in this thesis was validated.
From the analyses mentioned above some conclusions can be obtained:
• The models tuned with the parameters of the two experimental groups produced very similar
schemes for optimal inoculation days when one or two boosters were applied.
• In the analysis of the effect of varying parameter values on the selection of the optimal day for
inoculating a single booster, the greater changes were produced by KB and γm. The antigen
elimination rate generated slight changes on the days selected. The optimal days differed by no
more than one or two days. The remaining parameters did not significantly modify the optimal
day in this case.
• The frequency of the selected day, for one booster, using the parameter values of 5000 estimations
presented in the chapter four was also determined. As expected, this experiment showed that the
optimal days was found around the nominal one. For the 50 µg group the highest frequency was
obtained at the same day of the nominal case (day 28th) and 27.5% of the optimal days were
between 25th and 28th days. The third experimental group showed a similar pattern, 36% of the
optimal inoculations should be adminsitered in the same interval.
• The methodology employed to solve the constrained nonlinear binary optimization problem that
represents day selection for maximizing antibody production was based on genetic algorithms.
However, it was important to test the algorithm with a set of different random initial solutions
due to the fact that the GA could converge to a local minimum. In all cases, 100 different
populations were utilized in order to characterize the algorithm performance. It seemed that in
all conditions, 100 was enough for obtaining the global minimum.
• The sensitivity for the optimal trajectory using two boosters showed a similar behavior than that
obtained for secondary response (presented in the second chapter). Once again, the IgY production
rate, φ, was the parameter with the highest sensitivity. It was also found that variations on its
value modifies the total protein concentration, but maintains the same day selected for applying
the boosters.
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• A reduction in the value of the memory generation rate implied a significant delay in the days
selected for applying the boosters. On the contrary, when the value of this parameter was increased,
the optimal day remained almost constant.
• Using the solution based on genetic algorithms, a mid-term schedule was designed. This optimal
timetable produced 15% more IgYs than the total concentration obtained with the empirical
schedule. An important feature observed with the four booster simulation was that production of
the optimal schedule was almost the same for 90 or 150 days. This result represents a potential
reduction in the costs associated with bird feeding and keeping.
• Even though the difference among the values of the parameters estimated for each experimental
group and the bird 205, the optimal timetable represented an improvement in the immunoglobulin
production compared to the empirical timetable that applies one booster every month.
• The experimental validation of an optimal timetable was a remarkable result. All analyses sug-
gested that it was possible to obtain a secondary response if a booster was applied eleven days
before the day empirically selected. An experiment with eight hens corroborated that prediction.
In practice, this time reduction could decrease the cost of producing specific avian antibodies.
Additionally, the area under the curve index showed that total IgY yield was comparable, in
some cases even higher, to those obtained for groups and birds inoculated on days 11th and 39th
(empirical schedule).
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Chapter 6
Conclusions and future work
This document presented a methodology designed to optimize specific antibody production in birds
using a dynamical model. A set of six ordinary differential equations described the antigen recognition,
T and B lymphocyte activation, clonal expansion and immunological memory processes. On the other
hand, several experiments were carried out to characterize the kinetics of some molecular and cellular
populations using twelve hens. These data were used to tune the model response throughout parameter
estimation process. In this way, the model was capable of reproducing the experimental behavior
observed for two groups of birds inoculated with two different antigen concentrations. Day selection
for boosters application was defined as a constraint nonlinear binary optimization problem that was
solved using an approach based on genetic algorithms. Using this methodology, optimal timetables were
designed for cases of one, two and four boosters. Lastly, an experimental validation for the case of a
single booster was discussed.
In the mathematical model, the main populations of the humoral response were represented. The
dynamics of the antigen concentration, the antigen presenting cells, T and B active lymphocytes, B
memory cells and immunoglobulins were described. In addition, the model included 28 parameters,
three of which had not biological meaning and they were included only for starting the memory lym-
phocyte population and determine the shape of a saturation function. The initial guesses for this set
of parameters were obtained from avian and mammalian immunology reports or by simulation. With
these initial values, the model adequately represented the primary and secondary responses, the memory
effect and typical times required to observe a humoral response. The effect of varying the parameter
values on changes of the model variables were also analyzed. The normalized integral of the sensitivity
function was calculated and allowed to determine the parameters with higher effect on modifying the
model response.
In the experimental stage of this thesis, the poultry immune response against the proteinic antigen
Leishmania infantum was characterized in terms of the kinetics of lymphocyte populations in plasma
and specific IgYs in peripheral blood and yolk. Birds were organized in three experimental groups
corresponding to inoculations with different antigen concentrations: 0µg (control group), 50µg (second
group) and 500µg (third group) for the first immunization. For all groups, a booster with the half
of dose was applied almost a month later. A remarkable result of these experiments was that the
group immunized with ten times less antigen produced a higher total IgY concentration than the other
group. However, the plasma IgY dynamics for both experimental groups was very similar and the times
required to reach the peaks were the same. On the other hand, B lymphocyte behavior coincided with
the expected kinetics and allowed to define the maximum level reached by this population in peripheral
blood. Nevertheless, these measurements did not refer exclusively to the set of cells that specifically
recognize the inoculated antigen, but the whole set of circulating cells that bore the Bu1 receptor. The
dynamics of the CD4+ T lymphocytes was less consistent with the specific immunological response.
Therefore, these measurements were not used to establish any parameter value.
Measurements of plasma IgY concentration were utilized to estimate some parameter values in order
to fit the model response to the experimental data. Several questions were answered before achieving
this task. The mathematical model includes 28 parameters, while the measurement set was comprised
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only by 21 points. Therefore, it was necessary to select some parameters to make the estimation process
feasible. This process was defined by a least square optimization problem and several algorithms were
used to solve it. In all tests, only the simplex Nelder-Mead algorithm was capable of obtaining a
solution that adjusts the model response to the measurements. Additionally, the effect of varying the
initial guesses of the whole set of model’s parameters on the algorithm convergence was determined.
Results showed that estimates presented a clear trend to the nominal value despite of changes in some
parameter values. Finally, a comparison among estimates showed that the parameter values for both
experimental groups were very similar, whereas the results of the bird 205 were significantly different.
As a consequence, the model tuned with the parameter values of this particular bird generated very
delayed secondary responses.
The last chapter of this thesis presented the methodology proposed to determine those days of booster
application that maximize the IgY production. This decision may be defined as a constraint nonlinear
binary optimization problem. The solution of that problem was obtained using a genetic algorithm,
a heuristic technique inspired on the theory of species evolution. Even though the application of this
approach was limited to a single, two and four boosters in this document, the proposed methodology
can be used to determine any finite number of boosters in an established time horizon. Results for the
cases of one and two boosters were obtained using the model tuned with the parameter values of the
both experimental groups. The optimal days calculated were very similar in all cases. The effect of
varying parameter values on the optimal trajectories was calculated through a sensitivity analysis that
showed the robustness of some solutions. At the end of the chapter, an experimental validation of the
strategy for optimizing antibody production was described. The optimized timetable for the case of a
single booster suggested that a secondary response could be obtained in a shorter period of time than
that assumed in the empirical schedule. This prediction was correct.
The last section of each chapter included its main results. Conclusions drawn through this thesis are
summarized as follows. In the second chapter, the mathematical model was described and the sensitivity
of the parameters was analyzed. Some remarkable results were:
• A dynamical model comprised of six differential equations that adequately describes the behavior
of the adaptive immune system in birds was designed. This model includes presentation, activation,
and memory processes.
• The proposed model effectively represents transitions from primary to secondary response allowing
to study the effect of changing time of booster application.
• Even though the immune response includes delays, it was possible to build a mathematical model
based exclusively on differential equations (without delays) and simple functions as mass action,
sigmoid and Hill functions (saturations).
• The initial proposed parameter value set included experimentally established values, mainly for
mammals (mouse and rat) and some found for poultry. However, to the authors’ knowledge several
parameters have not been measured and it was necessary to determine them through simulation.
• Sensitivity analysis allowed to detect the scarce effect of some parameters such as: cellular pro-
duction rates or carrying capacities. Activation, death and, specially, IgY production rates had
very high sensitivities.
• Results of sensitivity analysis confirmed that arbitrary selection of some parameters does not imply
significant differences on model’s response. Therefore, these values will not produce important
changes in parameter estimation and optimization processes.
In the third chapter, the experimental stage of this project was described. The more significant results
were:
• The most used methodology to measure antibody concentrations is based on titer quantification
using serial dilutions. In this thesis measurements were obtained in terms of net values (mg/ml)
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rather than relative ones (titer). With known net IgY values, parameter estimation process was
facilitated.
• A similar total specific antibody production was obtained for both experimental groups, both
in blood and in yolk. In fact, the group inoculated with the lowest antigen dose yielded 30%
more antibodies than the group injected with 500µg of antigen, after normalization subtracting
preimmune levels.
• As mentioned in published reports, IgY measurements in peripheral blood and yolk are similar
except for a delay. Using average values of humoral response this time was established in three
days for both groups.
• Employing flow cytometry the entire kinetics of the immune response for CD4+ T and B lym-
phocyte concentrations in peripheral blood were characterized. Peaks values corresponding to the
secondary response will be used to adjust some of the initial guesses of the model parameters.
• Data of T and B lymphocyte dynamics confirmed consecutive responses, T cells increased their
number before the B cell concentration increment. This feature was observed in several hens.
However, T lymphocyte measurements were less consistent with the expected response, probably
due to the their lower clonal expansion.
• Values of cellular concentration were delayed with respect to IgY concentration rising, which
suggests that cellular kinetics in peripheral blood are detectable some time after clonal expansion
in germinal centers.
• An unexpected result of these experiments was the outlier presented after secondary response
peak. A sudden fall in IgY concentration was observed between the maximal point and the third
datum after the booster. This behavior was clearly identified in plasma for all hens and in yolk
for some birds.
• In addition to characterization of immunoglobulin and lymphocyte dynamics, an antibody pro-
duction against a Colombian strain of Leishmania infantum was successfully achieved. To the
best of the authors’ knowledge this specific parasite detection tool had not been produced.
Using the antibody measurements some parameter values of the model were estimated. From this stage
some conclusions were drawn:
• The number of parameters included in the estimation process does not determine the success in
fitting the model to the experimental data. There were not significant differences between the
errors calculated for estimations using any number from three to eight parameters.
• Parameters included in the estimation should be carefully selected in order to obtain a successful
fit. The IgY degradation rate (µIg), memory cell generation rate (γm) and the B lymphocyte
carrying capacity (KB), were the most important parameters to fit the model to the immune
response measurements.
• Four optimization algorithms were tested for solving the nonlinear least squares problem. Only
the simplex Nelder-Mead produced a consistent response. The remaining algorithms either did not
converge or produced responses qualitatively different from the experimental humoral response.
• When base lines were subtracted from each group measurements, the parameter estimation process
was also successful. Results showed that estimations differed very little from the values estimated
from the raw data.
• Parameter estimation and optimal timetable assessment (as described in the next chapter) were
implemented with two different computational tools that used two different numerical solvers.
Comparison between the two solving methodologies showed no significant differences.
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• The parameter estimation process for bird 205, the hen with the highest production peak, differed
from the other estimates. The estimated values were very different to those obtained using other
data sets and the algorithm converged to points far from the initial guesses. The B cell dynamics
for this hen showed a concentration peak much higher than that initially assumed. This feature
emphasized the well known fact that it is necessary to propose initial values close to the tuned
ones in order to obtain an effective fit.
• The analysis of the effect of variations in the initial model guesses showed that modifications as
large as 50% produced considerable differences in the estimated values, but with a clear trend to
approach the nominal value. Furthermore, there was not a significant change in the frequencies of
the estimated values when the variation range was widened from 20% to 50%.
• Estimated values found using data for the two experimental groups and bird 219 were similar,
showing differences of about 15%. The memory cell production rate, that chacterizes the transition
from primary to secondary responses, had a maximal difference of 7%. This result suggests a
similar optimal inoculation timetable for all hens when this particular antigen is used. The B
lymphocyte carrying capacity of the secondary response presented the maximal variation (50%);
this result makes sense, since the variation on peak levels among responses were considerable and
the rate of IgY production was fixed. Then, the only option was to modify, also considerably, the
value of this parameter.
Finally, it was presented the methodology to define and solve the optimization problem that repre-
sents the specific antibody production in birds. These are some results of that chapter:
• The models tuned with the parameters of the two experimental groups produced very similar
schemes for optimal inoculation days when one or two boosters were applied.
• In the analysis of the effect of varying parameter values on the selection of the optimal day for
inoculating a single booster, the greater changes were produced by KB and γm. The antigen
elimination rate generated slight changes on the days selected. The optimal days differed by no
more than one or two days. The remaining parameters did not significantly modify the optimal
day in this case.
• The frequency of the selected day, for one booster, using the parameter values of 5000 estimations
presented in the chapter four was also determined. As expected, this experiment showed that the
optimal days was found around the nominal one. For the 50 µg group the highest frequency was
obtained at the same day of the nominal case (day 28th) and 27.5% of the optimal days were
between 25th and 28th days. The third experimental group showed a similar pattern, 36% of the
optimal inoculations should be adminsitered in the same interval.
• The methodology employed to solve the constrained nonlinear binary optimization problem that
represents day selection for maximizing antibody production was based on genetic algorithms.
However, it was important to test the algorithm with a set of different random initial solutions
due to the fact that the GA could converge to a local minimum. In all cases, 100 different
populations were utilized in order to characterize the algorithm performance. It seemed that in
all conditions, 100 was enough for obtaining the global minimum.
• The sensitivity for the optimal trajectory using two boosters showed a similar behavior than that
obtained for secondary response (presented in the second chapter). Once again, the IgY production
rate, φ, was the parameter with the highest sensitivity. It was also found that variations on its
value modifies the total protein concentration, but maintains the same day selected for applying
the boosters.
• A reduction in the value of the memory generation rate implied a significant delay in the days
selected for applying the boosters. On the contrary, when the value of this parameter was increased,
the optimal day remained almost constant.
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• Using the solution based on genetic algorithms, a mid-term schedule was designed. This optimal
timetable produced 15% more IgYs than the total concentration obtained with the empirical
schedule. An important feature observed with the four booster simulation was that production of
the optimal schedule was almost the same for 90 or 150 days. This result represents a potential
reduction in the costs associated with bird feeding and keeping.
• Even though the difference among the values of the parameters estimated for each experimental
group and the bird 205, the optimal timetable represented an improvement in the immunoglobulin
production compared to the empirical timetable that applies one booster every month.
• The experimental validation of an optimal timetable was a remarkable result. All analyses sug-
gested that it was possible to obtain a secondary response if a booster was applied eleven days
before the day empirically selected. An experiment with eight hens corroborated that prediction.
In practice, this time reduction could decrease the cost of producing specific avian antibodies.
Additionally, the area under the curve index showed that total IgY yield was comparable, in
some cases even higher, to those obtained for groups and birds inoculated on days 11th and 39th
(empirical schedule).
6.1 Original contributions
To the authors’ knowledge, some of the results obtained in this thesis represent contributions to the
theoretical immunology and to the avian antibody production. These contributions are enumerated as
follows:
• A mathematical model was designed that adequately represents recognition, activation and im-
munological memory of the humoral avian immune response.
• The avian immune response against a proteinic antigen was characterized in this thesis. This is
the first study that includes a humoral (IgY) and cellular measurements towards the optimization
of the specific antibody production.
• The methodology proposed here for determining the optimal sequence of boosters that maximize
antibody production is not reported in literature. Even though this methodology requires more
research in order to make it a reliable tool, this solution approach offered a systemic vision of the
antibody production and established a way to think about the immunological memory.
• There were not antibodies for the particular strain of the parasite utilized in this study. Specific
antibodies generated against the proteinic extract of Leishmania infantum, will be very useful for
research and can be eventually used for implementing diagnostic tools for viceral leishmaniasis in
Colombia.
In addition, all techniques necessary for producing avian specific antibodies were standardized in this
project. The experiments also suggested that the model can be successfully used in our laboratory. This
was a very significant result of this work, since it was acquired the “know how” of a relatively simple
technology but with a great scientific and economical potential. There is no a specialized company in
Colombia that produces antibodies and the knowledge generated in this project suggests the possibility
of evaluating the economic feasibility of that type of business. It is important to remember that import
costs of some specific antibodies are huge and therefore an industry like that in the country could
represent an interesting option for developing diagnostic tools for local needs.
6.2 Future work
The methodology proposed in this thesis uses a model based on ordinary differential equations for
representing the dynamics of the avian immune system. This approach allowed to perform the parameter
estimation process and to define the optimization problem of booster day selection. However, other
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modeling options may enrich the knowledge about the problem of optimizing the antibody production.
For instance, models based on stochastic equations, agents or fuzzy techniques could be explored.
Measurements of immunoglobulin concentration in peripheral blood were employed to estimate some
parameter values. This type of measurements were chosen, since the model included IgY in plasma as a
variable and the set of data points in yolk was smaller than that obtained in blood. However, performing
the whole set of experiments described in thesis for each antigen may be expensive and impractical.
Therefore, the feasibility of estimating parameter values from the measurements in yolk would allow to
reduce the time and costs involved in applying the proposed methodology.
In the chapter four, the results of utilizing several algorithms for solving the optimization problem
that defined the parameter estimation process were presented. Nevertheless, for all cases a least squares
problem was used as objective function. Different approaches should be considered to perform the
parameter estimation, such as techniques based on Bayesian methods.
The strongest assumption used in this thesis was that memory lymphocyte population grew pro-
portionally to the primary response occurrence and maintained its maximum concentration constant.
A more complete description of the transition from primary to secondary response would improve the
model and produce more reliable results. A set of experiments for measuring the secondary response
intensity as a function of the time in which a booster is applied could verify the expected behavior.
Some of the immunized birds presented an outlier in the secondary response that is not reported in
literature. Other experimental assays may characterize the phenomenon and establish its occurrence
depending on the antigen used, concentration inoculated, route of delivery, etc.
The optimal inoculation scheme for the case of four boosters theoretically showed that a specific
pattern of immunization was capable of producing more protein in a short time. An experimental
verification of this timetable, using the same poultry breed and antigen described in this work, would
considerably strengthen the approach developed in this thesis.
For the case of two boosters, it was found that there is a set of combinations that produce a very
similar total IgY concentration. It would be possible to define a multi-objective optimization problem
that maximizes the antibody production as well as minimizes the total time required or that take into
account the laying cycles.
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